World Allergy Congress

New Horizons Session 1: Specific Immunotherapy (SIT): History, Mechanisms and Future - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: Richard F. Lockey (US) and Dermot Ryan (United Kingdom)

08:00 - 08:10

Welcoming Remarks

08:10 - 08:30

1-1NH: History of SIT

08:30 - 08:50

1-2NH: Mechanisms of Sub-Cutaneous Immunotherapy (SCIT) | Stephen Durham (United Kingdom)

08:50 - 09:10

1-3NH: Mechanisms of Sub-Lingual Immunotherapy (SLIT) | Jean-Pierre Allam (Germany)

09:10 - 09:30

1-4NH: Newer Forms of SIT | Rudolf Valenta (Austria)

New Horizons Session 1: Specific Immunotherapy (SIT): Which Patients for SIT and Anti-IgE? - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: Richard F. Lockey (US) and Barbara Rogala (Poland)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

1-5NH: For SCIT? | Harold Nelson (US)

10:30 - 10:55

1-6NH: For SLIT? | Giorgio Walter Canonica (Italy)

10:55 - 11:20

1-7NH: For Anti-IgE? | Daniel Jackson (US)

11:20 - 11:35

1-8NH: Presentation of the WAO Henning Løwenstein Research Award to Zoulfia Allakhverdi (Canada) and Natalija Novak (Germany)

11:35 - 11:45

Discussion

New Horizons Session 1: Specific Immunotherapy (SIT): Effectiveness of SIT - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: Eliana Risquez (Venezuela) , Anthony Frew (United Kingdom) and Carlo Tomino (Italy)

13:00 - 13:05

Welcoming Remarks

13:05 - 13:30

1-9NH: SLIT | Giovanni Passalacqua (Italy)

13:30 - 13:55

1-10NH: SIT and Children | Erkka Valovirta (Finland)

13:55 - 14:20

1-11NH: SIT and Asthma | Moises Calderon

14:20 - 14:30

Discussion

New Horizons Session 1: Specific Immunotherapy (SIT): Practical Considerations for SIT - This session is co-sponsored by ALK-Abello & MSD

Gran Cancún (Cancún Center)

Chairpersons: John Kelso (US) and Désirée Larenas Linnemann (Mexico)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:30

1-12NH: When Should SIT be Started and Why? | Lars Jacobsen (Denmark)

15:30 - 15:55

1-13NH: Adverse Effects | Linda Cox (US)

15:55 - 16:20

1-14NH: Cost Effectiveness and Compliance | Cheryl Hankin (US)

16:20 - 16:30

Discussion

World Allergy Training School 1764: World Allergy Training School

Coral Garden 1 (Fiesta Americana)

08:00 - 08:15

: Welcome and Objectives of the Course | Myron Zitt (US)

08:15 - 08:45

: Basic Mechanisms of Allergic Diseases | Michael A. Kaliner (US)

08:45 - 09:15

: Allergic Rhinitis: Pathophysiology, Diagnosis and Management | Ruby Pawankar (Japan)

09:15 - 10:00

: Skin Testing Workshop | Sandra González-Díaz (Mexico)

10:00 - 10:15

Coffee Break

10:15 - 10:45

: Asthma: Pathophysiology, Diagnosis and Management | Sandra González-Díaz (Mexico)

10:45 - 11:30

: Spirometry Workshop | Myron Zitt (US)

11:30 - 13:00

Luncheon

13:00 - 13:30

: Immunotherapy | Carlos E. Baena-Cagnani (Argentina)

13:30 - 14:00

: Anaphylaxis: Pathophysiology, Diagnosis and Management | Myron Zitt (US)

14:00 - 14:30

Coffee Break

14:30 - 15:00

: Not ever Food “Allergy” is Allergy | Sami Bahna (US)

15:00 - 15:30

: Asthma and Co-morbid Conditions | Nelson Rosario (Brazil)

New Horizons Session 2: Skin Diseases: Session 1 - This session is co-sponsored by Novartis

Cozumel (Cancún Center)

Chairpersons: María Isabel Rojo Gutiérrez and Marcus Maurer (Germany)

08:00 - 08:05

Welcoming Remarks

08:05 - 08:25

2-1NH: Allergic Skin Disease: Immunologic Consequences of Playing Host to Pathogenic Microbes | Mark Boguniewicz (US)

08:25 - 08:45

2-2NH: Itch: The Primary “Lesion” in Eczema | Johannes Ring (Germany)

08:45 - 09:05

2-3NH: Urticaria and Angioedema | Torsten Zuberbier (Germany)

09:05 - 09:25

2-4NH: Cutaneous Vasculitis | Roger Fox (US)

09:25 - 09:30

Discussion

New Horizons Session 2: Skin Diseases: Session 2 - This session is co-sponsored by Novartis

Cozumel (Cancún Center)

Chairpersons: Allen P. Kaplan (US) and David Fitzhugh (US)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:25

2-5NH: Hereditary Angioedema (HAE) | Bruce Zuraw (US)

10:25 - 10:45

2-6NH: Atopic Dermatitis | Prof. Dr. Peter Schmid-Grendelmeier (Switzerland)

10:45 - 11:05

2-7NH: Contact Dermatitis | Luz Fonacier (US)

11:05 - 11:25

2-8NH: Anti-IgE Therapy in Allergic Skin Diseases | Marcus Maurer (Germany)

11:25 - 11:30

Discussion

New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 1

Costa Maya (Cancún Center)

Chairpersons: Hae-Sim Park (South Korea) and Peter Creticos (US)

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

3-1NH: Unique Immunotherapy Approaches | Enrique Fernandez-Caldas (Spain)

08:30 - 08:55

3-2NH: Nanomedicine: Introduction and Overview | James Baker (US)

08:55 - 09:20

3-3NH: Genetics and Genomics Overview: Beyond Genome-Wide Association Studies (GWAS) | Deborah Meyers (US)

09:20 - 09:30

Discussion

New Horizons Session 3: Novel Scientific Approaches in Allergic and Respiratory Diseases: Session 2

Costa Maya (Cancún Center)

Chairpersons: Susan L. Prescott (Australia) and Kari Nadeau (US)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

3-4NH: Systems Biology Applications for Allergy and Asthma | Lanny Rosenwasser (US)

10:30 - 10:55

3-5NH: Nanomedicine Applications for Allergy and Vaccines | Shyam Mohapatra (US)

10:55 - 11:20

3-6NH: Genetics and Genomics for Severe Asthma and COPD | Stephen P. Peters (US)

11:20 - 11:30

Discussion

Poster Symposium 1: Allied Health

Coral Gallery 3 (Fiesta Americana)

Chairpersons: Connie Katelaris (Australia) , Dennis Ledford (US) and Birthe Dahl (Denmark)

12:30 - 13:15

Poster Viewing

13:15 - 00:00

1000: Reduction In Allergic Rhinitis Index by Decreasing Aero-Allergens and Malodor Causing Volatile Organic Compounds by Luna Air Purifiers Using Photo-Catalytic Oxidation (PCO) Technology | Nabarun Ghosh (US)

13:15 - 00:00

1001: The Missing Link!! Specialist Nurse-Led Education for Parents of Children with Atopic Eczema | Deryn Thompson (Australia)

13:15 - 00:00

1002: Sublingual Immunotherapy for Grass Pollen Allergy In Children: A Systematic Review and Meta-Analysis | Rebecca Bryson (United Kingdom)

13:15 - 00:00

1003: Effect of EPA-DHA Supplementation on Forced Expiratory Volume in One Second (FEV1) and Triglycerides in Obese Adolescents with Hypertriglyceridemia | Nancy Mendez Berreondo (Mexico)

13:15 - 00:00

1004: A Pilot Study of Caregiver's Recall of Their Child's Skin Test Results and Environmental Remediation Education | Kristen Townsend (US)

13:15 - 00:00

1005: Evaluation and Comparison of Lung Function by Plethysmography In Adolescents with Morbid Obesity, Not Morbid Obesity and Healthy Eutrophic Children | Luis Octavio Hernandez-Mondragon (Mexico)

13:15 - 00:00

1006: Delivering An Educational Model for Allergy Immunotherapy | Claire Murphy (US)

13:15 - 00:00

1007: Selecting Primal Therapy Appropriate for the Type of Pollinosis – TOPIC-J Study | Kimihiro Okubo (Japan)

13:15 - 00:00

1008: Olfactory Disfunctions in Patients with Chronic Rhinosinusitis | María Victoria Sánchez Vallecillo (Argentina)

13:15 - 00:00

1009: Perceptions of Caregivers of Patients with Cow's Milk Allergy Regarding the Treatment Antônio Carlos Pastorino (Brazil)

13:15 - 00:00

1010: Incidence of Systemic Reactions (SRs) to Prick (P) and Intradermal (ID) Tests, Response to Immediate (“Stat”) Epinephrine IM (epi IM) Dose Vs. BMI, Number of Delayed SRs, and WAO Systemic Reaction Grade | Dona Shearer (US)

13:15 - 00:00

1011: The “Allergy Blog” and Laypersons Questions: An Interactive Educational Experience | Jose Luiz Rios (Brazil)

13:15 - 00:00

1012: Anaphylaxis After Anesthetic Reversal | Sendy Chugo (Spain)

13:15 - 00:00

1013: Establishment of Reference Values for Differential Cell Counts in Nasal Lavage of Healthy Young Adults Jing Li (China)

New Horizons Session 4: Drug Allergy: New Insights in Drug Hypersensitivity

Cozumel (Cancún Center)

Chairpersons: Luis Felipe Chiaverini Ensina (Brazil) and Nelson Rosario (Brazil)

13:00 - 13:05

Welcoming Remarks

13:05 - 13:30

4-1NH: Immunogenetics of Severe Drug Hypersensitivity | Daniel Yerly (Switzerland)

13:30 - 13:55

4-2NH: Virus Infections and Drug Hypersensitivity | Barbara Daubner (Switzerland)

13:55 - 14:20

4-3NH: In-Vitro Diagnosis of Drug Allergy: Current Status and Perspectives | Thomas Fleisher (US)

14:20 - 14:30

Discussion

New Horizons Session 4: Drug Allergy: Management of Drug Hypersensitivity

Cozumel (Cancún Center)

Chairpersons: Roger Fox (US) and Barbara Daubner (Switzerland)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:30

4-4NH: Beta-Lactam Allergy Diagnosis and Management | Louis Mendelson (US)

15:30 - 15:55

4-5NH: Intra-Operative Reactions | Pascal Demoly (France)

15:55 - 16:20

4-6NH: Adverse Reactions to Biologics | Thomas Platts-Mills (US)

16:20 - 16:30

Discussion

New Horizons Session 5: Asthma and Co-Morbid Conditions: Session 1

Costa Maya (Cancún Center)

Chairpersons: Alejandra Macías-Weinmann and Mario Zernotti (Argentina)

13:00 - 13:05

Welcoming Remarks

13:05 - 13:30

5-1NH: Overview of Co-Morbid Conditions | Richard F. Lockey (US)

13:30 - 13:55

5-2NH: Polyposis | Marek L Kowalski (Poland)

13:55 - 14:20

5-3NH: Rhinosinusitis | Ruby Pawankar (Japan)

14:20 - 14:30

Discussion

New Horizons Session 5: Asthma and Co-Morbid Conditions: Session 2

Costa Maya (Cancún Center)

Chairpersons: Richard Martin (US) and Marek L Kowalski (Poland)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:30

5-4NH: Vitamin D, Obesity and Asthma | Juan Carlos Celedon (US)

15:30 - 15:55

5-5NH: Gastroesophageal Reflux Disease (GERD) or Laryngopharyngeal Reflux | Dennis Ledford (US)

15:55 - 16:20

5-6NH: Vocal Cord Dysfunction | Mario Zernotti (Argentina)

16:20 - 16:30

Discussion

Breakfast Symposium 1: Food Allergy and Anaphylaxis

Coral Gallery 1 (Fiesta Americana)

Speaker(s): A. Wesley Burks (US) , Alessandro Fiocchi (Italy)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 2: Clinical Process to Properly Prescribe Immunotherapy

Coral Gallery 2 (Fiesta Americana)

Speaker(s): Désirée Larenas Linnemann (Mexico) , Noel Rodriguez-Perez (Mexico)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 3: Neonatal Infant Interventions to Prevent Asthma and Allergic Disease

Coral Gallery 3 (Fiesta Americana)

Speaker(s): Susan L. Prescott (Australia) , Hugo P. Van Bever Sr. (Singapore)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 4: Biology of Aeroallergens in Latin America

Coral Island (Fiesta Americana)

Speaker(s): Luis Caraballo (Colombia) , Alfonso Cepeda (Colombia)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 5: Management of COPD

Coral Sea (Fiesta Americana)

Speaker(s): Nicola Hanania MD, (US) , Marc Peters-Golden (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 6: Kuwait Society of Allergy and Clinical Immunology Sister Society Session: Omalizumab (Anti-IgE) for Asthma

Coral Kingdom 1 (Fiesta Americana)

Speaker(s): Mona Al-Ahmad (Kuwait) , Michael S. Blaiss (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 7: Flushing Syndromes

Coral Kingdom 2 (Fiesta Americana)

Speaker(s): Cem Akin (US) , Allen P. Kaplan (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 8: What to Do with a Patient that Cannot Smell?

Coral Kingdom 3 (Fiesta Americana)

Speaker(s): Mark Dykewicz, MD (US) , Joaquim Mullol (Spain)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 9: Case Discussion on Patients with Possible Immune Deficiencies

Coral Garden 1 (Fiesta Americana)

Speaker(s): Mark Ballow (US) , John Sleasman (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 10: Differential Diagnosis of Headaches, Including Temporomandibular Joint Disorder (TMJ)

Coral Garden 2 (Fiesta Americana)

Speaker(s): Roger Fox (US) , Lyndon Mansfield (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 11: Inflammasomes and Allergic Diseases

Coral Garden 3 (Fiesta Americana)

Speaker(s): Hal Hoffman (US) , Shyam Mohapatra (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Plenary Session 1: Asthma: From Genetics to Treatment

Gran Cancún (Cancún Center)

Chairpersons: Alberto Escalante Dominguez and James Kiley

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

1-1PS: Identification of Novel Genes | Donata Vercelli (US)

09:00 - 09:25

1-2PS: Subphenotyping Asthma to Uncover Novel Genes | Eugene R. Bleecker (US)

09:25 - 09:50

1-3PS: Personalized Medicine – Is There a Future? | Stephen Liggett (US)

09:50 - 10:00

Discussion

Plenary Session 2: Mastocytosis and Mast Cell Activation Syndromes

Cozumel (Cancún Center)

Chairpersons: Francesca Levi-Schaffer (Israel) and Stephen Galli (US)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

2-1PS: Systemic Mastocytosis | Cem Akin (US)

09:00 - 09:25

2-2PS: Mast Cell Activation Syndromes | Luis Escribano

09:25 - 09:50

2-3PS: Anaphylaxis in Mastocytosis and Hymenoptera Allergy | Mariana Castells (US)

09:50 - 10:00

Discussion

Plenary Session 3: Novel Cytokines in Allergic Diseases

Costa Maya (Cancún Center)

Chairpersons: Andrew Wardlaw (United Kingdom) and Shyam Mohapatra (US)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

3-1PS: Asthma Phenotypes Shaped by Innate and Adaptive Immunity | Dale Umetsu, MD, PhD (US)

09:00 - 09:25

3-2PS: IL-33 | Susumu Nakae (Japan)

09:25 - 09:50

3-3PS: IL-1 and Inflammasomes | Hal Hoffman (US)

09:50 - 10:00

Discussion

Collaborating Partner Symposium 1: American Thoracic Society (ATS) Session: Emerging Issues in COPD

Gran Cancún 5 (Cancún Center)

Chairperson: Monica Kraft

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

1-1CPS: Biomarkers and COPD Phenotypes | Klaus Rabe (Germany)

11:10 - 11:30

1-2CPS: The Microbiome in Asthma and COPD | Richard Martin (US)

11:30 - 11:50

1-3CPS: COPD as a Systemic Disease and its Impact Upon Co-morbidities | Monica Kraft

11:50 - 12:15

Panel Discussion

Sister Society Symposium 1: Japanese Society of Allergology: Update on Atopic Dermatitis

Gran Cancún 1 (Cancún Center)

Chairpersons: Michihiro Hide (Japan) and Mark Boguniewicz (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

1-1SSS: Altered Skin Barrier Functions | Ichiro Katayama (Japan)

11:10 - 11:30

1-2SSS: Role of Dendritic Cells | Natalija Novak, Prof. Dr. (Germany)

11:30 - 11:50

1-3SSS: The Role of Food and Egg Allergy | Atsuo Urisu (Japan)

11:50 - 12:15

Panel Discussion

Symposium 1: Risk Factors for Recurrent Early Wheezing in Childhood

Gran Cancún 2 (Cancún Center)

Chairpersons: Carlos Nunes (Portugal) and Silvia Sanchez-Garcia (Spain)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

1-1SY: Overview | Fernando D. Martinez (US)

11:10 - 11:30

1-2SY: Viral Infections | Robert Lemanske, MD (US)

11:30 - 11:50

1-3SY: Allergens | Dennis Ownby (US)

11:50 - 12:15

Panel Discussion

Company Sponsored Symposium 1: Sanofi-Aventis: Controlling Allergic Rhinitis

Cozumel 2 (Cancún Center)

Chairpersons: José Antonio Sacre Hazouri (Mexico) and Mario Zernotti (Argentina)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

1-1CSS: Managing Rhinitis in Day-to-Day Practice: The International Survey on the Management of Allergic Rhinitis (ISMAR) Registry | Carlos E. Baena-Cagnani (Argentina)

11:10 - 11:30

1-2CSS: Co-morbidities in Children with Allergic Rhinitis | Eli Meltzer (US)

11:30 - 11:50

1-3CSS: Allergic Rhinitis: Evidence Based Medicine | Giorgio Walter Canonica (Italy)

11:50 - 12:15

Panel Discussion

Symposium 2: 2012 WAO International Scientific Conference: Superantigens and Severe Airway Disease

Gran Cancún 3 (Cancún Center)

Chairpersons: Lanny Rosenwasser (US) and Ashok Shah (India)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

2-1SY: New Insights Into Immunologic Mechanisms | Claus Bachert (Belgium)

11:10 - 11:30

2-2SY: Upper Airway | Hae-Sim Park (South Korea)

11:30 - 11:50

2-3SY: Lower Airway | Phillipe Gevaert (Belgium)

11:50 - 12:15

Panel Discussion

Sister Society Symposium 2: American Academy of Allergy, Asthma and Immunology: Eosinophilic Gastrointestinal (GI) Diseases

Cozumel 1 (Cancún Center)

Chairpersons: Dennis Ledford (US) and Mark Ballow (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

2-1SSS: Biology of Eosinophils | Bruce Bochner (US)

11:10 - 11:30

2-2SSS: Pathogenesis | Seema Aceves (US)

11:30 - 11:50

2-3SSS: Diagnosis and Management | Jonathan Spergel (US)

11:50 - 12:15

Panel Discussion

Collaborating Partner Symposium 2: National Institute of Allergy and Infectious Disease (NIAID): Immunological Features of Immunotherapy

Costa Maya 1 (Cancún Center)

Chairpersons: Alkis Togias (US) and Rudolf Valenta (Austria)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

2-1CPS: Immunological Models for Successful Immunotherapy | Cezmi Akdis (Switzerland)

11:10 - 11:30

2-2CPS: How the Immune System Generates Tolerance | Kari Nadeau (US)

11:30 - 11:50

2-3CPS: How Immunology Informs the Design of Immunotherapeutics | Stephen Durham (United Kingdom)

11:50 - 12:15

Panel Discussion

Symposium 3: Genetic Susceptibility to Airway Diseases

Isla Mujeres (Cancún Center)

Chairpersons: Michael Teng (US) and Stephen P. Peters (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

3-1SY: Limitation of Genetic Variants in Asthma Genetics and Advance of Epigenetics | Choon-Sik Park (South Korea)

11:10 - 11:30

3-2SY: Asthma | Donata Vercelli (US)

11:30 - 11:50

3-3SY: COPD | Eugene R. Bleecker (US)

11:50 - 12:15

Panel Discussion

Sister Society Symposium 3: Latin American Society of Allergy, Asthma and Immunology: Hot Topics in Latin America

Tulum (Cancún Center)

Chairpersons: Sandra González-Díaz (Mexico) and Carlos Baez Loyola (Mexico)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

3-1SSS: Air Pollution and Respiratory Disease | Juan Carlos Sisul Alvariza (Paraguay)

11:10 - 11:30

3-2SSS: Frequent Co-morbid Conditions with Asthma | Nelson Rosario (Brazil)

11:30 - 11:50

3-3SSS: Asthma Genotypes to Phenotypes | Carlos E. Baena-Cagnani (Argentina)

11:50 - 12:15

Panel Discussion

Symposium 4: Environmental Aspects of Asthma

Xcaret (Cancún Center)

Chairpersons: Roberto O. Aguila de la Coba (Cuba) and Ulrich Wahn (Germany)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

4-1SY: Asthma in Underserved Populations | Alvaro Cruz (Brazil)

11:10 - 11:30

4-2SY: Inner-City Asthma | Cheryl Hankin (US)

11:30 - 11:50

4-3SY: Rural Asthma | Roy Gerth van Wijk (Netherlands)

11:50 - 12:15

Panel Discussion

Symposium 5: Rhinosinusitis

Costa Maya 2 (Cancún Center)

Chairpersons: Ralph Mösges (Germany) and Lawrence DuBuske (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

5-1SY: Asthma Exacerbations | Marek L Kowalski (Poland)

11:10 - 11:30

5-2SY: Otitis Media | Robert Naclerio (US)

11:30 - 11:50

5-3SY: Management | Michael A. Kaliner (US)

11:50 - 12:15

Panel Discussion

Symposium 6: Obstructive Sleep Apnea (OSA) Syndrome and Allergic Respiratory Diseases

Bacalar (Cancún Center)

Chairpersons: Ivan Chérrez (Ecuador) and Stanley Fineman (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

6-1SY: Upper Airway Diseases | Athanasios Kaditis (Greece)

11:10 - 11:30

6-2SY: Asthma | Fulvio Braido (Italy)

11:30 - 11:50

6-3SY: Management | Timothy J. Craig (US)

11:50 - 12:15

Panel Discussion

Debates 1: Urticaria: Is There a Role for Sedating Antihistamines and Steroids?

Gran Cancún 4 (Cancún Center)

Chairperson: Michael S. Blaiss (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

1-1DB: Yes | Allen P. Kaplan (US)

11:05 - 11:20

1-2DB: No | Torsten Zuberbier (Germany)

11:20 - 11:25

Yes Rebuttal

11:25 - 11:30

No Rebuttal

11:30 - 11:45

Discussion

Sister Society Symposium 4: Brazilian Society of Allergy and Immunopathology: Debate: Allergy and Breast Feeding

Auditorium (Cancún Center)

Chairpersons: Joao Negreiros Tebyrica (Brazil) and A. Wesley Burks (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

4-1SSS: Pro | Renata R. Cocco

11:05 - 11:20

4-2SSS: Con | Hugo P. Van Bever Sr. (Singapore)

11:20 - 11:25

Pro Rebuttal

11:25 - 11:30

Con Rebuttal

11:30 - 11:45

Discussion

Poster Session 1: Asthma and Co-Morbid Conditions

Poster Hall (Cancún Center)

2000

Screening for Allergic Bronchopulmonary Aspergillosis in Patients with Aspergillus + Asthma From 2000-2010 | Paul Greenberger (US)

2001

Sleep-Disordered Breathing in Obese and Eutrophic Adolescents, Asthmatics and Not Asthmatics, in the Hospital Infantil of Mexico Federico Gómez | Alexander Morales (Mexico)

2002

Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-Sectional Studies James Baraniuk (US)

2003

Proteomics of Induced Sputum in COPD, Healthy Smokers and Chronic Bronchitis James Baraniuk (US)

2004

Incidence of Allergy In Patients with Benign Lesions of the Vocal Cords: Preliminary Report Ustun Osma (Turkey)

2005

Echocardiographic Findings In Obese Adolescents with and without Asthma | Lizette Montejano-Elías (Mexico)

2006

Asthma Prevalence and Body Mass Index in Children | Olf Herbarth (Germany)

2007

Evaluation and Comparison of Lung Volumes and Capacities In A Group of Morbid Obese, Obese and Eutrophic Adolescents | Jeannette Mendiola Marin (Mexico)

2008

Difficult-to-Treat Asthma with Idiopathic Chronic Eosinophilic Pneumonia | Norbert Pauk (Czech Republic)

2009

Diagnosis and Management of Post-Radiation Pneumonitis In Patients with Asthma Kostas N. Syrigos (Greece)

2010

Pathogenesis of Radiation-Induced Pneumonitis In Patients with Chronic Obstructive Pulmonary Disease Ekaterini Syrigou (Greece)

2011

Medication Responses in Chronic Fatigue Syndrome (CFS) and Non-CFS Subjects James Baraniuk (US)

2012

Psychogenic Intractable Sneezing. Case Report Karla Mejia (Mexico)

2013

Clinical Investigation of Cough Associated with or without Cough-Variant Asthma or Bronchial Asthma In the Outpatient Cases Including Pertussis, Chlamydophilia Pneumoniae Bronchitis, and Mycoplasma Pneumoniae Bronchitis | Hirokazu Nakajima (Japan)

2014

GERD Screening by the Use of F-Scale and Allergy Screening for Diagnosis and Treatment of Chronic Cough | Ryuichi Nishihira (Japan)

2015

Diagnosis of Gastroesophageal Reflux Disease in Patients with Chronic Cough | Rosana Camara Agondi (Brazil)

2016

Botox Injections in Larynx As a Treatment for Vocal Cord Dysfunction | Juan Esteban Perez (US)

2017

The Importance of Recognizing Vocal Cord Dysfunction in the Presence of Allergy and Asthma | Karine Issa-El-Khoury (Canada)

2018

Myasthenia Gravis and Asthma, Relationship Between Two Different Disorders of the Immune System | Andrea Aida Velasco-Medina (Mexico)

2019

Immunological Characteristics of PATIENTS with Bronchial Asthma and Obesity | Anna Konischeva (Russia)

2020

Association Between Body Mass Index, Asthma Severity and Quality of Life in Allergic Asthmatic Adults | Jose Antonio Olvera-Marquez (Mexico)

Poster Session 2: Pediatric Asthma

Poster Hall (Cancún Center)

2021

Not All Who Wheeze Have Asthma - Tracheal Diverticulum with Stenosiis of Trachea In 9 Years Old Boy | Frantisek Kopriva (Czech Republic)

2022

Reccurent Wheezing in Childhood - Is It Always Asthma? | Andrea Daniela Muti (Romania)

2023

Bronchial Hyperresponsiveness In Children with Suggestive Asthma Symptoms | Silvia Sanchez-Garcia (Spain)

2024

Relationship Between Fractional Exhaled Nitric Oxide (FeNO) and Forced Expiratory Volume in One Second (FEV1) and Forced Vital Capacity (FVC) in Children with Asthma | Myung-Sung Kim (South Korea)

Poster Session 3: Pediatric Asthma Epidemiology

Poster Hall (Cancún Center)

2025

Evaluation of the September Epidemic of Asthma Exacerbation in Children in Our Practice | Agnes Nemeth (Hungary)

2026

Elevated Asthma Prevalence in Mexican-American Children in El Paso TX | Alma Ruiz-Payan (US)

2027

Prevalence of Bronchitis and Revealing of the Risk Factors in the Children's Population | Nino Adamia (Georgia)

2028

Atopic Phenotype In Children Under 6 Years with Persistent Wheezing In El Salvador | Mauricio Flores (El Salvador)

2029

Comparison of Exhaled Nitric Oxide and Spirometry in Hispanic/Latino Children Living in Miami to Those Living in Latin America | Miguel J Lanz (US)

2030

Maximum Expiratory Flow in Health Children From the Metropolitan Area of Monterrey Mexico | Dora Valdes (Mexico)

2031

Sensitization to Mites. Relation with Atopic Diseases In School Children From San Antonio De Los Baños | Alexander Diaz Rodriguez (Cuba)

2032

Clinical and Immunological Findings in Childhood Asthma | Andrea Daniela Muti (Romania)

2033

Prevalence of Bronchial Asthma in Rural Indian Children: A Cross Sectional Study From South India | Animesh Jain (India)

2034

Viral Respiratory Infections and the Development of Atopy and Asthma | Cissy B Kartasasmita CB (Indonesia)

2035

Clinical Characteristics of Eosinophilic Asthma Compared to Noneosinophilic Asthma in Children | Yong Ju Lee (South Korea)

Poster Session 4: Aerobiology

Poster Hall (Cancún Center)

2036

Connections in Health-Web 2.0, Tele-Aerobiology, Through a Global Allergy Database | Dan Dalan (US)

2037

Thunderstorm-Related Asthma in Patients Sensitised to Olea Europaea Pollen: Twenty Emergency Department Visits for Asthmatic Symptoms in One Single Day | Laura Losappio (Italy)

2038

The Revised Edition of Korean Calendar for Allergenic Pollens | Jae-won Oh (South Korea)

2039

Aerobiological Study of Anemophilous Pollens in the City of Toluca, Mexico | Maria Cid del Prado - Izquierdo (Mexico)

2040

Allergenic Significance of Airborne Rhizopus Stolonifer (Ehrenb.) Vuill., a Common Bread Mold | Gaurab Sircar (India)

2041

Aerobiological and Immunological Studies On Coconut Pollen Allergy | Bodhisattwa Saha (India)

2042

Sensitization to Casuarina Equisetifolia and Pinus Spp Pollen In A Group of Mexican Patients | Andrea Aida Velasco-Medina (Mexico)

2043

PATTERNS of Skin Prick Test Positivity In 519 PATIENTS with Allergic Rhinitis and Asthma In Mexico CITY | Karla Paola Ruiz Cervantes (Mexico)

2044

Risk Factors and Their Impact On Development and Severity of Allergic Diseases In the CIS-Region | Tatiana Slavyanskaya (Russia)

2045

Monitoring of AIR-Pollutants Concentration In CHILDREN with ALLERGIC DISEASES | Manana V. Chikhladze (Georgia)

2046

Analysis of An After-Care Questionnaire In Allergic People to Dust Mites Using Anti-Dust Mites Bed Covers | Nabile Boukhettala (France)

2047

Changing Scenario of Airborne Allergens in Bangalore India | Anand Pendakur (India)

Poster Session 5: Mechanisms of Asthma and Allergic Inflammation

Poster Hall (Cancún Center)

2048

Human Mononuclear Phagocytes Are Regulated by A Cross-Talk with Epithelial Cells | Ilja Striz (Czech Republic)

2049

Activation of PAR-2 Induces Myofibroblast Transformation Via a TGF-β and GSK-3β/β-Catenin Dependent Pathway in Tissue Remodeling in the Asthmatic Lung | Tomoko Suzuki (Japan)

2050

Investigating the Role of IL-4 Receptor Alpha Signalling Through CD4⁺ T Cells in Ovalbumin-Induced Allergic Airway Disease | Jaisubash Jayakumar (South Africa)

2051

CD70-CD27 Interaction Regulates Asthmatic Response in a Murine Model of Asthma | Fumihiko Makino (Japan)

2052

Plasminogen Activator Inhibitor-1, Fibrinogen and Lung Function In Adolescents with Asthma and Obesity | Fengyang Huang (Mexico)

2053

Increased Surfactant Protein-D In Young Infants with Bronchiolitis | Hai Lee Chung (South Korea)

2054

Peculiarities of Immune Response In Young Children with Recurrent Wheezing | Olga Gromadina (Russia)

2055

Participation of Invariant NKT Cells (Vα24Jα18) During Asthma Exacerbation in Children | Juan Carlos Carpio-Pedroza (Mexico)

2056

Dexamethasone Can Reverse the Alteration of Airway Epithelial Responses to Rhinovirus Infection by Th2 Cytokines | Min-Suk Yang (South Korea)

2057

Cytokine Profile Characterization in Patients Infected with AH1N1 Influenza Virus Atzin Robles-Contreras (Mexico)

2058

Basal T Cell Subpopulations of Normal Humans Vary by Stress Hormone Receptor Polymorphisms Gailen Marshall (US)

2059

The Protective Effects of Exogenous IGFBP-3 on Allergic Airway Inflammation Through Blockade of VEGF Production | Seung Yong Park (South Korea)

2060

Antioxidants Attenuate Airway Remodeling by Regulating NF-ÊB, Nrf2, and HIF in a Murine Model of Chronic Asthma | Seoung Ju Park (South Korea)

2061

CCL3L1 protein did not affect IL-6 expression, but significantly up-regulated IL-10 expression in the allergic response | Byoung Whui Choi (South Korea)

2062

Caspase-9 Is Involved in CD30 Activation Induced Eosinophil Apoptosis | Jin Tack Kim (South Korea)

2063

Role of NLR (nucleotide oligomerization domain(NOD) – like receptor) on allergic inflammation in a mouse model of allergic rhinitis | Soo Whan Kim (South Korea)

2064

Mutant IL-3: A Common Down Regulator for Components of IgE Mediated Signal Transduction Pathway | Anand Singh (India)

2064A

IL-17 Role in the Regulatory Function of B Cells | Alejandro Vazquez-Tello (Saudi Arabia)

2064B

Role of Th-17 Cytokines in Steroid Insensitivity in Peripheral Blood Mononuclear Cells. Relationship to GR-Alpha and GR-Beta Expression | Alejandro Vazquez-Tello (Saudi Arabia)

Poster Session 6: Allergy to Antimicrobials

Poster Hall (Cancún Center)

2065

Penicillin Allergy Evaluation: Experience From a Drug Allergy Clinic in Kuwait | Mona Al-Ahmad (Kuwait)

2066

Association Between Genetic Polymorphisms of ABCC2 Transporter and the Susceptibility to Maculopapular Eruption Induced by Antituberculosis Drugs | Sang-Hoon Kim (South Korea)

2067

The Real Use of Beta-Lactams After "Penicillin Allergic" Label Removal | Shai Cohen (Israel)

2068

Hypersensitivity to Beta-Lactam Antibiotics Evaluation Using the European Network Drug Allergy (ENDA) Algorithm José Luiz Rios (Brazil)

2069

Clinical Features of Drug Rash with Eosinophilia and Systemic Symptoms Syndrome Caused by Antituberculous Medications | Sang-Ha Kim (South Korea)

Poster Session 7: Drug Allergy 1

Poster Hall (Cancún Center)

2070

Non-Steroidal Anti-Inflammatory Drugs Hypersensitivity: Patterns of Reaction | Luis Felipe Chiaverini Ensina (Brazil)

2071

Epidemiology of Immediate Type Adverse Drug Reactions and Rashes Elicited by NSAID | Tamar Kinaciyan (Austria)

2072

Test In Vitro to Investigate the Cytotoxicity and Cellular Nonspecific Stimulation of Basophils with Indomethacin | Zamir Calamita (Brazil)

2073

Aspirin Desensitization Treatment : A Case Report | Mirta Alvarez (Cuba)

2074

Adverse Drug Reactions to Anti-Asthmatics In Patients with Bronchial Asthma | Cheol-Woo Kim (South Korea)

2075

Presentation of Three Cases of Allergic Reactions to Triptorelin | Maria Cristina Diaz (Argentina)

2076

Adverse Drug Reactions in Hospitalized Patients Pedro Giavina-Bianchi (Brazil)

2077

An Unusual Reaction to Intravenous Iron Sucrose | Michael Balduzzi (US)

2078

Urticaria and Arthralgias In a Nine-Year-Old with Recurrent Urinary Tract Infections | Ahmed Butt (US)

2079

Jessner-Kanoff Lymphocytic Infiltrate As a Side Effect of Immunotherapy | Arzu Didem Yalcin (Turkey)

2080

Improvement of Oral Lichenoid Reaction Symptoms After Removal of Amalgam Restorations: An Anusual Case of Type IV Hypersensitivity Oguzhan Yildiz (Turkey)

2081

Hypersensitivity Reactions to Interferon Based Treatment for Hepatitis C: A Single Center 20-Year Experience | Ioannis Sidiropoulos (Greece)

Poster Session 8: Food Allergy

Poster Hall (Cancún Center)

2082

Effect of Hydrolysis and Polymerization on Bovine Beta-Lactoglobulin Immunoreactivity | Mariana Battaglin Villas-Boas (Brazil)

2083

Immunoreactivity of Polymerized and Digested Beta-Lactoglobulin to IgE From Milk Allergic Patients | Mariana Battaglin Villas-Boas (Brazil)

2084

Identification of Novel Allergens in the Fish Parasite Anisakis Simplex Maaike Dooper (Norway)

2085

Milk Components As a Tool in Predicting Tolerance in Cow's Milk Allergy Ana Paula Beltran Moschione Castro (Brazil)

2086

Uncommon Occupational Allergy to Rice: As a Food Allergen | María Socorro Pérez-Bustamante (Spain)

2087

Frequency of Food Hypersensitivity Mediated by IgG in Patients Received in a Venezuelan Laboratory During 2011 | Cristina Najm (Venezuela)

2088

IgE-Mediated Responses towards Fish Parasite Anisakis, Crab and House Dust Mite in Norwegian Shrimp Allergic Individuals | Maaike Dooper (Norway)

Poster Session 9: Food Allergy: Epidemiology

Poster Hall (Cancún Center)

2089

Patterns of Sensitization to Common Food and Inhalant Allergens and Allergic Symptoms in Preschool Children | Man Yong Han (South Korea)

2090

Food Allergy Prevalence and Symptomatology in Inner City African Americans: A Retrospective Study | Mario Rodenas (US)

2091

PREVALENCE of FOOD Allergy In ADULT PATIENTS of SERVICE Allergy and CLINICAL Immunology – Centro Medico Nacional Siglo XXI - IMSS Mexico DF | Nelva Guillén (Mexico)

2092

Sensitization to Food Allergens in Patients of the Allergy Service of the University Hospital of Monterrey, Mexico | Luis Dominguez (Mexico)

2093

Frequency of Food-Sensitization by Prick-to-Prick Test and Atopy Patch Test In Allergic Children | Jonathan Maya (Mexico)

2094

Increasing Incidence of Food Allergy In Zimbabwe | Elopy Sibanda (Zimbabwe)

2095

Ten Years Follow up of Japanese Survey on Immediate Type Food Allergy | Takanori Imai (Japan)

2096

Association Between Cows Milk Allergy and Gastroesophageal Reflux Disease on Mexican People | Fernando Ramirez Jimenez (Mexico)

2097

An Investigation of Food Choice Behaviour of Food Allergic and Non-Food Allergic Children | Isolde Sommer (United Kingdom)

Poster Session 10: Incidence and Prevalence of Food Allergy

Poster Hall (Cancún Center)

2098

Nationwide Survey of Immediate Type Food Allergy in Japan | Takanori Imai (Japan)

2099

The Prevalence of Food Allergy in Children Under 2 Years in Three Cities in China | Jing Chen (China)

2100

Skin Sensitization to Carmine Before Onset of Systemic Allergy to Ingested Carmine | Yoshinori Katada (Japan)

2101

Milk, the Most Commonly Undeclared Food Allergen Causing Unexpected Allergic Reactions in Sweden Between 2004 and 2011 Ylva Sjogren-Bolin (Sweden)

2102

Cross Sectional Study of 1,822 Pediatric Food Allergy Patients | Takatsugu Komata (Japan)

2103

Surface Plasmon Resonance Imaging: New Tool for Immunodiagnostics of Food Allergy | Oussama Abou Chakra (France)

Poster Session 11: Food Allergy: Gastrointestinal Manifestations

Poster Hall (Cancún Center)

2104

Probiotic Effect of the Regulation of Innate Immune Response, DC and Adaptive Cellular Immune Response and the Balance TH1, TH2, TREG Through Sensors TLR-2 and TLR-4, On the Intestinal Mucosa In Balb/c Health Status and Balb/c Status of Exposure to LPS | Azwin Lubis (Indonesia)

2105

Gluten Induced Systemic Disease (GISD) with Distinct Clinical Phenotype Different From Celiac Disease | Nataliya M. Kushnir (US)

2106

Patterns of Food Allergens in Kenyan Children | Rose Kamenwa (Kenya)

2107

Coincidence of Celiac Disease and Gluten Allergy | Katarzyna Markiewicz (Poland)

2108

Immunoreactivity of ß-Lactoglobulin and Identification of the Peptides Generated After Simulated Orogastrointestinal Digestion Iván López-Expósito (Spain)

Poster Session 12: IgE

Poster Hall (Cancún Center)

2109

Levels of IL-4, INF-γ, Total IgE and IgG4 in Serum of Allergic Children within Areas of Risk of Lead Exposure in Torreon Coahuila, Mexico | Karen Giselle Chavez Villarreal (Mexico)

2110

Relationship of Blood Lead Levels with Total IgE in Teenagers with Environmental Exposure in Torreon Coahuila, Mexico | Rocío Meza-Velazquez (Mexico)

2111

IgE From Birch Pollen Allergic Patients Cross-Reacts with Two Distinct Bet v 1 Related Proteins in Mung Beans: Vig r 1 and Cytokinin-Specific Binding Protein | Eva Guhsl (Austria)

2112

Heterogeneity of the IgE Response to Allergenic Determinants of Cefotiam in Serum Samples From Patients with Cefotiam–Induced Occupational Allergy | Jeong-Eun Kim (South Korea)

2113

Evaluating Total Serum IgE Levels in Patients with Chronic Hepatitis B and C | Sükran Köse (Turkey)

2114

Relationship Between Total Serum IgE, Atopy, and Obesity in Children with or without Family History of Atopic Disease | Budi Setiabudiawan (Indonesia)

2115

The Candidate Peptides in IgE for Allergy Vaccine Design | Gholam Ali Kardar (Iran)

Poster Session 13: Anti-IgE

Poster Hall (Cancún Center)

2116

REFRACTORY CHRONIC Urticaria Treated with Omalizumab | Martinez Saenz (Mexico)

2117

Clinical Experience in Allergic Asthma Patients: Omalizumab with Immunotherapy | Arzu Didem Yalcin (Turkey)

2118

Evaluation of Adverse Events Associated to Administration of Omalizumab | R Maximiliano Gomez (Argentina)

2119

Gender and Different Prevalence in Asthma Treatment with Anti-IgE (omalizumab) | Vincenzo Patella (Italy)

2120

Fetal Loss in Severe Asthma and Posterior Healthy Pregnancy and Birth with the Use of Omalizumab - Case Report | Fábio Kuschnir (Brazil)

2121

Vasculitic Urticaria Treated with Omalizumab. Case Report | María Elena Ramírez Del Pozo (Mexico)

2122

Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report Massimo Triggiani (Italy)

2123

A 4-Year Follow-up in Children with Moderate/Severe Asthma After Withdrawal 1 Year Omalizumab Treatment | Alvaro Teijeiro (Argentina)

2124

Serum Soluble TRAIL Levels In Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment | Arzu Didem Yalcin (Turkey)

2125

Total Antioxidant Capacity, Hydrogen Peroxide, Malondialdehyde and Total Nitric Oxide Concentrations In Patients with Severe Persistent Allergic Asthma: Its Relation to Omalizumab Treatment | Arzu Didem Yalcin (Turkey)

2126

Near-Fatal Asthma Treated with Omalizumab | Elvia Angelica Contreras Contreras (Mexico)

2127

Use of Omalizumab In Chronic Moderate to Severe Persistent Asthma-An Indian Experience | Qamar Ansari (India)

2128

Use of Monoclonal Antibody Omalizumab in the Treatment of Urticaria Chronic | Jorge Vargas Correa (Mexico)

Poster Session 14: Immunotherapy

Poster Hall (Cancún Center)

2129

Allergen Standardisation in Allergens and Allergoids – Challenges and Considerations Alan Bullimore (United Kingdom)

2130

Development of In-House References of House Dust Mite Allergen Vaccines | Arelis Más Quintero (Cuba)

2131

Therapeutic Effect and Safety of Tropical Mite Allergen Vaccines by Subcutaneous Route in Allergic Asthmatics Patients | Raúl Lázaro Castro Almarales (Cuba)

2132

Therapeutic Effect and Security in Asthmatics Adults Patients Treated with Dermatophagoides Pteronyssinus Allergen Sublingual Immunotherapy | José Rodríguez (Cuba)

2133

Safety of Sublingual Immunotherapy with Standardized Vaccines of Domestic Mites | Mirta Alvarez (Cuba)

2134

The Effect of Specific Immunotherapy On the Clinical Response In Patients with Grass-Polen Induced Rhinoconjunctivitis | Zoran Arsovski (Macedonia)

2135

Does Sublingual Immunotherapy Work with an Immune Deviation Mechanism? Francesco Marcucci (Italy)

Poster Session 15: Hymenoptera Allergy

Poster Hall (Cancún Center)

2136

When Honeybees Attack: Adrenal Insufficiency as a Late Consequence of Massive Exposure | David Robinson (US)

2137

Efficacy of Immunotherapy with Allergenic Extract of Aedes Aegypti in the Treatment of Large Local Reaction to Mosquito Bites in Children | Maria Amelia Manrique (Mexico)

2138

Specific Venom IgE Decrease During 5 Years of Venom Immunotherapy (VIT): Clinical Relevance in Stung and Not Stung Patients | Valerio Pravettoni (Italy)

2139

Skeeter Syndrome a Case Report and Literature Review | Diego Garcia-Calderin (Mexico)

2140

Bee Venom Immunotherapy with Standardized Extract, Two Case Comunication and Clinical Progress | Aristoteles Alvarez Cardona (Mexico)

2141

Clinical Case. Bee Venom Anaphylaxis | Adriana Barreto-Sosa (Mexico)

2142

Urticarial Vasculitis AFTER Bee-STING THERAPY | June-Hyuk Lee (South Korea)

Oral Abstract Session 1: Allergen Immunotherapy 1

Gran Cancún 1 (Cancún Center)

Chairpersons: Noel Rodriguez-Perez (Mexico) and Enrico Compalati (Italy)

12:45 - 13:00

2156: Ultra-Rush Specific Immune Therapy with Depigmented and Polymerized Allergen Extracts Is Effective and Safe in Patients with Severe SAR Highly Sensitized Against Pollen Allergens Ulrich Amon (Germany)

13:00 - 13:15

2157: Dose Optimizing Study of A Depigmented Polymerized Allergen Extract of Birch Pollen by Means of Conjunctival Provocation Test | Angelika Sager (Germany)

13:15 - 13:30

2158: Double-Blind Study on The Use of Transfer Factor (TF) Combined With Sublingual Immunotherapy in Management of Patients With Allergic Rhinitis in Mexican Population | María Isabel Rojo Gutiérrez (Mexico)

13:30 - 13:45

2159: The Risk of Severe Treatment Related Adverse Events is Significantly Lower in Children Compared to Adults when Treated With Standardised Timothy Grass Allergy Immunotherapy Tablets: Post Hoc Analysis of 7 Clinical Trials | Jens Strodl Andersen (Denmark)

13:45 - 14:00

2160: Post-treatment, long-term clinical efficacy of a 300 IR sublingual tablet of 5-grass pollen allergen extract in adults with grass pollen-induced allergic rhinoconjunctivitis Michèle Lheritier-Barrand (France)

14:00 - 14:15

2161: Escherichia coli Heat-labile Enterotoxin (LTS61K) Modulates Dendritic Cell Function and Attenuates Airway Inflammation in Mouse Model of Allergic Asthma | Jiu_yao Wang (Taiwan)

Oral Abstract Session 2: Allergen Structure 1

Gran Cancún 2 (Cancún Center)

Chairpersons: Enrique Fernandez-Caldas (Spain) and Oussama Abou Chakra (France)

12:45 - 13:00

2162: Comprehensive Detection of Allergens in Grass Pollen Extracts by Mass Spectrometry | Steffen Augustin (Germany)

13:00 - 13:15

2163: Gene Expression Pattern of Arabidopsis EXPB1, a Non-Allergenic Homologue of Grass Group 1 Pollen Allergens | Prem Bhalla (Australia)

13:15 - 13:30

2164: Comprehensive Expression of Recombinant House Dust Mite Allergens for Component-Resolved Diagnosis | Yoshiharu Watakabe (Japan)

13:30 - 13:45

2165: A Bioinformatic Approach to Allergen Nomenclature Applied to Allergens From the Non-Biting Midge Chironomus Thummi Thummi | Heimo Breiteneder (Austria)

13:45 - 14:00

2166: Pollen Allergens Differ From Non-Allergenic Pollen Proteins by Their Lower Extent of Evolutionary Conservation | Christian Radauer (Austria)

14:00 - 14:15

2167: Sensitization to Betula Verrucosa and Rbet v1 in Spain | Barbara Cases (Spain)

Poster Symposium 2: Asthma Treatment

Bacalar (Cancún Center)

Chairpersons: Michael Schatz (US) and Paul O'Byrne (Canada)

12:45 - 13:30

Poster Viewing

13:30 - 00:00

2143: Reduction in Asthma Deteriorations in Subjects with Persistent Asthma Not Well Controlled on Low-, Medium-, or High-Dose Inhaled Corticosteroids: A Pooled Analysis From Three Clinical Trials Using Combined Mometasone Furoate/Formoterol | Steven Weinstein (US)

13:30 - 00:00

2144: Efficacy Comparison of Mometasone Furoate/Formoterol Versus Fluticasone Propionate/Salmeterol Combination Therapies in Subjects with Persistent Asthma: Noninferiority and Onset-of-Action Findings Hendrik Nolte (US)

13:30 - 00:00

2145: Efficacy and Safety of Two Doses of Mometasone Furoate/Formoterol Combination Treatment in Subjects with Severe Asthma | Steven Weinstein (US)

13:30 - 00:00

2146: Effect of Mometasone Furoate/Formoterol Combination Therapy on Nocturnal Awakenings in Subjects with Persistent Asthma Hendrik Nolte (US)

13:30 - 00:00

2147: Quality of Life Improvements in Persistent Asthma Subjects Receiving Combined Mometasone Furoate and Formoterol Hendrik Nolte (US)

13:30 - 00:00

2148: Efficacy and Safety of Combined Mometasone Furoate/Formoterol 100/10ìg Twice Daily in Subjects with Asthma Inadequately Controlled on Low-Dose Inhaled Corticosteroids | Eli Meltzer (US)

13:30 - 00:00

2149: Prevalence of Swallowing Dysfunction in Severe Asthma: Preliminary Results Adelmir Souza-Machado (Brazil)

13:30 - 00:00

2150: Small Airway Function Is Consistently Improved in Asthma Patients Treated with Mometasone Furoate Delivered by a Dry Powder Inhaler Ariel Teper (US)

13:30 - 00:00

2151: Influence of Montelukast on the State of Eosinophil Activation in Asthmatic Children | Valéria Botan (Brazil)

13:30 - 00:00

2152: The Impact of Administration of Leukotriene Receptor Antagonists, Pranlukast-EK to Infants with Bronchial Asthma | Norifumi Ogawa (Japan)

13:30 - 00:00

2153: Effectiveness of Montelukast In 60 Cuban Patients with Moderate and Severe Asthma and Rhinitis | Mirta Alvarez (Cuba)

13:30 - 00:00

2154: Effect of the Treatment with Montelukast In Asthmatic Patient | Roberto O. Aguila de la Coba (Cuba)

13:30 - 00:00

2155: The Effectiveness of Two Different Methods of Salbutamol Nebulization in Children with Asthma | Andrzej Emeryk (Poland)

Oral Abstract Session 3: Allergic Models of Inflammation

Gran Cancún 3 (Cancún Center)

Chairpersons: Giovanni Melioli (Italy) and Harald Renz (Germany)

12:45 - 13:00

2168: Common and Rare Variation In the T Helper 2 Gene Pathway Predicts Allergic Asthma Phenotypes | Rebecca Slager (US)

13:00 - 13:15

2169: Role of Myeloid Derived Suppressor Cells in Asthma Srinivas Nagaraj (US)

13:15 - 13:30

2170: Mir-150 Suppresses Lung Inflammation In A Mouse Model of Experimental Asthma | Jia-Wang Wang (US)

13:30 - 13:45

2171: Serine Protease Inhibitor Attenuates OVA Induced Inflammation In Mouse Model of Allergic Airway Disease | Sanjay Saw (India)

13:45 - 14:00

2172: Potential Role of Scavenger Receptors in Human Mast Cell Cytokine Response to Oxidized LDL Francesca Levi-Schaffer (Israel)

Oral Abstract Session 4: Allergic Rhinitis

Gran Cancún 4 (Cancún Center)

Chairpersons: Mark Dykewicz, MD (US) and Yeong Ho Rha (South Korea)

12:45 - 13:00

2173: Allergic Rhinitis to Ragweed Pollen | Ioana Corina Bocsan (Romania)

13:00 - 13:15

2174: Ragweed Allergy – What Role Does It Play in Bavaria? | Mareike McIntyre (Germany)

13:15 - 13:30

2175: Nasal Nitric Oxide and Nasal Polyposis As Determinants of Asthma Control | Enrico Heffler (Italy)

13:30 - 13:45

2176: Peak Nasal Inspiratory Flow Levels In Children with Allergic Rhinitis and Their Health Related Quality of Life (HRQL) | Major K. Nagaraju (India)

13:45 - 14:00

2177: Exhaled Nitric Oxide and Airway Function in Seasonal Allergic Rhinitis | Masanobu Shinogami (Japan)

Oral Abstract Session 5: Atopic Dermatitis 1

Gran Cancún 5 (Cancún Center)

Chairpersons: Prof. Dr. Peter Schmid-Grendelmeier (Switzerland) and Atsuo Urisu (Japan)

12:45 - 13:00

2178: Contribution of IL-33 and Nuocyte to Experimental Allergic Dermatitis | Yasutomo Imai (Japan)

13:00 - 13:15

2179: S100A8/A9, A DAMP Molecule Activated by IL-17 and House Dust Mite Is Upregulated In Atopic Dermatitis Kwang Hoon Lee (South Korea)

13:15 - 13:30

2180: Arginase I Levels Are Decreased In Pediatric Patients with Atopic Dermatitis | Victoria Dimitriades (US)

13:30 - 13:45

2181: Polyprenol Could Prevent Loss of Filaggrin In Epithelial Cells In Atopic Dermatitis | Ivans S Kuznecovs (Latvia)

13:45 - 14:00

2182: Role of Sweating On Impaired Skin Barrier Functions In Atopic Dermatitis | Aya Takahashi (Japan)

14:00 - 14:15

2183: Reduced Occurrence of Early Atopic Dermatitis Due to Immunoactive Prebiotics Among Low Atopy Risk Infants | Christoph Grüber (Germany)

Oral Abstract Session 6: Conjunctivitis

Cozumel 2 (Cancún Center)

Chairpersons: Sergio Bonini (Italy) and Leonard Bielory (US)

12:45 - 13:05

: Test Title

13:05 - 13:20

2184: Ocular Signs and Symptoms Elicited by a Naturalistic Allergen Challenge in An Environmental Exposure Chamber Model Versus a Direct Allergen Instillation Model | Michael S. Blaiss (US)

13:20 - 13:35

2185: Increased Frequency of CD4+ CD25+ FOXP3- in Allergic Conjunctivitis Patients | Jorge Galicia-Carreón (Mexico)

13:35 - 13:50

2186: Increased Frequency of CD4+ CCR4+ CCR9+ Cells in Patients with Allergic Conjunctivitis | Miguel E Alonso-Sánchez (Mexico)

13:50 - 14:05

2187: Long-Term IFN-g Treatment Alters Allergic Inflammation-Associated Gene Expression in Conjunctival Fibroblasts | Naoko Okada (Japan)

14:05 - 14:20

2188: Hyperosmolar Conjunctival Provocation Test (HCPT) in the Evaluation of Ocular Symptoms Nelson Rosario (Brazil)

14:20 - 14:35

2189: Tear IFN-g Is Increased After Sublingual Immunotherapy in Allergic Conjunctivitis Patients and Correlates with Clinical Improvement | Gustavo Aguilar-Velazquez (Mexico)

Oral Abstract Session 7: Immunodeficiency

Isla Mujeres (Cancún Center)

Chairpersons: John Sleasman (US) and Mark Ballow (US)

12:45 - 13:00

2190: Anxiety and Depression in Patients with Variable Common Immunodeficiency in the Service of Allergy and Clinical Immunology - Centro Médico Nacional Siglo XXI | Nelva Guillén (Mexico)

13:00 - 13:15

2191: Transient Immune Reconstitution Following Gastric Bypass Surgery with Ensuing Sjogren's Syndrome | John Kim (US)

13:15 - 13:30

2192: Computed Tomography Findings Consistent with Rhinosinusitis, Clinical Correlation and Quality of Life in Patients with Common Variable Immunodeficiency. Original Article | Elizabeth Mendieta (Mexico)

13:30 - 13:45

2193: Subcutanous Vivaglobulin® Replacement Therapy in Patients with Primary Immunodeficiency Confers Protective Antibody Titers to Major Organisms | Doanh Nguyen (US)

13:45 - 14:00

2194: Case Report: Recurrent Mucocutaneous Candidiasis and Recurrent Diarrhea by Gram Negative Bacteria | Juan Aldave Becerra (Peru)

14:00 - 14:15

2195: Bronchiectasis: Localization and Characteristics, Identified by Using a High Resolution CT Scan in Adults with Common Variable Immunodeficiency | Laura Mendoza (Mexico)

Oral Abstract Session 8: Indoor Risk Factors for Asthma

Tulum (Cancún Center)

Chairpersons: Thomas Platts-Mills (US) and Myron Zitt (US)

12:45 - 13:00

2196: The Relationship of Pets, Vitamin D and IgE Concentrations to Upper Respiratory Infections In the First Year of Life | Dennis Ownby (US)

13:00 - 13:15

2197: Prevalence of Cockroach and Mouse Sensitization Among Children Hospitalized for Wheezing and Asthma | Terri Moncrief (US)

13:15 - 13:30

2198: Is Pet Ownership Associated with Higher Vitamin D? | Christine Cole Johnson (US)

13:30 - 13:45

2199: Sick Building Syndrome (SBS) Among Workers of Two Buildings and Exposure to Indoor Fungal Allergens in Rio De Janeiro, Brazil | Jose Laerte Boechat (Brazil)

13:45 - 14:00

2200: Asthma Among Office Workers and Exposure to Chemical and Biological Indoor Pollutants Jose Laerte Boechat (Brazil)

14:00 - 14:15

2201: Taxonomic Identification of the House Dust Mites Associated to Allergic Patients In Six Locations From Mexico | Naomi Cuervo (Cuba)

Oral Abstract Session 9: Mechanisms of Asthma

Xcaret (Cancún Center)

Chairpersons: Daniel Jackson (US) and Bradley Undem (US)

12:45 - 13:00

2202: EGCG Down-Regulates Mucin Gene Expression Through the MAPK Signaling Pathway in Asthma | Yong-Dae Kim (South Korea)

13:00 - 13:15

2203: Enhancer of Zeste Homolog 2: A Pivotal Role in Pulmonary Artery Smooth Muscle Cell Proliferation | Salman Aljubran (US)

13:15 - 13:30

2204: The Features of Airway Remodeling Are More Severe in Female Mice | Masahide Takeda (Japan)

13:30 - 13:45

2205: Ovalbumin-Induced Bronchial Asthma Is Compromised in Apoptosis Signal-Regulating Kinase-Deficient Mice | Junichiro Mizuguchi (Japan)

13:45 - 14:00

2206: Role of the CC−Chemokine Receptor CCR9 In the Regulation of Inflammatory Process During Allergic Airway Inflammation | Cynthia López-Pacheco (Mexico)

14:00 - 14:15

2207: Serum IL6 and Soluble IL6R Are Correlated with Lung Function In Non-Hispanic Whites with Asthma | Gregory Hawkins (US)

Oral Abstract Session 10: Sublingual Immunotherapy 1

Costa Maya 1 (Cancún Center)

Chairpersons: Moises Calderon and Peter Creticos (US)

12:45 - 13:00

2208: Safety and Dose-dependent Efficacy of a Novel Ragweed Allergen Immunotherapy Tablet in North American and European Patients: Preliminary Findings | Hendrik Nolte (US)

13:00 - 13:15

2209: Economic Evaluation of Grass Tablets for Immunotherapy (Oralair) Compared to Placebo in Adults and Children in Italy | Amerigo Cicchetti (Italy)

13:15 - 13:30

2210: The Post-Treatment Efficacy of House Dust Mite Sublingual Allergen Immunotherapy Tablets in Adults with Allergic Rhinitis | Karl-Christian Bergmann (Germany)

13:30 - 13:45

2211: Efficacy of Immnunotherapy with An Oral Bacterial Lysate and Vitamin C In the Primary Prevention of Acute Respiratory Tract Infections In Children Luciano Cortigiani (Argentina)

13:45 - 14:00

2212: Impact of Pollen Exposure on the Treatment Effect of Ragweed and Grass Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis: Preliminary Findings | Sandra Gawchik (US)

14:00 - 14:15

2213: Efficacy of Timothy Grass Allergy Immunotherapy Tablet (AIT) Treatment in Canadian Children and Adults with Grass Pollen-Induced Allergic Rhinoconjunctivitis (ARC) | Jacques Hebert (Canada)

Oral Abstract Session 11: Urticaria and Angioedema

Costa Maya 2 (Cancún Center)

Chairpersons: David Lang (US) and Jonathan Bernstein (US)

12:45 - 13:00

2214: The Efficacy of Human Plasma-Derived C1-Inhibitor Concentrate Used for Prophylactic Treatment In Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Dorottya Csuka (Hungary)

13:00 - 13:15

2215: Pre-Procedural Administration of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prevention of Hereditary Angioedema (HAE) Attacks After Medical, Dental, or Surgical Procedures David Mariano (US)

13:15 - 13:30

2216: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Treatment of Hereditary Angioedema (HAE) Attacks Marc Riedl (US)

13:30 - 13:45

2217: Treatment of Acquired Angioedema with the Bradykinin Receptor Antagonist Icatibant | Maria Concetta Siani (Italy)

13:45 - 14:00

2218: Early Versus Delayed Treatment of Swelling Attacks with Icatibant, a Bradykinin 2 Receptor Antagonist, in Patients with Hereditary Angioedema Due to C1-INH Deficiency | Konrad Bork (Germany)

14:00 - 14:15

2219: Assessment of Chronic Spontaneous Urticaria by Serum-Induced TNFα and MMP-9 Release | Sidsel Falkencrone (Denmark)

Year in Review 1: Atopic Dermatitis

Gran Cancún 5 (Cancún Center)

15:00 - 15:35

1-1YiR: Pathophysiology | Mark Boguniewicz (US)

15:35 - 16:10

1-2YiR: Treatment | Prof. Dr. Peter Schmid-Grendelmeier (Switzerland)

16:10 - 16:30

Discussion

Workshop 1: Evidence Based Recommendations for Clinical Practice - WAO Special Committee on Evidence Based Medicine

Coral Gallery 1 (Fiesta Americana)

Chairperson: Luigi Terracciano (Italy)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

1-1WS: WAO Position Paper: Diagnosis and Rational for Action Against Cows Milk Allergy (DRACMA) | Holger Schünemann (Canada)

15:20 - 15:35

1-2WS: Evidence Based Use of Diagnostic Tests | Jan Brozek (Canada)

15:35 - 15:50

1-3WS: DRACMA in Clinical Practice | Alessandro Fiocchi (Italy)

15:50 - 16:30

Discussion

University Training Programs 1: Harvard University: Adverse Drug Reactions and Managements

Gran Cancún 1 (Cancún Center)

Chairpersons: Miguel Blanca (Spain) and David Khan (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

1-1UTP: Chemo-Therapeutic Agents | Mariana Castells (US)

15:20 - 15:35

1-2UTP: Monoclonal Antibodies | Aleena Banerji (US)

15:35 - 15:50

1-3UTP: Antibiotics | David Khan (US)

15:50 - 16:05

1-4UTP: Non-Steroid Anti-Inflammatory Drugs (NSAIDs) | Katharine Woessner

16:05 - 16:30

Panel Discussion

Workshop 2: Adverse Reactions to Non-Steroid Anti-Inflammatory Drugs (NSAIDS)

Coral Gallery 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

2-1WS: Respiratory | Marek L Kowalski (Poland)

15:20 - 15:35

2-2WS: Cutaneous | Mario Sanchez-Borges (Venezuela)

15:35 - 15:50

2-3WS: Desensitization | Pascal Demoly (France)

15:50 - 16:30

Discussion

Company Sponsored Symposium 2: MSD: Uncontrolled Asthma: Burden, Patient Perceptions and Clinical Implications

Cozumel 2 (Cancún Center)

Chairperson: Jorge Maspero (Argentina)

15:00 - 15:10

Chairman's Welcome and Introduction

15:10 - 15:25

2-1CSS: Uncontrolled Asthma and Its Burden | Paolo Tassinari (Venezuela)

15:25 - 15:45

2-2CSS: Bridging the Gap Between Patient Perceptions and Realities in Asthma: Findings from the Asthma Insight and Management Surveys | Jorge Maspero (Argentina)

15:45 - 16:15

2-3CSS: Role of New Fixed Dose Combinations in the Management of Uncontrolled Asthma | Steven Weinstein (US)

16:15 - 16:30

Panel Discussion & Summary

Workshop 3: Update on Vaccinations for the Allergist and Immunologist

Coral Gallery 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

3-1WS: Pediatric Considerations | James Oleske (US)

15:20 - 15:35

3-2WS: Geriatric Considerations | Monroe James King (US)

15:35 - 15:50

3-3WS: Adverse Reactions | John Kelso (US)

15:50 - 16:30

Discussion

Workshop 4: Management of Asthma Exacerbations

Coral Sea (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

4-1WS: Outpatient Management | Paul O'Byrne (Canada)

15:20 - 15:35

4-2WS: Emergency Department Management | Gustavo Rodrigo (Uruguay)

15:35 - 15:50

4-3WS: Intensive Care Unit Management | Arturo Gomez-Gonzalez (Mexico)

15:50 - 16:30

Discussion

Sister Society Symposium 5: INTERASMA: Control and Prevention of Asthma Exacerbation

Tulum (Cancún Center)

Chairpersons: You-Young Kim (South Korea) , Carlos E. Baena-Cagnani (Argentina) and Carlos Nunes (Portugal)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

5-1SSS: Asthma Exacerbation | Louis-Philippe Boulet (Canada)

15:25 - 15:45

5-2SSS: Biologic Therapeutics as Preventive Medications | Lawrence DuBuske (US)

15:45 - 16:05

5-3SSS: Asthma Evolution from Childhood to Adulthood | Carlos Nunes (Portugal)

16:05 - 16:30

Discussion

Workshop 5: Skin Prick Testing: What Can We Still Improve?

Coral Kingdom 1 (Fiesta Americana)

15:00 - 15:15

5-1WS: Which Allergens to Use

15:15 - 15:30

5-2WS: Techniques | Désirée Larenas Linnemann (Mexico)

15:30 - 15:45

5-3WS: Reporting Results | Paul Greenberger (US)

15:45 - 16:00

Hands-On Demonstration

16:00 - 16:10

Result Writing

16:10 - 16:30

Case Reports

Sister Society Symposium 6: American College of Allergy, Asthma and Immunology: When Food Allergies are Unusual, Unexpected, and Potentially Fatal

Costa Maya 2 (Cancún Center)

Chairperson: Gailen Marshall (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

6-1SSS: Atypical Manifestations | Amal Assa'ad (US)

15:25 - 15:45

6-2SSS: Non-Ingestant Routes | Sami Bahna (US)

15:45 - 16:05

6-3SSS: Food-Induced Anaphylaxis: Diagnosis and Treatment | Dana Wallace (US)

16:05 - 16:30

Panel Discussion

Workshop 6: University Training Program - University of Sao Paulo: Allergy and Asthma: Risk Factors, Diagnosis and Treatment

Coral Kingdom 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

6-1WS: Risk Factors for Allergy and Asthma in Latin America | Virginia Paes Leme Ferriani (Brazil)

15:20 - 15:35

6-2WS: Cross-Reactive IgE Responses to Invertebrates | L. Karla Arruda (Brazil)

15:35 - 15:50

6-3WS: Immunotherapy with Mite Vaccines: Risk Factor for Shrimp Allergy? | Ariana Yang

15:50 - 16:30

Discussion

Symposium 7: Allergen Avoidance Strategies

Gran Cancún 2 (Cancún Center)

Chairpersons: Harold Nelson (US) and Antonio Castillo (Dominican Republic)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

7-1SY: Dust Mites | Roy Gerth van Wijk (Netherlands)

15:25 - 15:45

7-2SY: Storage Mites | Enrique Fernandez-Caldas (Spain)

15:45 - 16:05

7-3SY: Molds | Jonathan Bernstein (US)

16:05 - 16:30

Panel Discussion

Workshop 7: Undergraduate and Postgraduate Training in Allergy: New Developments - WAO Specialty and Training Council

Coral Kingdom 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

7-1WS: Allergy Education and Training: The WAO White Book on Allergy | Ruby Pawankar (Japan)

15:20 - 15:35

7-2WS: WAO Guidelines on Undergraduate Allergy Education and Training | Paul Potter (South Africa)

15:35 - 15:50

7-3WS: WAO Guidelines on Postgraduate Allergy Education and Training | Connie Katelaris (Australia)

15:50 - 16:30

Discussion

Workshop 8: Hands-On Session: Pulmonary Function

Coral Garden 1 (Fiesta Americana)

15:00 - 15:05

Introductory Remarks

15:05 - 15:15

8-1WS: Pulmonary Function: Hands-On | Dennis Ownby (US)

15:15 - 15:25

8-2WS: Pulmonary Function: Hands-On | Robert C. Strunk

15:25 - 15:35

8-3WS: Pulmonary Function: Hands-On | Choon-Sik Park (South Korea)

15:35 - 16:30

Hands-On Demonstration

Symposium 8: Mast Cell: The Central Inflammatory Cell

Gran Cancún 4 (Cancún Center)

Chairpersons: Larry Schwartz (US) and Elham Hossny (Egypt)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

8-1SY: Mast Cells as Regulators and Effectors | Stephen Galli (US)

15:25 - 15:45

8-2SY: Mast Cells, Eosinophils and Nerves | Allison Fryer (US)

15:45 - 16:05

8-3SY: Mast Cells: Novel Ways for Suppression | Francesca Levi-Schaffer (Israel)

16:05 - 16:30

Panel Discussion

Symposium 9: Asthma and COPD: Are They a Spectrum of the Same Disease?

Cozumel 1 (Cancún Center)

Chairpersons: Yehia El-Gamal (Egypt) and James Baraniuk (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

9-1SY: Pathophysiology | Nicola Hanania MD, (US)

15:25 - 15:45

9-2SY: Severe Asthma vs. COPD | Sally Wenzel (US)

15:45 - 16:05

9-3SY: Treatment Responses | Ronald Dahl (Denmark)

16:05 - 16:30

Panel Discussion

Workshop 9: Hands-On Session: Rhinolaryngoscopy (Session 1)

Coral Garden 2 (Fiesta Americana)

Speaker(s): Mark Glaum (US) , José Antonio Sacre Hazouri (Mexico)

15:00 - 15:05

Introductory Remarks

15:05 - 16:10

Demonstration

Symposium 10: Genetic Respiratory Diseases and Their Association with Asthma

Xcaret (Cancún Center)

Chairpersons: Deborah Meyers (US) and Marc Peters-Golden (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

10-1SY: Alpha1 Antitrypsin | Stephen P. Peters (US)

15:25 - 15:45

10-2SY: Ciliary Dyskinesia | Jose L. Lezana

15:45 - 16:05

10-3SY: Cystic Fibrosis | Nelson Rosario (Brazil)

16:05 - 16:30

Panel Discussion

Workshop 10: The Internet and Allergy

Coral Garden 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

10-1WS: WAO Resources on the Internet | Juan Carlos Ivancevich (Argentina)

15:20 - 15:35

10-2WS: The Internet as a Source of Learning for the Allergist | Ves Dimov (US)

15:35 - 15:50

10-3WS: Can Internet Surveys Help Us Understand Allergic Disorders? | Martin Penagos (Mexico)

15:50 - 16:30

Discussion

Symposium 11: Pregnancy: Allergic Diseases and Asthma

Costa Maya 1 (Cancún Center)

Chairpersons: Kamal Hanna (Egypt) and Myron Zitt (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

11-1SY: Rhinitis and Pregnancy | Glenis Scadding (United Kingdom)

15:25 - 15:45

11-2SY: Asthma and Pregnancy | Michael Schatz (US)

15:45 - 16:05

11-3SY: Anaphylaxis and Pregnancy | F. Estelle R. Simons (Canada)

16:05 - 16:30

Panel Discussion

Debates 2: Small Airways: Are They Important in the Pathogenesis of Asthma?

Gran Cancún 3 (Cancún Center)

Chairpersons: Qutayba Hamid (Canada) and Charles Irvin (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

2-1DB: Pro | Monica Kraft

15:20 - 15:35

2-2DB: Con | Ignacio J. Ansotegui (Spain)

15:35 - 15:40

Pro Rebuttal

15:40 - 15:45

Con Rebuttal

15:45 - 16:00

Discussion

Debates 3: Is the Hygiene Hypothesis Important?

Isla Mujeres (Cancún Center)

Chairpersons: Robert Lemanske, MD (US) and Dale Umetsu, MD, PhD (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

3-1DB: Pro | Tari Haahtela (Finland)

15:20 - 15:35

3-2DB: Con | Susan L. Prescott (Australia)

15:35 - 15:40

Pro Rebuttal

15:40 - 15:45

Con Rebuttal

15:45 - 16:00

Discussion

Plenary Session 4: WAO Presidential Plenary Session

Bacalar (Cancún Center)

Chairpersons: Ruby Pawankar (Japan) and Giorgio Walter Canonica (Italy)

16:30 - 16:35

Welcoming Remarks

16:35 - 16:50

4-1PS: History of the World Allergy Organization | Michael A. Kaliner (US)

16:50 - 17:05

4-2PS: Discovery and History of IgE | S.G.O. Johansson

17:05 - 17:20

4-3PS: Presidential Address | Richard F. Lockey (US)

17:20 - 17:30

Discussion

Breakfast Symposium 12: Diagnostic and Therapeutic Approach to Multiple Food Allergic Children

Coral Gallery 1 (Fiesta Americana)

Speaker(s): Motohiro Ebisawa (Japan) , Hugh Sampson (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 13: Practical Considerations for Prescribing Sublingual Immunotherapy (SLIT)

Coral Gallery 2 (Fiesta Americana)

Speaker(s): Moises Calderon, Giovanni Passalacqua (Italy)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 14: Pruritus: Scratching the Surface

Coral Gallery 3 (Fiesta Americana)

Speaker(s): Iris Ale (Uruguay) , James Baraniuk (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 15: University Training Program - Universidad Autonoma de Nuevo Leon: Insect Allergy

Coral Island (Fiesta Americana)

Speaker(s): Alfredo Arias-Cruz (Mexico) , Sandra González-Díaz (Mexico)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 16: Treatment of the Asthmatic Patient Under Age 5

Coral Sea (Fiesta Americana)

Speaker(s): Carlos E. Baena-Cagnani (Argentina) , Alfonso Cepeda (Colombia) , Stanley Szefler (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 17: Evaluation of Patients for Antibody Deficiency

Coral Kingdom 1 (Fiesta Americana)

Speaker(s): Zuhair Ballas (US) , Sara Espinosa (Mexico)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 18: Exercise-Induced Asthma and Allergic Conditions

Coral Kingdom 2 (Fiesta Americana)

Speaker(s): Matteo Bonini (Italy) , Enrico Heffler (Italy)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 19: Pharmacotherapy for the Geriatric Asthma Patient

Coral Kingdom 3 (Fiesta Americana)

Speaker(s): Monroe James King (US) , Dennis Ledford (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 20: Anti-IgE: Beyond Asthma

Coral Garden 1 (Fiesta Americana)

Speaker(s): Michael S. Blaiss (US) , Yehia El-Gamal (Egypt)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 21: Diagnosis and Management of Anaphylaxis

Coral Garden 2 (Fiesta Americana)

Speaker(s): Cem Akin (US) , F. Estelle R. Simons (Canada) , Myron Zitt (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 22: Differential Diagnosis of Cough

Coral Garden 3 (Fiesta Americana)

Speaker(s): Pramod Kelkar (US) , Paul Potter (South Africa)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Plenary Session 5: Specific Immunotherapy (SIT)

Gran Cancún (Cancún Center)

Chairpersons: Richard F. Lockey (US) and Noel Rodriguez-Perez (Mexico)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

5-1PS: Mechanisms | Cezmi Akdis (Switzerland)

09:00 - 09:25

5-2PS: Preventions of New Sensitizations and Asthma | Anthony Frew (United Kingdom)

09:25 - 09:50

5-3PS: Novel Immunotherapies | Thomas B. Casale (US)

09:50 - 10:00

Discussion

Plenary Session 6: Asthma Phenotypes: Implications for Treatment

Cozumel (Cancún Center)

Chairpersons: You-Young Kim (South Korea) and Christian Virchow (Germany)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

6-1PS: Eosinophilic/Th2 | Jan Lötvall (Sweden)

09:00 - 09:25

6-2PS: Neutrophilic | Monica Kraft

09:25 - 09:50

6-3PS: Pharmacogenetics in Therapy | Elliot Israel (US)

09:50 - 10:00

Discussion

Plenary Session 7: Microbiome: A New Window to Health and Allergic Diseases?

Costa Maya (Cancún Center)

Chairpersons: Tari Haahtela (Finland) and Christopher Karp (US)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

7-1PS: Asthma | Homer Boushey (US)

09:00 - 09:25

7-2PS: Atopic Dermatitis | Richard Gallo (US)

09:25 - 09:50

7-3PS: Sinusitis | Claus Bachert (Belgium)

09:50 - 10:00

Discussion

University Training Programs 2: Wake Forest University: Translational Medicine and Personalized Asthma Management

Bacalar (Cancún Center)

Chairpersons: Sally Wenzel (US) and Donata Vercelli (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

2-1UTP: Defining Asthma Susceptibility and Severity with Genomic Medicine | Deborah Meyers (US)

11:05 - 11:20

2-2UTP: Asthma Phenotypes, Heterogeneity and Severity: The Basis of Asthma Management | Eugene R. Bleecker (US)

11:20 - 11:35

2-3UTP: Understanding Therapeutic Heterogeneity and Responsiveness in Asthma: Future Trends | Stephen P. Peters (US)

11:35 - 11:50

2-4UTP: Biologic Asthma Therapies and Individualized Medicine | Mark Dykewicz, MD (US)

11:50 - 12:15

Panel Discussion

Collaborating Partner Symposium 3: National Institute of Allergy and Infectious Disease (NIAID) and National Heart, Lung and Blood Institute (NHLBI): Standardizing Outcomes in Asthma Clinical Research

Gran Cancún 3 (Cancún Center)

Chairperson: Alkis Togias (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

3-1CPS: Standardizing Asthma Outcomes Measures: Overview of the NIH Asthma Outcomes Project | Alkis Togias (US)

11:05 - 11:20

3-2CPS: Defining and Measuring Asthma Exacerbations | David Peden (US)

11:20 - 11:35

3-3CPS: Defining and Measuring Asthma Symptoms | Robert Lemanske, MD (US)

11:35 - 11:50

3-4CPS: Defining and Measuring Asthma Control | Michael Schatz (US)

11:50 - 12:05

3-5CPS: Biomarkers as Outcome Measures in Asthma Clinical Research | Stanley Szefler (US)

12:05 - 12:15

Panel Discussion

Company Sponsored Symposium 3: Nestle Nutrition Institute: Dietary Prevention and Management of Allergies in Childhood – An Outlook into the Future

Cozumel 2 (Cancún Center)

Chairperson: Ferdinand Haschke Prof, MD, PhD

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

3-1CSS: Oral Tolerance Induction: Are we any Closer to a Cure for Food Allergy? | Mimi Tang (Australia)

11:10 - 11:30

3-2CSS: Treatment and Management of Severe Cases of Food Allergy | Ralf G. Heine (Australia)

11:30 - 11:50

3-3CSS: Nutrition in Allergic Children: Recommendations and Guidelines | Christophe Dupont (France)

11:50 - 12:15

Panel Discussion

Sister Society Symposium 7: European Academy of Allergy and Clinical Immunology: Phenotypes and Endotypes of Allergic Disease

Costa Maya 1 (Cancún Center)

Chairpersons: Cezmi Akdis (Switzerland) and Jan Lötvall (Sweden)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

7-1SSS: Molecular Markers of Phenotypes and Endotypes | Ioana Agache (Romania)

11:10 - 11:30

7-2SSS: Infection and Asthma Endotypes | Adnan Custovic (United Kingdom)

11:30 - 11:50

7-3SSS: Phenotypes of Food Allergy | Maria Antonella Muraro

11:50 - 12:15

Panel Discussion

Symposium 12: Eosinophilic Respiratory Problems

Gran Cancún 1 (Cancún Center)

Chairpersons: John Kelso (US) and Riccardo Polosa (Italy)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

12-1SY: Aspirin-Exacerbated Respiratory Disease (AERD) | Hae-Sim Park (South Korea)

11:10 - 11:30

12-2SY: Churg Strauss Syndrome | John Sleasman (US)

11:30 - 11:50

12-3SY: Allergic Bronchopulmonary Aspergillosis (ABPA) | Paul Greenberger (US)

11:50 - 12:15

Panel Discussion

Symposium 13: Immunomodulators in Allergic/Immunologic Diseases

Gran Cancún 4 (Cancún Center)

Chairpersons: Zuhair Ballas (US) and Erika Jensen-Jarolim (Austria)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

13-1SY: Immune-modulatory Strategies in Severe Atopic Eczema | Johannes Ring (Germany)

11:10 - 11:30

13-2SY: Long-Term Use of Omalizumab: Is the IgE Response Modified? | Ulrich Wahn (Germany)

11:30 - 11:50

13-3SY: Anticytokine Therapies for Autoinflammatory Diseases | Hal Hoffman (US)

11:50 - 12:15

Panel Discussion

Symposium 14: Clinical Use of Probiotic Products for Allergy – A WAO Paper - WAO Special Committee on Food Allergy

Gran Cancún 5 (Cancún Center)

Chairpersons: A. Wesley Burks (US) and Rosa Elena Huerta Hernández (Mexico)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

14-1SY: Presentation of the WAO Paper | Alessandro Fiocchi (Italy)

11:10 - 11:30

14-2SY: The Microbiological Underpinnings | Claudia Traidl-Hoffmann (Germany)

11:30 - 11:50

14-3SY: Probiotics and Allergic Diseases | Leonard Bielory (US)

11:50 - 12:15

Panel Discussion

Symposium 15: Patient Education and Treatment Compliance in Allergic Rhinitis - Supported through an unrestricted educational grant from Takeda

Isla Mujeres (Cancún Center)

Chairpersons: Ruby Pawankar (Japan) and Eli Meltzer (US)

10:45 - 10:55

15-1SY: Introduction to Allergic Rhinitis Surveys | Ruby Pawankar (Japan)

10:55 - 11:15

15-2SY: In Asia Pacific | Connie Katelaris (Australia)

11:15 - 11:35

15-3SY: In the United States | Michael S. Blaiss (US)

11:35 - 11:55

15-4SY: In Latin America | R Maximiliano Gomez (Argentina)

11:55 - 12:15

Panel Discussion

Symposium 16: Smooth Muscle and Asthma

Tulum (Cancún Center)

Chairpersons: Andrew Wardlaw (United Kingdom) and Narasaiah Kolliputi (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

16-1SY: Inflammatory Cell | Klaus Rabe (Germany)

11:10 - 11:30

16-2SY: Response Element | Reynold A. Panettieri, Jr. (US)

11:30 - 11:50

16-3SY: Thermoplasty | Mario Castro (US)

11:50 - 12:15

Panel Discussion

Symposium 17: Neural Mechanisms in Airway Diseases

Xcaret (Cancún Center)

Chairpersons: Stephen Liggett (US) and Michael A. Kaliner (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

17-1SY: Cough Reflex | Bradley Undem (US)

11:10 - 11:30

17-2SY: Nasal Reflexes | James Baraniuk (US)

11:30 - 11:50

17-3SY: Novel Treatments for Neuromechanisms | Allison Fryer (US)

11:50 - 12:15

Panel Discussion

Symposium 18: Hereditary Angioedema (HAE) and the WAO Consensus Document - WAO HAE International Alliance

Costa Maya 2 (Cancún Center)

Chairpersons: Timothy J. Craig (US) and Michihiro Hide (Japan)

10:45 - 10:50

Welcoming Remarks

10:50 - 10:55

18-1SY: Summary of the WAO Document | Timothy J. Craig (US)

10:55 - 11:15

18-2SY: Pathogenesis | Michael Frank (US)

11:15 - 11:35

18-3SY: Clinical Presentation | Marco Cicardi (Italy)

11:35 - 11:55

18-4SY: New Approaches to Treatment | Aleena Banerji (US)

11:55 - 12:15

Panel Discussion

Symposium 19: Air Pollution and Climate Change and Their Effects on Allergic Respiratory Diseases - WAO Special Committee on Climate Change

Auditorium (Cancún Center)

Chairpersons: Menachem Rottem (Israel) and Juan Jose Luis Sienra-Monge (Mexico)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

19-1SY: Air Pollution, Climate Change and Extreme Events Leading to Asthma Exacerbations | Gennaro D'amato (Italy)

11:10 - 11:30

19-2SY: Air Pollution, Climate Change and Hygiene Hypothesis | Ignacio J. Ansotegui (Spain)

11:30 - 11:50

19-3SY: Interaction Between Outdoor and Indoor Air Pollution | Thomas Platts-Mills (US)

11:50 - 12:15

Panel Discussion

Debates 4: Skin Test or In-Vitro Test for Food Allergy?

Gran Cancún 2 (Cancún Center)

Chairpersons: Alvaro Cruz (Brazil) and Rudolf Valenta (Austria)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

4-1DB: In-Vitro | Motohiro Ebisawa (Japan)

11:05 - 11:20

4-2DB: Skin Test | Linda Cox (US)

11:20 - 11:25

In-Vitro Rebuttal

11:25 - 11:30

Skin Test Rebuttal

11:30 - 11:45

Discussion

Debates 5: Sublingual Immunotherapy (SLIT) vs Subcutaneous Immunotherapy (SCIT)

Cozumel 1 (Cancún Center)

Chairperson: Enrico Compalati (Italy)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

5-1DB: SCIT | Anthony Frew (United Kingdom)

11:05 - 11:20

5-2DB: SLIT | Giovanni Passalacqua (Italy)

11:20 - 11:25

SCIT Rebuttal

11:25 - 11:30

SLIT Rebuttal

11:30 - 11:45

Discussion

Poster Session 16: Asthma

Poster Hall (Cancún Center)

3000

The Correlation of Cholesterol Lowering Statin Drugs and Worsening Asthma Control In Mild Persistent Asthmatics | Safa Nsouli (US)

3001

Studies On The Relationship Between Airway Inflammatory Responses In Patients With Asthma Or Not-Yet Onset Asthma And Air Pollution | Mariko Yamaura (Japan)

3002

The Relationship Between Maternal Atopy and Childhood Asthma | Salome Abbott (South Africa)

3003

Sensitization of Severe Allergic Asthma Patients Pedro Giavina-Bianchi (Brazil)

3004

Reference Values and Influencing Factors of Exhaled Nitric Oxide In Healthy Korean Adults | Min-Suk Yang (South Korea)

3005

Association of Feno with IgE Levels in Patients with Allergic Asthma | Joselit Torres (Venezuela)

3006

The Relationship of Fractional Exhaled Nitric Oxide(FeNO) and Acute Exacerbation of Childhood Asthma | Yeong Ho Rha (South Korea)

3007

Relationship Between Exhaled Nitric Oxide and Levels of Asthma Control in Asthma Patients Treated with Inhaled Corticosteroid | Ho Joo Yoon (South Korea)

3008

Relationship Between Aeroallergen Sensitization and Asthma Severity in Mexican Children | Blanca Maria Morfin-Maciel (Mexico)

3009

Association of Asthma and IgE Levels Elianny Chavez (Venezuela)

3010

The Method of Antigen Specific Damage of Leucocytes by Food Additives in Patients with Bronchial Asthma | Nadya Titova (Belarus)

3011

Effect of Ascorbic Acid on Aiway Hyperresponsiveness in Bronchial Asthma | Young S Hwang (South Korea)

Poster Session 17: Asthma Diagnostic Tools

Poster Hall (Cancún Center)

3012

Bronchial Hyperresponsiveness In Obese Adolescents | Gabriela Ramírez (Mexico)

3013

Development of a Questionnaire for the Assessment of Bronchial Hyperresponsiveness in Korea | Seong Yong Lim (South Korea)

3014

Clinical Analysis of Salbutamol Responsiveness After Acetylcholine-Induced Bronchoconstriction in Childhood Asthma | Tomio Kondo (Japan)

3015

Preoperative Cardiopulmonary Exercise Testing (CPET) In Severe Asthma Patients | Ekaterini Syrigou (Greece)

3016

Annual Change of Peak Expiratory Flow Rate in Asthma and COPD | Kwang HA Yoo (South Korea)

3017

Evaluation of Chest Computed Tomography in Patients with Asthma Pedro Giavina-Bianchi (Brazil)

3018

Exercise-Induced Airway Obstruction and Vitamin D Deficiency Enrico Heffler (Italy)

3019

Lung Age/Chronological Age Index As Indicator of Clinical Improvement or Severity in Asthma Patients | Maria Isabel Castrejon (Mexico)

3020

Transition From Cough Variant Asthma to Asthma with Reduced FEV1 | June-Hyuk Lee (South Korea)

Poster Session 18: Pathophysiology of Childhood Asthma

Poster Hall (Cancún Center)

3021

Involvement of IL-10 Gene Promoter Polymorphisms in the Susceptibility for Childhood Asthma Kyu-Earn Kim (South Korea)

3022

Serum NT-3 and NT-4 Levels Are Associated with Clinical Severity In Asthmatic Children Marta Rachel (Poland)

3023

Serum Levels of Human Chitinase-Like Protein YKL-39 but Not YKL-40 Was Lower in Childhood Asthma | Yuzaburo Inoue (Japan)

3024

Association Between Eosinophilic Airway Inflammation and Persistent Airflow Limitation in Asthmatic Children Hyun Hee Lee (South Korea)

Poster Session 19: Pediatric Asthma Treatment

Poster Hall (Cancún Center)

3025

Correlation Between Quality of Life and Treatment Adherence in Childhood Asthma | García Jessica (Mexico)

3026

Effect of Diet Supplementation with EPA-DHE On Pulmonary Function Tests and Metacholine Bronchial Challenge Test In Obese Mexican Children | Luisa Guadalupe Pineda-Bahena (Mexico)

3027

Use of Complementary and Alternative Medicines by Children Suffering From Asthma At Mangalore, India | Animesh Jain (India)

3028

Long-Term Follow up Outcomes of Early Intervention with Anti-Inflammatory Therapy in Patients with Asthma Under 2 Year-Old | Masanori Ikeda (Japan)

3029

Asthma Treatment May Be Useful to Treat Recurrent Wheezing In Infancy | Herberto Jose Chong Neto (Brazil)

3030

Safety and Inhaler Use with Mometasone Furoate Delivered Via Dry Powder Inhaler for Children with Persistent Asthma Ariel Teper (US)

3031

Effect of Asthma Clinical Pathway for Children in the Emergency Department: 2007 Vs. 2008 | Hyun Hee Kim (South Korea)

3032

Trans Oro Pharyngeal Spacer For Inhalers Hari Kishan (India)

Poster Session 20: Aeroallergen Sensitization

Poster Hall (Cancún Center)

3033

Fungal Sensitization and Its Relation to Asthma and Allergic Rhinitis in Children Aged 6-7 Years | Alexander Diaz Rodriguez (Cuba)

3034

Study on the Sensitization Rates to Airbone Pollen and Mold in Children Dae Hyun Lim (South Korea)

3035

Influence of Degree of Specific Allergic Sensitivity on Severity of Rhinitis and Asthma in Chinese Allergic Patients | Jing Li (China)

3036

Allergic Sensitization to Domestic Mites In Santo Domingo, Dominican Republic | Antonio Castillo (Dominican Republic)

3037

Prevalence Sensitizing to Most Common Allergens in Elderly in Western Mexico" | Martín Bedolla-Barajas (Mexico)

3038

Cross Reactivity Between Cypress Pollen and Plant Food in Queretaro, Mexico | Alejandra Medina-Hernández (Mexico)

3039

Study of the Allergenic Crossreactivity and Allergenic Composition of Dermatophagoides Pteronyssinus and Blomia Tropicalis | Barbara Cases (Spain)

3040

Ficus Benjamina Sensitization in Adult Patients with Rhinitis Claudia Gallego (Mexico)

3041

Identification and Statistic Analysis Related with Climatic Variability and Transportation of the Most Abundant Spores in Mexicali, Mexico | Silvia Ahumada (Mexico)

Poster Session 21: Dust Mite Allergy

Poster Hall (Cancún Center)

3042

Standardization and Characterization of Dust Mite Extracts Manufactured in the USA | Greg Plunkett (US)

3043

Detection of Der p 2 in the House Dust and Correlation with Mite Number in An Environmental Survey | Jaw-Ji Tsai (Taiwan)

3044

Daily Vacuum Cleaning Significantly Reduces House Dust Mite Allergen, Endotoxin and β-Glucan Content of Mattresses Rob Siebers (New Zealand)

3045

Differences in Indoor Allergen Quantification in Hispanic/Latino Children Living in Miami to Those Living in Latin America | Miguel J Lanz (US)

3046

House Dust Mite Fauna and Its Relationship to Allergen Skin Tests in Six Mexican States | Bárbara Isabel Ferández Duro (Cuba)

3047

Oral Mite Anaphylaxis Is Caused by Mite-Contaminated Okonomiyaki Mix in Japan | Kentaro Takahashi (Japan)

Poster Session 22: Testing for Sensitization

Poster Hall (Cancún Center)

3048

Utility of Component-Based Allergen Chip (ImmunoCAP ISAC®) in Diagnosis of Allergic Rhinitis | Joo Hyun Jung (South Korea)

3049

Prevalence of Skin Reactivity to Blomia Tropicalis Antigen in Patients with Respiratory Allergy At Hospital Universitario De Puebla | Erica Marisol Martínez Villegas (Mexico)

3050

Prevalence of Sensitization to Parietaria, Pinus, Cupressus and Morus Pollens in Patients From CRAIC | Liborio Rafael Leal-Garcia (Mexico)

3051

Prevalence of Skin Reactivity to Antigen Mus Musculus in Patients with Respiratory Allergy | Chrystopherson Caballero (Mexico)

3052

Atopy Patch Test to Aeroallergens Extracts Is Useful In Allergic Diseases Diagnosis When Skin Prick Test Is Negative | Rocio Tordecilla (Chile)

3052A

Is Nasal Provocation Test Useful In Selecting Allergen for Immunotherapy In Children? | Ilknur Bostanci (Turkey)

3053

Clinical and Laboratory Studies of the Fate of Intranasal Allergen Eija Yli-Panula (Finland)

3054

Effect of Enzymatically Modified Isoquercitrin, a Flavonoid, on Symptoms of Japanese Cedar Pollinosis | Toshio Tanaka (Japan)

3055

Prevalence of Allergen Sensitization In Children with Atopy Suspicion Between Six Months and Five Years of Age Rosario Rojas (Chile)

3056

Prevalence Allergic Diseases and Allergic Sensitization Among Urban Office Workers As Compared with a Forest Service Workers | Woo Kyung KIM (South Korea)

3057

Photoaging Attenuates Skin Test Response to Histamine More Than Natural Aging David Fitzhugh (US)

Poster Session 23: Occupational Allergies

Poster Hall (Cancún Center)

3058

Prevalence of Latex Sensitization Between Medicine and Dentistry Students From Nuevo Leon University | Arya González (Mexico)

3059

Profile of Latex Sensitization in Children with Myelomeningocele of São Paulo, Brazil | Adriano Sa (Brazil)

3060

Specific IgE to Recombinant Allergens of Latex and Foods in Patients with Spina Bifida | Laila Sabino Garro (Brazil)

3061

Association Between Clinical History and Specific IgE Recombinants Latex Allergens | Laila Sabino Garro (Brazil)

3062

Contact Reactions to Latex, Its Additives and Irritant Threshold In Healthcare Practitioners | Razvigor Darlenski (Bulgaria)

3063

Occupational Flaxseed Allergy (Conjunctivitis): A Case Report Arnaldo Capriles- Hulett (Venezuela)

3064

Occupational asthma: description of a new allergen | Lizette del Carmen Miguel Polo (Spain)

Poster Session 24: Contact Dermatitis

Poster Hall (Cancún Center)

3065

Patch Testing Results In Contact Dermatitis From the Allergist's Perspective | Marcella Aquino (US)

3066

Contact Allergy to Medicaments in Consecutively Patch-Tested Patients in Uruguay | Valeria Pomies (Uruguay)

3067

Evaluation of Allergen Sensitivity In Patients with Contact Dermatitis In Antalya | Arzu Didem Yalcin (Turkey)

3068

Better Protection From Eczema Among Turkish Migrants' Children Carries Over From Preschool Age to Adolescence | Christoph Grüber (Germany)

Poster Session 25: Atopic Dermatitis

Poster Hall (Cancún Center)

3069

Early Clinical Differential Diagnosis Between Infant Atopic Dermatitis and Seborrheic Eczema | Rubens Marcelo Souza Leite (Brazil)

3070

Sensitization to Contactants In Patients with Atopic Dermatitis | Fausto Matsumoto (Brazil)

3071

Sensitization to Aeroallergens and Risk of Respiratory Allergy in Atopic Dermatitis Children | Natalya Migacheva (Russia)

3072

Nutritional Evaluation of Children with Atopic Dermatitis | Xiomara Lopez Campos (Cuba)

3073

Quality of Life In Pediatric Patients with Atopic Dermatitis | Xiomara Lopez Campos (Cuba)

3074

Epidemiology of Atopic Dermatitis In the Allergy Service of A Third Level Medical Center | Luis Rafael Sanchez-Gallardo (Mexico)

3075

Epidemiology of Atopic Dermatitis Cases In the Allergy Service of A Third Level Medical Center | Luis Rafael Sanchez-Gallardo (Mexico)

3075

Gene-Environment Interactions on the Development of Atopic Dermatitis in Preschool Children: Mold Is the Main Environmental Factor Soo-Jong Hong (South Korea)

3076

FcRg-Mediated Immune Responses Modulate the Exacerbation of Clinical Symptoms in Atopic Dermatitis of NC/Tnd Mice | Kumiko Oida (Japan)

Poster Session 26: Drug Allergy 2

Poster Hall (Cancún Center)

3077

Hypersensitivity Syndrome Associated with Phenytoin Sodium | Elizabeth Mendieta (Mexico)

3078

Drug Hypersensitivity Reactions In Hospitalized Patients: What Is the Hole of the Allergist? | Luciana Kase Tanno (Brazil)

3079

Allergic Reactions to Local Anesthetics: Detection by Skin Tests and Subcutaneous Provocation. Analysis of 160 Cases José Luiz Rios (Brazil)

3080

Protamine Allergy | Christine Hafner (Austria)

3081

Description of Drug Allergy Study Conducted In A Teaching Hospital Between October 2007 and March 2011 | Consuelo Fernanda Rodríguez Martínez (Chile)

3082

Lung Toxicity Induced by Novel Antineoplastic Therapies In Cancer Patients | Kostas N. Syrigos (Greece)

3083

Redness of Skin: SSSS in a 10 Month Old Healthy Baby | Agnes Nemeth (Hungary)

3084

Desensitization Protocol to Methotrexate | Jonathan Maya (Mexico)

3085

Clinical Features of Dress Syndrome In 42 Patients | Mi-Ran Park (South Korea)

3086

Risk Factors Associated to Mortality In Mexican Children with Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis | Luis Octavio Hernandez-Mondragon (Mexico)

Poster Session 27: Aspirin-Exacerbated Respiratory Disease

Poster Hall (Cancún Center)

3087

Successful Treatment of Severe Nonallergic Asthma by Omalizumab. An Observation | Karl-Christian Bergmann (Germany)

3088

Relationship Between Aeroallergen Sensitization and Asthma Severity in Patients with Aspirin-Exacerbated Respiratory Disease | Chihiro Mitsui (Japan)

3089

Persistence of Nasal and Bronchial Symptoms in Patients with Samter's Syndrome with Treatment Medical and Surgical in a 2 Year Period | Hugo Alberto Azuara Trujillo (Mexico)

3090

Clinics and Laboratory Characteristics of Asthmatic Patients with Aspirin Exacerbated Respiratory Disease (AERD) Pedro Giavina-Bianchi (Brazil)

3091

Association Analysis of Member RAS Oncogene Family Gene Polymorphisms with Aspirin Intolerance in Asthmatic Patients Tae-Hoon Kim (South Korea)

3092

Nasal Nitric Oxide Levels After Lysine Aspirin Nasal Challenge In Subjects with Aspirin Induced Asthma | Damian Tworek (Poland)

3093

IL1B but Not IL8 Polymorphisms Are Increased in Aspirin Exacerbated Respiratory Disease Patients Versus Aspirin Tolerant Asthmatics | Fernando Gandhi Pavon Romero (Mexico)

3094

Fatty Acid Binding Protein 1 Is Related with Development of Aspirin-Exacerbated Respiratory Disease | Tae-Hoon Kim (South Korea)

Poster Session 28: Immunotherapy Training

Poster Hall (Cancún Center)

3095

Immunotherapy (IT) Training in Canada: Perspectives of Fellows-in-Training on the First Immunotherapy Training Manual | Teresa Pun (Canada)

3096

Immunotherapy (IT) Training in Canada: Current Experience of Fellows-in-Training | Teresa Pun (Canada)

Poster Session 29: Food Allergy Case Reports

Poster Hall (Cancún Center)

3097

Lentil Allergy: First Report From Venezuela Arnaldo Capriles Hulett (Venezuela)

3098

Cow's Milk Allergy and Persistent Changes in a Multiple Food Allergy, a Case Report Carla Bastías (Chile)

3099

A Rare Case of Food-Induced Anaphylaxis to Pink Peppercorns | John Kim (US)

3100

Multiple Manifestations of Food Allergy in a Patient with a Change of Eating Habits Carla Bastías (Chile)

3101

Wheat-Dependent Exercise-Induced Anaphylaxis Occurred in OAS Patient After Using Soap Containing Hydrolyzed Wheat Proteins: Effect of Soap on Keratinocyte Inflammasome | Aya Tanaka (Japan)

Poster Session 30: Food Allergy: Diagnosis and Treatment

Poster Hall (Cancún Center)

3102

Possible Prenatal Sensitization: "the Case of the Hidden Cake" | José Antonio Ortega Martell (Mexico)

3103

The Evaluation of Allergen Sensitivity In Food Allergy Patients In Antalya, Turkey | Arzu Didem Yalcin (Turkey)

3104

Clinical Correlation of Prick and Prick-to- Prick Skin Tests to Food in a Group of Children with Allergy Symptoms Armando Partida-Gaytan (Mexico)

3105

Comparison Skin Prick Test Using Commercial and Native Extracts of Allergens in Diagnosis of Food Allergy | Zbigniew Bartuzi (Poland)

3106

Natural History of Food Allergy in Childhood -3 Years' Follow up of Pediatric Food Allergy Patients- | Miho Hasegawa (Japan)

3107

Comparative Analysis of Patients with Birch Pollinosis and Patients with Associated Plant Food Allergy | Zbigniew Bartuzi (Poland)

3108

Frequency and Characterization of Oral Allergy Syndrome in Mexican Adults with Nasal Pollinosis | Martín Bedolla Barajas (Mexico)

3109

Edirne Primary School Teacher Knowledge of Food Allergies and Emergency Treatment Facilities in Schools | Mehtap Yazicioglu (Turkey)

Poster Session 31: Eosinophilic Diseases

Poster Hall (Cancún Center)

3110

International Survey On Evaluation and Management of Eosinophilic Esophagitis | Gisoo Ghaffari (US)

3111

Allergen Specific Immunotherapy As a Treatment for Eosinophilic Esophagitis | Juan Esteban Perez (US)

3112

Eosinophilic Esophagitis and Eosinophil Cationic Proteins As Marker of Disease During the Follow-up | Erminia Ridolo (Italy)

Poster Session 32: Immunodeficiency

Poster Hall (Cancún Center)

3113

Severe Autoimmunity with Polyarticular Joint Disease Requiring Anti-TNF Therapy and T+B-NK+ Immunodeficiency In a Family with Small Stature and Intermediate Radiation Sensitivity Jun Lu (US)

3114

Autoimmunity in Patients with Allergy and Immunodeficiency: As Result of the Immune Chronic Inflammation | Julia Mendez-Inocencio (Mexico)

3115

HPV, HSV2, HIV and Chlamydia Trachomatis Infections As a Potential Accompanying Factor for Immunodeficiency and Development of Allergic Processes. Final Results | Maria Gołębiowska-Wawrzyniak (Poland)

3116

A 3 Years-Old Child with Specific Antibody Deficiency and Allergic Rhinitis. Case Report | Maria Edith Gonzalez Serrano (Mexico)

3117

Silvery-Gray Hair Patient with Neurologic Deterioration | Luisa Gamez (Mexico)

3118

Differences IN Humoral and Cellular Immunity IN Young and OLD Individuals | Arzu Didem Yalcin (Turkey)

3119

Analysis of the Immune Status in the Acute Phase of Viral Respiratory Infections in Children | Olga Bede (Hungary)

3120

Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stem Cells | Maryam Ayatollahi (Iran)

3121

Immunosuppressed Murine Model for Studies in Allergy: Evaluation of Immunosuppression Induced by Cyclophosphamide, Dexamethasone and Cyclosporin in Balb-C Mice | Adriano Pereira (Brazil)

Poster Session 33: Primary Immunodeficiency

Poster Hall (Cancún Center)

3122

Intravenous Immunoglobulin in Leukocyte Adhesion Deficiency | Said Arablin Oropeza (Mexico)

3123

Descriptive Analysis of the Immunological Behavior of Patients with Ataxia Telangiectasia Attended in the National Institute of Pediatrics in the Past 30 Years | Beatriz Adriana Llamas (Mexico)

3124

Alteration of Humoral and Cellular Immunity in Patients with Ataxia-Telangiectasia At Reference Center in Sao Paulo/Brazil | Lorena Ornellas (Brazil)

3125

Clinical Features of Patients with Ataxia-Telangiectasia At Reference Center in Sao Paulo/Brazil | Josemar Matos (Brazil)

3126

Attentiveness to Primary Immunodeficiency: Survey of Pediatricians in United Arab Emirates | Suleiman Al-Hammadi (United Arab Emirates)

3127

The Diagnosis of Primary Immune Deficiency in Adults Should Not Be Missed: A Delayed Diagnosis Can Be Devastating Abdullah Baysan (Turkey)

3128

Global Prevalence and Types of Autoimmune Diseases Found in Children with Primary Immunodeficiencies; a Single-Center Experience | María Guadalupe Ramírez Vázquez (Mexico)

3129

Malignancies associated to Primary Immunodeficiencies. A 40 year review | Corin España (Mexico)

3130

An Earlier, Moore Severe Presentation of G6PC3 Deficiency in a Male Infant From Mexico | Alonso Cruz (Mexico)

3131

Immunoglobulin A deficiency, HPV and Oral Cancer | Jorge Alvarez (Argentina)

Poster Session 34: X-linked and Common Variable Immunodeficiency

Poster Hall (Cancún Center)

3132

Long Term Follow-up of Patients with Common Variable Immunodeficiency (CVID) in Rio De Janeiro, Brazil: Clinical Phenotypes and Prognosis | Amanda Seba (Brazil)

3133

Quality of Life in Patients with Common Variable Immunodeficiency in the Department of Allergy and Clinical Immunology - Centro Medico Nacional Siglo XXI | Freya Helena Campos Romero (Mexico)

3134

"PREVALENCE of COMMON Variable Immunodeficiency In ADULT PATIENTS” Specialty HOSPITAL – Centro Medico Nacional Siglo XXI - MSS - Mexico CITY | Nelva Guillén (Mexico)

3135

Infections in 14 Patients with Common Variable Immunodeficiency, Retrospective Study | Elizabeth Mendieta (Mexico)

3136

Autoimmune Thrombocytopenic Purpura Associated with Common Variable Immunodeficiency | Elizabeth Mendieta (Mexico)

3137

CVID: A Common but Still Underdiagnosed Disease | Claudia Gallego (Mexico)

3138

Infections in Patients Diagnosed with Common Variable Immunodeficiency Arzu Didem Yalcin (Turkey)

3139

Phenotypic and Functional Analysis of B Cells In Patients with Common Variable Immunodeficiency Dolores Mogica Martínez (Mexico)

3140

X-Linked Agammaglobulinemia: Report of 4 Cases of Mexican Patients At Civil Hospital of Guadalajara Dr Juan I. Menchaca | Maria Enriqueta Nuñez-Nuñez (Mexico)

3141

Congenital Agamaglobulinemia | Cinthia Perez Ortiz (Paraguay)

3142

Case Report: Hypogammaglobulinemia Induced by Oxcarbazepine Rosario Rojas (Chile)

3143

X- Linked Agammaglobulinemia and Moebius Syndrome, First Case Reported | Margarita Ortega-Cisneros (Mexico)

Poster Session 35: HIV-Related Problems

Poster Hall (Cancún Center)

3144

Peculiarities of HIV-Specific Immune Response in Discordant Couples | Evgenia Zhukova (Russia)

3145

Detection of Dengue Virus in HIV-1-Infected Patients During the Epidemic in 2009 in Colima, Mexico | Uriel A. López-Lemus (Mexico)

3146

HPV, HSV2, HIV and Chlamydia Trachomatis Infections As a Potential Accompanying Factor for Immunodeficiency and Development of Allergic Processes Final Results | Katarzyna Markiewicz (Poland)

Poster Symposium 3: Allergic Rhinitis

Bacalar (Cancún Center)

Chairpersons: Glenis Scadding (United Kingdom) and Michael A. Kaliner (US)

12:45 - 13:30

Poster Viewing

13:30 - 00:00

3148: Allergen Sensitization In Children with Allergic Rhinitis and Asthma In Guatemala | Ann Michelle Rigalt (Guatemala)

13:30 - 00:00

3149: The Impact of Breast-Feeding Duration and Mode of Delivery on Allergic Rhinitis in Korean Children: Cohort of Allergic Rhinitis in Korea (COAR-Korea) Study | Doo Hee Han (South Korea)

13:30 - 00:00

3150: The Efficacy of a Nasal Corticosteroid Ciclesonide for the Treatment of Serous Otitis Media In Atopic Children | Safa Nsouli (US)

13:30 - 00:00

3151: A Study Evaluating the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol In the Relief of Nasal Symptoms of Seasonal Allergic Rhinitis Shailesh Desai (US)

13:30 - 00:00

3152: Combination of a Nasal Antihistamine Olopatadine and a Leukotriene Receptor Antagonist Montelukast Sodium for the Treatment of Seasonal Allergic Patients Not Currently Controlled On Monotherapy Intranasal Antihistamine or a Leukotriene Receptor Antagonist | Safa Nsouli (US)

13:30 - 00:00

3153: Desloratadine Is Safe and Well Tolerated in Adults ³55 Years Old Gokul Gopalan (US)

13:30 - 00:00

3154: Augmentation of CXCL10 Expression in Nasal Fibroblasts Derived From Patients with Recalcitrant Chronic Rhinosinusitis Associated with Bronchial Asthma | Mamoru Yoshikawa (Japan)

13:30 - 00:00

3155: Correlation Between Cu/Zn-SOD and Macrophages or MUC5AC in Eosinophilic Chronic Rhinosinusitis with Nasal Polyps | Noritsgu Ono (Japan)

13:30 - 00:00

3156: Relationship Between Allergic Rhinitis and Dental-Facial Abnormalities | Miguel Alejandro Medina (Mexico)

Oral Abstract Session 12: Food & Drug Allergy: Late-Breakers

Gran Cancún 1 (Cancún Center)

Chairpersons: Daniel Yerly (Switzerland) and Emilia María Hidalgo Castro

12:45 - 13:00

3157: DELAYED- TYPE HYPERSENSITIVITY TO AMINOPENICILLINS: “HANDS DESQUAMATION SYNDROME” | Lizette del Carmen Miguel Polo (Spain)

13:00 - 13:15

3158: Influence of Transglutaminase and the Reducing Agent Glutathione in the Gastric Digestion and Immunogenicity of Beta-Lactoglobulin Mariana Battaglin Villas-Boas (Brazil)

13:15 - 13:30

3159: Immediate and no immediate reactions induced by iodinated contrast medium nonionic among hospitalized patients: incidence and severity | Martín Bedolla-Barajas (Mexico)

13:30 - 13:45

3160: Severe Cutaneus Drug Reactions: Description of a Serie Cases | Fátima Fernandes (Brazil)

14:00 - 14:15

3162: Frequency of Sensitization for Food and Aero-Allergens in Patients Recieved in a Venezuelan Laboratory During 2010-2011 Period Cristina Najm (Venezuela)

Oral Abstract Session 13: Allergen Structure 2

Gran Cancún 2 (Cancún Center)

Chairpersons: Heimo Breiteneder (Austria) and Barbara Cases (Spain)

12:45 - 13:00

3163: Proteomic and Immunological Characterization of Ragweed Allergens | Steffen Augustin (Germany)

13:00 - 13:15

3164: Proteomic Analysis of Major and Minor Allergens From Isolated Pollen Cytoplasmic Granules | Oussama Abou Chakra (France)

13:15 - 13:30

3165: Cross-Reactivity Between Olive Pollen and 3 Species of Grasses in Madrid, Spain | Enrique Fernandez-Caldas (Spain)

13:30 - 13:45

3166: Molecular Properties and Immunological Reactivity of Arabidopsis EXPB1, a Non-Allergenic Homologue of Grass Group 1 Allergens | Mohan Singh (Australia)

13:45 - 14:00

3167: Protein-protein interactions determine IgE reactivity to polygalacturonase from Cupressus sempervirens pollen | Youcef Shahali (France)

14:00 - 14:15

3168: Grafting of Bet v 1 Epitopes Onto Its Homologue Api g 1 Reveals Patient-Specific IgE Recognition Profiles | Barbara Gepp (Austria)

Oral Abstract Session 14: Anaphylaxis

Gran Cancún 3 (Cancún Center)

Chairpersons: F. Estelle R. Simons (Canada) and Felicidad Cua-Lim (Philippines)

12:45 - 13:00

3169: Immunologic Evaluation of the Patients with Ranitidine Anaphylaxis | Hyun-Jung Jin (South Korea)

13:00 - 13:15

3170: Body Mass Index (BMI) and Immediate (“Stat”) Dose of Epinephrine IM (epi IM) Needed to Treat Subcutaneous Allergen Immunotherapy (SCIT) Systemic Reactions (SRs) | Michel Alkhalil (US)

13:15 - 13:30

3171: Muscle Relaxant Induced Allergic Reactions | Gyu-Young Hur (South Korea)

13:30 - 13:45

3172: Features of 51 Patients with Perioperative Anaphylaxis History | Laila Sabino Garro (Brazil)

13:45 - 14:00

3173: Drug Induced Anaphylaxis In A University Hospital In Sao Paulo, Brazil | Marcelo Vivolo Aun (Brazil)

14:00 - 14:15

3174: Analysis of Anaphylactic Reactions to Biological Agents Reported to the Italian Pharmacovigilance Database Giovanna Zanoni (Italy)

Oral Abstract Session 15: Global Asthma Epidemiology

Gran Cancún 4 (Cancún Center)

Chairpersons: Jing Li (China) and Gailen Marshall (US)

12:45 - 13:00

3175: Recurrent Wheezing In Infancy: Epidemiological Changes Between EISL Phase I and III | Herberto Jose Chong Neto (Brazil)

13:00 - 13:15

3176: Asthma Admission Rates in Germany: An Analysis of the Nationwide DRG-Statistic of the Year 2009 | Maria Weyermann (Germany)

13:15 - 13:30

3177: Prevalence and Classification of Asthma In Freshmen Students of A Guatemalan University and Its Relationship with Aeroallegens Sensitization | Juan Pablo Maselli (Guatemala)

13:30 - 13:45

3178: Asthma Mortality in Brazil (1998-2006) Adelmir Souza-Machado (Brazil)

13:45 - 14:00

3179: Dose Response Relationship Between Ascaris Sensitisation and Atopy and Bronchial Hyper-Responsiveness but Not Allergic Diseases in Black South Africans | Michael Levin (South Africa)

14:00 - 14:15

3180: Association of Matrix Metalloproteinase-7 and -12 Genes Polymorphisms with Asthma: A Case-Control Study of MMP-7 and -12 In a Japanese Population | Fumiya Yamaide (Japan)

Oral Abstract Session 16: Hereditary Angioedema

Gran Cancún 5 (Cancún Center)

Chairpersons: Michael Frank (US) and Bruce Zuraw (US)

12:45 - 13:00

3181: Hereditary Angioedema and Normal C1-Inhibitor (HAE Type III): A Novel Mutation In the Coagulation Factor 12 Gene | Konrad Bork (Germany)

13:00 - 13:15

3182: Immuno-Safety of Recombinant Human C1 Inhibitor in Patients with Hereditary Angioedema: An Integrated Analysis Anurag Relan (Netherlands)

13:15 - 13:30

3183: Clinical Efficacy of Recombinant Human C1 Inhibitor in Patients with Acute Hereditary Angioedema Attacks Marc Riedl (US)

13:30 - 13:45

3184: Open-Label Use of Nanofiltered C1 Esterase Inhibitor (Human) (C1 INH-nf) for the Prophylaxis of Hereditary Angioedema (HAE) Attacks William Lumry (US)

13:45 - 14:00

3185: The Efficacy and Safety of Human Plasma-Derived C1-Inhibitor Concentrate Administered for the Treatment of Attacks in Pediatric Patients with Hereditary Angioedema Due to C1-Inhibitor Deficiency | Henriette Farkas (Hungary)

14:00 - 14:15

3186: Treatment of Idiopathic Nonhistaminergic Angiodema with Icatibant | Ramon Lleonart (Spain)

Oral Abstract Session 17: Immunomodulators

Cozumel 2 (Cancún Center)

Chairpersons: Jorge Kalil (Brazil) and Anthony Frew (United Kingdom)

12:45 - 13:00

3187: Modulation of Human Basophilic Responses by a Fibroleukin-Allergen Fusion Protein | Maaike Dooper (Norway)

13:00 - 13:15

3188: Immunogenicity and Safety Aspects of Adeno-Associated Virus–Like Particles (AAVLPs) As Carriers for B-Cell Vaccines | Erika Jensen-Jarolim (Austria)

13:15 - 13:30

3189: M-Cell Targeting by Neuraminidase Functionalized Microparticles for Future Application in Oral Immunotherapy Cornelia Schultz (Austria)

13:30 - 13:45

3190: Neisseria Meningitidis Derived Proteoliposome As An Adjuvant for Allergen Vaccines | Wendy Ramírez González (Cuba)

13:45 - 14:00

3191: Immunomodulatory Effects of Manumycin-Type Antibiotics On Human Macrophages | Ilja Striz (Czech Republic)

Oral Abstract Session 18: Inhaled Corticosteroids for Asthma

Isla Mujeres (Cancún Center)

Chairpersons: Diana Deleanu (Romania) and Stanley Szefler (US)

12:45 - 13:00

3192: A Post-Hoc Analysis of Asthma Control and Lung Function Following Treatment with Ciclesonide 80 µg HFA-MDI Twice Daily In Subjects with Mild-to-Moderate Persistent Asthma Previously Receiving Low Dose Fluticasone Propionate/Salmeterol | Eli Meltzer (US)

13:00 - 13:15

3193: The Particle Size of Mometasone Furoate 100 Mcg and 200 Mcg Dry Powder Formulations | Robert Berger (US)

13:15 - 13:30

3194: Clinical Efficacy of Once-Daily Mometasone Furoate in Children with Persistent Asthma Switched From Treatment with Fluticasone Propionate Ariel Teper (US)

13:30 - 13:45

3195: Inhaled Mometasone Furoate Improved Efficacy in Pediatric Asthma Patients Regardless of Previous Inhaled Corticosteroid Therapy: Pooled Data From the Ariel Teper (US)

13:45 - 14:00

3196: Comparison of the Use Ciclesonide Versus Fluticasone for the Treatment of Asthma in Children | Said Arablin Oropeza (Mexico)

14:00 - 14:15

3197: Mometasone Furoate Vs Fluticasone Propionate in Mild Persistent Asthma: Retrospective Analysis of Asthma Control and Adherence Felicia Allen-Ramey (US)

Oral Abstract Session 19: Mechanisms of Allergic Inflammation

Tulum (Cancún Center)

Chairpersons: Mubeccel Akdis (Switzerland) and Hirohisa Saito (Japan)

13:00 - 13:15

3199: Type I and III Interferon Are Attenuated in a Human Invitro Model of Alternatively Activated Macrophages | Ashraf EL Fiky (US)

13:15 - 13:30

3200: A Highly Sensitive and Specific Universal Mirna Profiling Method | Jia-Wang Wang (US)

13:30 - 13:45

3201: Caspase-4 Plays a Role in the Activation of the Cryopyrin/NLRP3 Inflammasome | Ruan Cox Jr. (US)

13:45 - 14:00

3202: Genome-Wide Association Studies of Asthma Indicate Opposite Immunopathogenesis Direction From Autoimmune Diseases | Xingnan Li (US)

14:00 - 14:15

3203: Allergy Is An Epithelial Barrier Disease | Risto Renkonen (Finland)

Oral Abstract Session 20: Patho-Biology of Nasal Polyps

Xcaret (Cancún Center)

Chairpersons: Robert Naclerio (US) and Mark Glaum (US)

12:45 - 13:00

3204: Mutiplex Analyses of Cytokine and Chemokine Release From the Cultured Fibroblast of Nasal Polyp: The Effect of IL-17A | Katsuhisa Ikeda (Japan)

13:00 - 13:15

3205: Expression of Chemokine Receptors CCR1, CCR3, CCR4, CCR5, CCR8 and CXCR3 in Human Nasal Polyps (NP); Cmparison with NP From Allergic Patients with Aspirin Intolerance | Petra Fundova (Czech Republic)

13:15 - 13:30

3206: Characterization of Two Epithelial Cell Air-Liquid Interface (ALI) Culture Models for Human Healthy Nasal Mucosa and Nasal Polyps | Fco. de Borja Callejas (Spain)

13:30 - 13:45

3207: Corticosteroid Treatment Reduces Tissue Eosinophilia and the Expression of Matrix Metalloproteinases (MMP-1, MMP-2, MMP-7, MMP-9) and Their Tissue Inhibitor (TIMP-1) in Nasal Polyps | Fco. de Borja Callejas (Spain)

13:45 - 14:00

3208: Expression and Localization of CysLT2 Receptor In Human Nasal Mucosa | Shirasaki Hideaki (Japan)

14:00 - 14:15

3209: Increased Expression and Role of Thymic Stromal Lymphopoietin In Nasal Polyposis | Satoko Kimura (Japan)

Oral Abstract Session 21: Respiratory Infections

Costa Maya 1 (Cancún Center)

Chairpersons: Robert C. Strunk and Hyun Hee Kim (South Korea)

12:45 - 13:00

3210: Inhibition of AKT Kinase Activity Decreases Replication of Human Respiratory Syncytial Virus Michael Teng (US)

13:00 - 13:15

3211: Abnormal Immune Response Against Respiratory Pathogens In Olympic Athletes | Marcin Kurowski (Poland)

13:15 - 13:30

3212: The Immune Response Against Respiratory Pathogens in Patients with Chronic Rhinosinusitis/Nasal Polyps and Asthma with or without Sensitivity to Aspirin | Agnieszka Olszewska-Ziąber (Poland)

13:30 - 13:45

3213: Immunologic and Clinical Characteristics of Pediatric Population with Human Influenza Virus H1N1 infection in Federal Hospital of Mexico | Jaime Mellado-Abrego (Mexico)

13:45 - 14:00

3214: Evaluation of Various Forms of Sinusitis Using Bone SPECT | Sergul Ulus (Turkey)

14:00 - 14:15

3215: Rhinitis: WHERE IS the Biofilm? | Matteo Gelardi (Italy)

Oral Abstract Session 22: Rhinitis Treatment 1

Costa Maya 2 (Cancún Center)

Chairpersons: Michael S. Blaiss (US) and Teet Pullerits (Sweden)

12:45 - 13:00

3216: A 6-Week Study of the Efficacy and Safety of Ciclesonide Hydrofluoroalkane Nasal Aerosol In the Relief of Nasal Symptoms of Perennial Allergic Rhinitis John Karafilidis (US)

13:00 - 13:15

3217: 3-D Visualization of the Anti-Obstructive Effect of Levocetirizine | Nils Achilles (Germany)

13:15 - 13:30

3218: Levels of VCAM and ICAM In Patients with Allergic Rhino-Conjunctivitis and H1 Antihistamines | Ioana Adriana Bujor (Romania)

13:30 - 13:45

3219: Once Daily Intranasal Fluticasone Furoate Decreases Daytime Sleepiness and Improves Cognitive Performance in Symptomatic Seasonal Allergic Rhinitis | Alejandro Diaz (US)

13:45 - 14:00

3220: International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR). Physicians' View | H A Badellino (Argentina)

14:00 - 14:15

3221: International Survey on the Management of Allergic Rhinitis by Physicians and Patients (ISMAR): The Patients' View | Alvaro Teijeiro (Argentina)

Oral Abstract Session 23: Sublingual Immunotherapy 2

Auditorium (Cancún Center)

Chairpersons: Giorgio Walter Canonica (Italy) and Linda Cox (US)

12:45 - 13:00

3222: Therapeutic Effect and Safety of the Sublingual Immunotherapy with Tropical House Dust Mite Allergen Vaccines in Asthmatic Cuban Adult Patiens | Raúl Lázaro Castro Almarales (Cuba)

13:00 - 13:15

3223: Candidate for Response Monitoring or Prognostic Biomarkers In Two-Year Sublingual Immunotherapy for Japanese Cedar Pollinosis | Takashi Fujimura (Japan)

13:15 - 13:30

3224: Efficacy and Safety of 300IR 5-Grass Pollen Sublingual Allergen Immunotherapy Tablets in US Adults with Grass-Pollen Allergic Rhinoconjunctivitis | Linda Cox (US)

13:30 - 13:45

3225: Establishing the Effectiveness, Cost-Effectiveness and Safety of Oral and Sublingual Immunotherapy for Food Allergy: A Systematic Review and Meta-Analysis of Intervention Studies | Ulugbek Nurmatov (United Kingdom)

13:45 - 14:00

3226: Safety of Timothy Grass Allergy Immunotherapy Tablet In North American Adults and Children | Peter Creticos (US)

14:00 - 14:15

3227: Safety and Tolerability of Timothy Grass Allergy Immunotherapy Tablet In Adults and Children with Allergic Rhinoconjunctivitis: Post Hoc Analysis of 7 Clinical Trials | Hendrik Nolte (US)

Year in Review 2: Rhinosinusitis

Costa Maya 2 (Cancún Center)

15:00 - 15:35

2-1YiR: Pathophysiology | Robert Naclerio (US)

15:35 - 16:10

2-2YiR: Treatment | Glenis Scadding (United Kingdom)

16:10 - 16:30

Discussion

Collaborating Partner Symposium 4: American Lung Association - Asthma Clinical Research Network: Asthma in the Elderly (AIE): Challenges and Opportunities

Gran Cancún 4 (Cancún Center)

Chairpersons: Shyam Mohapatra (US) and Alvaro Cruz (Brazil)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

4-1CPS: Diagnostic and Management Challenges | Nicola Hanania MD, (US)

15:25 - 15:45

4-2CPS: Atopy and Aging: An Ongoing Challenge | Monroe James King (US)

15:45 - 16:05

4-3CPS: Immunologic Changes in Aging | Linda Rogers (US)

16:05 - 16:30

Panel Discussion

Company Sponsored Symposium 4: Robert Michael Education Institute: A Worldwide Perspective on Hereditary Angioedema (HAE): Current Practices, Evolving Therapies, and Special Populations

Cozumel 2 (Cancún Center)

Chairpersons: Konrad Bork (Germany) and Michael Frank (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

4-1CSS: HAE Epidemiology and Worldwide Practices | Marcus Maurer (Germany)

15:25 - 15:45

4-2CSS: HAE Treatments: Improving Outcomes with Evolving Therapies | Bruce Zuraw (US)

15:45 - 16:05

4-3CSS: HAE in Special Populations: A Focus on Women and Type III HAE | Marc Riedl (US)

16:05 - 16:30

Panel Discussion

Sister Society Symposium 8: German Society for Allergology and Clinical Immunology: Microbes - Friends or Foes of Allergic Disease?

Gran Cancún 2 (Cancún Center)

Chairpersons: Mubeccel Akdis (Switzerland) and Massimo Triggiani (Italy)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

8-1SSS: Role of Skin-Colonizing Microbes in Atopic Dermatitis | Thomas Werfel (Germany)

15:25 - 15:45

8-2SSS: From Staphylococcus Aureus Enterotoxins to Nasal Polyps and Asthma | Claus Bachert (Belgium)

15:45 - 16:05

8-3SSS: The Role of Microbes in Allergy Protection | Harald Renz (Germany)

16:05 - 16:30

Discussion

Sister Society Symposium 9: Mexican College of Pediatricians Specialized in Allergy and Clinical Immunology: Food Allergy

Cozumel 1 (Cancún Center)

Chairpersons: José Antonio Ortega Martell (Mexico) and Fernando Iduñate-Palacios

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

9-1SSS: WAO Position Paper: Diagnosis and Rational for Action Against Cows Milk Allergy (DRACMA) | Rosa Elena Huerta Hernández (Mexico)

15:25 - 15:45

9-2SSS: Risk Factors for Food Allergy for the Latin American Population | Emilia María Hidalgo Castro

15:45 - 16:05

9-3SSS: Food Hypersensitivity and Atopic Dermatitis in Toddlers | Elizabeth Estrada Reyes (Mexico)

16:05 - 16:30

Panel Discussion

Sister Society Symposium 10: Allergy Society of South Africa: Aetiology of Allergy - Can Africa Help Provide the Answer?

Isla Mujeres (Cancún Center)

Chairpersons: Allen P. Kaplan (US) and Sami Bahna (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:30

10-1SSS: Linking Allergy and Asthma - Lessons from Africa | Michael Levin (South Africa)

15:30 - 15:55

10-2SSS: Food Allergy in South Africa: Increasing Prevalence | Claudia Gray (South Africa)

15:55 - 16:20

10-3SSS: Eosinophilic Esophagitis in South Africa | Michael Levin (South Africa)

16:20 - 16:30

Panel Discussion

Workshop 11: Betalactams Reactions

Coral Gallery 1 (Fiesta Americana)

15:00 - 15:05

Introductory Remarks

15:05 - 15:20

11-1WS: Diagnosis of Betalactam Sensitivity | Louis Mendelson (US)

15:20 - 15:35

11-2WS: Desensitization | David Khan (US)

15:35 - 15:50

11-3WS: Cross Reactions | Daniel Yerly (Switzerland)

15:50 - 16:30

Discussion

Sister Society Symposium 11: Korean Academy of Allergy, Asthma and Clinical Immunology: Severe Asthma

Costa Maya 1 (Cancún Center)

Chairpersons: Hee-Bom Moon (South Korea) and Ho Joo Yoon (South Korea)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

11-1SSS: Clinical Features of Severe Asthma: Korean Cohort Study | You Sook Cho (South Korea)

15:25 - 15:45

11-2SSS: Findings from the US Cohort Study | Sally Wenzel (US)

15:45 - 16:05

11-3SSS: Management of Severe Asthma | Heung-Woo Park (South Korea)

16:05 - 16:30

Panel Discussion

Workshop 12: Chronic Cough

Coral Gallery 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

12-1WS: Mechanisms | James Baraniuk (US)

15:20 - 15:35

12-2WS: Children | Pramod Kelkar (US)

15:35 - 15:50

12-3WS: Adults | Riccardo Polosa (Italy)

15:50 - 16:30

Discussion

Workshop 13: Severe Cutaneous Drug Reactions

Coral Gallery 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

13-1WS: Acute Severe Drug Reactions: Genes to Biomarkers | Miguel Blanca (Spain)

15:20 - 15:35

13-2WS: Drug Reaction with Eosinophilia and Systemic Symptom (DRESS) Syndrome | Mariana Castells (US)

15:35 - 15:50

13-3WS: Toxic Epidermal Necrolysis (TEN) and Steven Johnson Syndrome | Ichiro Katayama (Japan)

15:50 - 16:30

Discussion

Workshop 14: Advances in the Diagnosis and Management of Ocular Allergy

Coral Island (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

14-1WS: Pathophysiology of Conjunctival Inflammation | Sergio Bonini (Italy)

15:20 - 15:35

14-2WS: The Clinical Spectrum of Ocular Allergy | Connie Katelaris (Australia)

15:35 - 15:50

14-3WS: Ocular Allergy Treatment | Leonard Bielory (US)

15:50 - 16:30

Discussion

Workshop 15: Contact Dermatitis in Children

Coral Sea (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

15-1WS: Mechanisms of Allergic Contact Dermatitis | Claudia Traidl-Hoffmann (Germany)

15:20 - 15:35

15-2WS: New Contact Allergens | Luz Fonacier (US)

15:35 - 15:50

15-3WS: Contact Dermatitis in Children: Do We Need Regular Patch Testing? | Iris Ale (Uruguay)

15:50 - 16:30

Discussion

Workshop 16: Obstructive Sleep Disorders in Breathing in Childhood

Coral Kingdom 1 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

16-1WS: School and Behavior Problems | Michael S. Blaiss (US)

15:20 - 15:35

16-2WS: Allergic Rhinitis | Timothy J. Craig (US)

15:35 - 15:50

16-3WS: Adenotonsillar Hypertrophy | Athanasios Kaditis (Greece)

15:50 - 16:30

Discussion

Workshop 17: The Use of Forms and Templates in Office Practice

Coral Kingdom 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

17-1WS: History, Physical Examination and Skin Testing | Michael A. Kaliner (US)

15:20 - 15:35

17-2WS: Immunotherapy | Dana Wallace (US)

15:35 - 15:50

17-3WS: Patient Information | Désirée Larenas Linnemann (Mexico)

15:50 - 16:30

Discussion

Workshop 18: University Training Program - University of South Florida: Hands-On Session: Rhinolaryngoscopy (Session #2)

Coral Kingdom 3 (Fiesta Americana)

Speaker(s): Roger Fox (US) , Mario Zernotti (Argentina)

15:20 - 16:30

Hands-On Demonstration

Workshop 19: Controversies Surrounding Long-Acting Beta Agonists (LABAs) in Asthma

Coral Garden 1 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

19-1WS: Safety of LABAs | Jan Brozek (Canada)

15:20 - 15:35

19-2WS: Step-Down Therapy | Robert C. Strunk

15:35 - 15:50

19-3WS: Step-Up Therapy | Homer Boushey (US)

15:50 - 16:30

Discussion

Symposium 20: Chronic Rhinosinusitis (CRS) in Children

Gran Cancún 5 (Cancún Center)

Chairpersons: Joel Oyoqui Flores (Mexico) and Juan Carlos Ivancevich (Argentina)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

20-1SY: A Walk Through the Guidelines for the Diagnosis and Management of Rhinosinusitis | Eli Meltzer (US)

15:25 - 15:45

20-2SY: Clinical Characteristics | Hector Stone-Aguilar (Mexico)

15:45 - 16:05

20-3SY: Management | José Antonio Sacre Hazouri (Mexico)

16:05 - 16:30

Panel Discussion

Workshop 20: Decreasing the Prevalence of Allergic Diseases and Asthma - The WAO World Allergy Action Plan

Coral Garden 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

20-1WS: Changing the Allergy Paradigm - Time to Act | Tari Haahtela (Finland)

15:20 - 15:35

20-2WS: Allergy Health in Children | Mika Mäkelä

15:35 - 15:50

20-3WS: Allergy as an Immune Adaptation Syndrome | Joshua Boyce (US)

15:50 - 16:30

Discussion

Workshop 21: Diagnostic Procedures for Rhinitis

Coral Garden 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

21-1WS: Nasal Challenges | Alkis Togias (US)

15:20 - 15:35

21-2WS: Assessing the Sense of Smell | Joaquim Mullol (Spain)

15:35 - 15:50

21-3WS: Clinical Considerations and Quality of Life: Implications for Treatment | Mark Dykewicz, MD (US)

15:50 - 16:30

Discussion

Symposium 21: The Innate and Adaptive Immune Systems

Tulum (Cancún Center)

Chairpersons: Alejandro Escobar-Gutiérrez (Mexico) and James Oleske (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

21-1SY: Innate | Elena Perez (US)

15:25 - 15:45

21-2SY: Adaptive Immune System | Cezmi Akdis (Switzerland)

15:45 - 16:05

21-3SY: Laboratory Testing | Thomas Fleisher (US)

16:05 - 16:30

Panel Discussion

Symposium 22: New Concepts about Occupational Asthma

Xcaret (Cancún Center)

Chairpersons: Louis-Philippe Boulet (Canada) and Jan Lötvall (Sweden)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

22-1SY: Genetic Predisposition | Hae-Sim Park (South Korea)

15:25 - 15:45

22-2SY: Pathogenesis | David Peden (US)

15:45 - 16:05

22-3SY: Prevention and Therapy | Jonathan Bernstein (US)

16:05 - 16:30

Panel Discussion

Symposium 23: WAO Junior Members Group

Bacalar (Cancún Center)

Chairpersons: Matteo Bonini (Italy) and Silvia Sanchez-Garcia (Spain)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

23-1SY: How a Protein Becomes an Allergen and an Allergen a Candidate for Correct Diagnosis and/or Immunotherapy. Ole e 11 as a Model to Study | Guillermo Salamanca (Spain)

15:20 - 15:35

23-2SY: Allergic Rhinitis and Oral Malocclusion in Children | Claudia Gallego (Mexico)

15:35 - 15:50

23-3SY: Sensitization to Fungi and its Relation to Asthma and Allergic Rhinitis | Alexander Diaz Rodriguez (Cuba)

15:50 - 16:05

23-4SY: Skin Irritation and Allergic Contact Sensitization in Atopic Dermatitis | Razvigor Darlenski (Bulgaria)

16:05 - 16:20

23-5SY: Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy | Kiyotake Ogura (Japan)

16:20 - 16:30

Discussion

Debates 6: Environmental Control for Allergic Diseases: Does it Work?

Gran Cancún 1 (Cancún Center)

Chairpersons: Juan Carlos Sisul Alvariza (Paraguay) and David Lang (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

6-1DB: Pro | Thomas Platts-Mills (US)

15:20 - 15:35

6-2DB: Con | Adnan Custovic (United Kingdom)

15:35 - 15:40

Pro Rebuttal

15:40 - 15:45

Con Rebuttal

15:45 - 16:00

Discussion

Debates 7: Atopic Eczema: Barrier Dysfunction or Immune Deviation?

Gran Cancún 3 (Cancún Center)

Chairpersons: Myron Zitt (US) and Tatiana Slavyanskaya (Russia)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

7-1DB: Immune Deviation in Atopic Eczema is Crucial | Johannes Ring (Germany)

15:20 - 15:35

7-2DB: Barrier Dysfunction in Atopic Eczema is Crucial | Richard Gallo (US)

15:35 - 15:40

Barrier Dysfunction Rebuttal

15:40 - 15:45

Immune Deviation Rebuttal

15:45 - 16:00

Discussion

Breakfast Symposium 23: Topical Treatments of Atopic Dermatitis

Coral Gallery 1 (Fiesta Americana)

Speaker(s): Adnan Custovic (United Kingdom) , Tatiana Slavyanskaya (Russia) , Claudia Traidl-Hoffmann (Germany)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 24: Clinical and Laboratory Diagnosis of Autoimmune Diseases

Coral Gallery 2 (Fiesta Americana)

Speaker(s): James Baker (US) , Dennis Ledford (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 25: Milk Induced Disorders

Coral Gallery 3 (Fiesta Americana)

Speaker(s): Amal Assa'ad (US) , Hirohisa Saito (Japan)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 26: Gastrointestinal (GI) Complaints in Food Allergy

Coral Island (Fiesta Americana)

Speaker(s): Dan Atkins (US) , Ichiro Nomura (Japan)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 27: Sister Society Session - Danish Society of Allergology: Basophil Activation as a Measure of Allergic Response

Coral Sea (Fiesta Americana)

Speaker(s): S.G.O. Johansson, Kaare Lund

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 28: Genes, Allergens and Asthma

Coral Kingdom 1 (Fiesta Americana)

Speaker(s): Juan Carlos Celedon (US) , Luis Caraballo (Colombia)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 29: How to Publish a Scientific Paper

Coral Kingdom 2 (Fiesta Americana)

Speaker(s): Lanny Rosenwasser (US) , Larry Schwartz (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 30: Otitis Media

Coral Kingdom 3 (Fiesta Americana)

Speaker(s): Robert Naclerio (US) , Mario Zernotti (Argentina)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 31: Choosing a Career Path in Allergy and Immunology

Coral Garden 1 (Fiesta Americana)

Speaker(s): Stanley Fineman (US) , Sandra González-Díaz (Mexico)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 32: Cold Induced Skin Disorders

Coral Garden 2 (Fiesta Americana)

Speaker(s): Hal Hoffman (US) , Marcus Maurer (Germany)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Breakfast Symposium 33: Complementary and Alternative Medicine: Does it Work?

Coral Garden 3 (Fiesta Americana)

Speaker(s): Leonard Bielory (US) , David Peden (US) , William Silvers (US)

07:00 - 07:05

Welcoming Remarks

07:05 - 08:15

Question and Answer

Plenary Session 8: Environment and Allergy

Gran Cancún (Cancún Center)

Chairpersons: Alfonso Cepeda (Colombia) and Enrique Fernandez-Caldas (Spain)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

8-1PS: Allergic Diseases and Climate Change | Jeffrey Demain (US)

09:00 - 09:25

8-2PS: Biodiversity Hypothesis | Tari Haahtela (Finland)

09:25 - 09:50

8-3PS: Innate Immunity to Microbes and Allergy | Christopher Karp (US)

09:50 - 10:00

Discussion

Plenary Session 9: Obesity and Asthma

Cozumel (Cancún Center)

Chairpersons: Revaz I. Sepiashvili (Russia) and Athanasios Kaditis (Greece)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

9-1PS: Obesity, Airway Hyperresponsiveness and Inflammation | Fernando Holguin (US)

09:00 - 09:25

9-2PS: Does Obesity Influence Medication Response? | Marc Peters-Golden (US)

09:25 - 09:50

9-3PS: Obesity and Asthma Control/Severity | Louis-Philippe Boulet (Canada)

09:50 - 10:00

Discussion

Plenary Session 10: New Concepts in Mast Cell Mediators

Costa Maya (Cancún Center)

Chairpersons: Cem Akin (US) and Mariana Castells (US)

08:30 - 08:35

Welcoming Remarks

08:35 - 09:00

10-1PS: Novel Leukotriene Receptors | Joshua Boyce (US)

09:00 - 09:25

10-2PS: Tryptase: From Anaphylaxis to Mastocytosis | Larry Schwartz (US)

09:25 - 09:50

10-3PS: Prostaglandin D2 (PGD2): Therapeutic Implications | Andrew Wardlaw (United Kingdom)

09:50 - 10:00

Discussion

Year in Review 3: Asthma

Gran Cancún 1 (Cancún Center)

10:45 - 11:20

3-1YiR: Pathophysiology | Sally Wenzel (US)

11:20 - 11:55

3-2YiR: Treatment | Paul O'Byrne (Canada)

11:55 - 12:15

Discussion

Collaborating Partner Symposium 5: National Heart, Lung and Blood Institute (NHLBI) Clinical Research Network’s New Findings on the Stepwise Approach to Managing Asthma

Cozumel 2 (Cancún Center)

Chairpersons: James Kiley and Thomas B. Casale (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

5-1CPS: Step Up Therapy in Children | Daniel Jackson (US)

11:10 - 11:30

5-2CPS: Adjusting Therapy in Adults | Elliot Israel (US)

11:30 - 11:50

5-3CPS: Intermittent Versus Daily Inhaled Corticosteroid Therapy in Children | Fernando D. Martinez (US)

11:50 - 12:15

Panel Discussion

Collaborating Partner Symposium 6: Insights from the Global Allergy and Asthma Network (GA²LEN)

Xcaret (Cancún Center)

Chairpersons: Joaquim Mullol (Spain) and Marek L Kowalski (Poland)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

6-1CPS: Can the Severity of Allergy be Uniformly Defined? | Sergio Bonini (Italy)

11:10 - 11:30

6-2CPS: GA²LEN in Europe and Beyond | Torsten Zuberbier (Germany)

11:30 - 11:50

6-3CPS: GA²LEN, WAO and Guidelines | Giorgio Walter Canonica (Italy)

11:50 - 12:15

Panel Discussion

Sister Society Symposium 12: Southern European Allergy Societies (SEAS): Immunotherapy

Gran Cancún 5 (Cancún Center)

Chairpersons: Carlos Nunes (Portugal) and Luigi Fontana

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

12-1SSS: Safety and Efficacy with Polimerized Extracts | Ignacio J. Ansotegui (Spain)

11:10 - 11:30

12-2SSS: Omalizumab Plus Immunotherapy | Mario Morais de Almeida (Portugal)

11:30 - 11:50

12-3SSS: Economical Impact | Massimo Triggiani (Italy)

11:50 - 12:15

Panel Discussion

Sister Society Symposium 13: Venezuelan Society of Allergy and Immunology: Genetic and Epigenetic Implications in Allergic and Asthmatic Latin Americans

Isla Mujeres (Cancún Center)

Chairperson: Luis Sarmiento (Venezuela)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

13-1SSS: Genetics | Paolo Tassinari (Venezuela)

11:10 - 11:30

13-2SSS: Prescription Patterns | Fernan Caballero-Fonseca

11:30 - 11:50

13-3SSS: Specific Immunotherapy | Eliana Risquez (Venezuela)

11:50 - 12:15

Panel Discussion

Symposium 24: Why are Small Airways Important in Asthma? - This WAO Symposium is supported through unrestricted educational grants from Teva and Takeda

Gran Cancún 2 (Cancún Center)

Chairpersons: Lanny Rosenwasser (US) and Christian Virchow (Germany)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

24-1SY: Pathophysiology of Small Airways Disease | Qutayba Hamid (Canada)

11:10 - 11:30

24-2SY: Physiology of Small Airways Disease | Charles Irvin (US)

11:30 - 11:50

24-3SY: Particle Deposition and Pharmacotherapy of Small Airways Disease | Lanny Rosenwasser (US)

11:50 - 12:15

Panel Discussion

Symposium 25: WAO Anaphylaxis Guidelines - WAO Anaphylaxis Special Committee

Gran Cancún 3 (Cancún Center)

Chairpersons: Yehia El-Gamal (Egypt) and Stephen Galli (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

25-1SY: Epidemiology | Paul Greenberger (US)

11:10 - 11:30

25-2SY: Clinical Aspects and Diagnosis | Mario Sanchez-Borges (Venezuela)

11:30 - 11:50

25-3SY: Treatment | F. Estelle R. Simons (Canada)

11:50 - 12:15

Panel Discussion

Symposium 26: Vitamin D: How Important in Allergic Diseases?

Gran Cancún 4 (Cancún Center)

Chairpersons: Robert Lemanske, MD (US) and Jeffrey Demain (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

26-1SY: Anaphylaxis | Carlos Camargo (US)

11:10 - 11:30

26-2SY: Asthma | Attilio Boner

11:30 - 11:50

26-3SY: Viral-Respiratory Infections | Robert C. Strunk

11:50 - 12:15

Panel Discussion

Symposium 27: 2013 EAACI-WAO World Allergy & Asthma Congress - Milan, Italy: Novel and Emerging Therapeutic Strategies for Allergy and Asthma

Cozumel 1 (Cancún Center)

Chairpersons: Cezmi Akdis (Switzerland) and Ruby Pawankar (Japan)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

27-1SY: Immunomodulators - A Brave New World | Zuhair Ballas (US)

11:10 - 11:30

27-2SY: Inducing Immune Tolerance to Allergens - Implications for Treatment | Mubeccel Akdis (Switzerland)

11:30 - 11:50

27-3SY: Preventive Strategies | Susan L. Prescott (Australia)

11:50 - 12:15

Panel Discussion

Symposium 28: Immunobiologic Approaches in Allergy

Costa Maya 2 (Cancún Center)

Chairpersons: Riccardo Polosa (Italy) and Hal Hoffman (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:10

28-1SY: Translational Research and Immunomodulators in Allergy | Jorge Kalil (Brazil)

11:10 - 11:30

28-2SY: Anti-IgE Use in Allergy | Pedro Giavina-Bianchi (Brazil)

11:30 - 11:50

28-3SY: Anti-Eosinophil Strategies | Seema Aceves (US)

11:50 - 12:15

Panel Discussion

Debates 8: Genetically Modified Foods: Are They a Problem?

Costa Maya 1 (Cancún Center)

Chairpersons: Hugh Sampson (US) and Thomas Holzhauser (Germany)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

8-1DB: Pro | Dan Atkins (US)

11:05 - 11:20

8-2DB: Con | Amal Assa'ad (US)

11:20 - 11:25

Pro Rebuttal

11:25 - 11:30

Con Rebuttal

11:30 - 11:45

Discussion

Debates 9: Long-Acting Beta Agonists (LABAs) vs. Tiotropium for Asthma

Auditorium (Cancún Center)

Chairpersons: Reynold A. Panettieri, Jr. (US) and Allison Fryer (US)

10:45 - 10:50

Welcoming Remarks

10:50 - 11:05

9-1DB: LABAs | Klaus Rabe (Germany)

11:05 - 11:20

9-2DB: Tiotropium | Mario Castro (US)

11:20 - 11:25

LABAs Rebuttal

11:25 - 11:30

Tiotropium Rebuttal

11:30 - 11:45

Discussion

Poster Session 36: Epidemiology of Allergic Rhinitis

Poster Hall (Cancún Center)

4000

Treatment of Nasal Allergies: Results From the Allergies Surveys in America, Asia Pacific, Latin America, and Middle East | Michael S. Blaiss (US)

4001

Comorbid Allergy-Related Respiratory Conditions Among Children and Adults Diagnosed with Allergic Rhinitis: Findings From Research Jointly Funded by the AAAAI and ACAAI | Cheryl Hankin (US)

4002

Survey of Rhinitis Phenotypes | Sergio Bonini (Italy)

4003

Prevalence and Risk Factors Associated to Symptoms of Rhinoconjunctivitis In Mexican School Children. A Multicenter Study | Mayra Alondra Livano Prez (Mexico)

4004

Oral Allergy Syndrome and United Airways Disease: Is There a Functional Connection? | Carlo Lombardi (Italy)

4005

Epidemiological and Clinical Characteristics of Allergic Conjunctivitis Patients in a Reference Center of Mexico City | Atzin Robles-Contreras (Mexico)

4006

The Classification of Allergic Rhinitis and ITS Cytological Correlate | Matteo Gelardi (Italy)

4007

Incidence of Allergic Diseases on Children Under 5 Years in Juarez Hospital Mexico | María Isabel Rojo Gutiérrez (Mexico)

Poster Session 37: Diagnostic Test for Allergic Rhinitis

Poster Hall (Cancún Center)

4008

Comparison of Skin and Conjunctival Reactivity to Aeroallergens Nelson Rosario (Brazil)

4009

Correlation Between Skin Prick Test and MAST Results In Patients with Chronic Rhinitis Jin Hee Cho (South Korea)

4010

Cutaneous Response to Patch Tests with Dermatophagoides Farinae and Dermatophagoides Pteronyssinus in Patients with Chronic Rhinitis | Diego Garcia-Calderin (Mexico)

4011

Skin Prick Test Reactivity Compared to Serum Specific IgE by ISAC in Patients with Rhinitis | Laura Araujo (Brazil)

4012

Alteration of Smell In Patients with Persistent Allergic Rhinitis Alvaro Teijeiro (Argentina)

4013

Effectiveness of an Educational Intensive Course on A/I Clinical and Diagnostic Procedures Morna Dorsey (US)

Poster Session 38: Allergic Rhinitis

Poster Hall (Cancún Center)

4014

PCR Analysis of Microorganisms in Chronic Rhinosinusitis with Nasal Polyps | Mikio Hirotsu (Japan)

4015

Incidence of Allergy to Artemisia Vulgaris and Salsola Kali In Sabzevar City | Zahra Matloobi (Iran)

4016

The Prevalence of Allergic Rhinitis in Adolescent in the “La Paz-Bolivia” City. (3600 m.s.n.m.) | Abel Marcelo Moncada Alcon (Bolivia)

4017

Pattern of Positive Sensitization in Patient with Asthma and Rhinitis to 3600 Msnm (La Paz-Bolivia) | Abel Marcelo Moncada Alcon (Bolivia)

4018

Epidemiology of Allergic Rhinitis Cases In the Allergy Service of A Third Level Medical Center. Six Year Experience | Luis Rafael Sanchez-Gallardo (Mexico)

4019

The Evaluation of Allergen Sensitivity In Allergic Rhinoconjunctivitis and Allergic Asthma Patients In Antalya, Turkey | Arzu Didem Yalcin (Turkey)

4020

Allergic Disease Severity and Relations | Filipa Viveiros (Portugal)

4021

Frequency of Patients with Clinical Manifestations of Allergic Rhinitis without Evidence of Systemic Atopy and Specific IgE Sensitization | Norma de Paula Motta Rubini (Brazil)

4022

H1 Antihistamines INFLUENCE On PRO-INFLAMMATORY Cytokines LEVEL In PATIENTS with Allergic Rhinitis | Ioana Corina Bocsan (Romania)

4023

International Survey On the Management of Allergic Rhinitis by Physicians and Patients (ISMAR) | R M Gomez (Argentina)

4024

Effectiveness of Sinus Surgery for Lower Airway Disease | Ryoji Kagoya (Japan)

4025

Berberine Inhibits Myofibroblast Differentiation in Nasal Polyp-Deroved Fibroblast Via p-38 Pathway | Heung-man Lee (South Korea)

4026

Results of the Rhinoconjunctivitis Related Quality of Life Questionnaire Administered to Subjects with Seasonal Allergic Rhinitis Following Treatment with Ciclesonide Hydrofluoralkane Nasal Aerosol Shailesh Desai (US)

4027

Mold Sensitization in Chronic Rhinosinusitis Patients | Radoslaw Gawlik (Poland)

4028

“Nasal Cytology Is Important In the Classification of Patients with Allergic and Non-Allergic Rhinitis.” | Olavo Mion (Brazil)

4029

The Examination of the Association Between the Chronic Rhinosinusitis and the Inflammation of the Lower Respiratory Airway by Using the Exhaled Nitric Oxide(NO) and the Respiratory Function Test | Hiroyoshi Yoshinami (Japan)

4030

Peak Inspiratory Flow Rate Is More Sensitive Than Acoustic Rhinometry or Rhinomanometry In Detecting Nasal Obstruction Using the Allergen Challenge Chamber | Tetsuya Terada (Japan)

4031

Nasal Poliposis and Allergic Disease. Dr. Salvador Allende Hospital | Ada Castillo Méndez (Cuba)

4033

Use of the CT Navigation In the Rhinology and Head Surgery | Petra Fundova (Czech Republic)

4034

Rupatadine oral solution is efficacious and safe in children ( aged 6-11 years) with persistent allergic rhinitis | Paul Potter (South Africa)

4035

Assessment of the Quality of Methodological Rigour and Reporting of Clinical Practice Guidelines for the Management of Allergic Rhinitis – QUGAR study | Agnieszka Padjas (Poland)

4036

Health-Related Quality of Life and Prognostic Value of Acoustic Rhinometry in Patients with Perennial Allergic Rhinitis Treated with Fix Combination of Montelukast plus Desloratadine | Cemal Cingi (Turkey)

Poster Session 39: Conjunctivitis

Poster Hall (Cancún Center)

4037

Tear IL-4 Is Decreased in Allergic Conjunctivitis Patients with Negative Skin Test After Dialyzable Leukocyte Extracts Treatment | Gustavo Aguilar-Velazquez (Mexico)

4038

Histochemical Study of Allergic Inflammation in Conjunctiva From Ovalbumin Sensitized Rabbits After Ocular or Nasal Challenge | Rocio Batle (Argentina)

4039

Prevalence of Allergic Conjunctivitis in Childhood Herberto Jose Chong Neto (Brazil)

4040

Effects of Omalizumab in Children with Atopic Keratocojunctivitis: A New Treatment for Severe Ocular Allergies? – Report of Two Cases | Fábio Kuschnir (Brazil)

4041

Allergic Conjunctivitis, Allergic Comorbitidies and the Most Common Allergens Identified In A Group of Mexican Patients | Guillermina Cortés-Morales (Mexico)

4042

Giant Papillary Conjuntivitis without Associated Triggers. Report of Two Cases | Aida Gonzalez-Carsolio (Mexico)

4043

Contact Allergy Due to Ophthalmic Drugs in Uruguay | Valeria Pomies (Uruguay)

4044

Increased Frequency of γδ T Cells in Patients with Allergic Conjunctivitis | Miguel E Alonso-Sánchez (Mexico)

4045

Zero Itch in Eyes Treated with Olopatadine Hydrochloride Ophthalmic Solution, 0.2% in Bilateral Conjunctival Allergen Challenge Studies | Michael S. Blaiss (US)

Poster Session 40: Mastocytosis

Poster Hall (Cancún Center)

4046

Mastocytosis and IgE-Dependent Sensitization: Report of 2 Cases Carla Bastías (Chile)

4047

Mastocytosis: Importance As Differential Diagnosis In Skin Diseases. Report of Two Cases | Aida Gonzalez-Carsolio (Mexico)

Poster Session 41: Anaphylaxis

Poster Hall (Cancún Center)

4048

Basophil-Mediated Anaphylaxis Triggered by Drug-Activated Complement Alternative Pathway without Mastocyte's Nor Immunoglobulins Involvement | Giacomo Manfredi (Italy)

4049

Wait At Least 60 Minutes After Eating | Stella Gandhi (US)

4050

First Report of Anaphylactic Shock Caused by the Ingestion of Mite-Infested Flour In Panama | Olga Melcina Barrera de Pino (Panama)

4051

Recurrent Anaphylaxis in Cow's Milk Allergy: What Is Wrong? | Marcela Asanuma Odaira (Brazil)

4052

Epidemiology of Anaphylaxis In Adults Treated In the Emergency Department, of the University Hospital of Monterrey N.L Mexico, During : 2005-2010 | Maricruz Calva (Mexico)

4053

Comprehensive Anaphylaxis Mangement In Schools and Childcare Through Resources, Legislation and Adrenaline Autoinjector Provision | Valerie Noble (Australia)

4054

Buckwheat Pillow Exposure Predisposes to Buckwheat Food-Induced Anaphylaxis | John Kuryan (US)

Poster Session 42: Radiocontrast Media Allergy

Poster Hall (Cancún Center)

4055

Frequency, Characteristics and Outcome of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media | Thatchai Kampitak (Canada)

4056

Seafood Allergy and Radiocontrast Media: Perceptions of Radiologists and Interventional Cardiologists in Canada | Teresa Pun (Canada)

4057

FREQUENCY of POSITIVE Skin Test for Iodinated Contrast In Outpatient Clinic of Allergy In Rio De Janeiro, Brazil Fábio Kuschnir (Brazil)

4058

Test and Manage Protocol for 841 Patients Requiring Iodinated Contrast Media (ICM) in Pediatrics | Maria Cristina Diaz (Argentina)

Poster Session 43: Hereditary Angioedema

Poster Hall (Cancún Center)

4059

A 26-Year Review of Long-Term Safety of a Human Pasteurized C1 Inhibitor Concentrate | Konrad Bork (Germany)

4060

Efficacy of Icatibant Vs Fresh Frozen Plasma for Attacks of Hereditary Angioedema:Analysis of Indivudual Symptoms by Attack Site | Alicia Lara (Mexico)

4061

Characterization of the Factors Triggering An Edematous Attack in Hereditary Angioedema Dorottya Csuka (Hungary)

4062

Hereditary Angioedema: Report of Ten Mexican Patients At West National Medical Center, in Guadalajara City | Ileana Madrigal (Mexico)

4063

Clinical Features and Outcome of 82 Patients with Hereditary Angioedema Pedro Giavina-Bianchi (Brazil)

4064

Differences of Complement Activation Profile Between Type I and Type II of Hereditary Angioedema Due to C1-inhibitor Deficiency | Dorottya Csuka (Hungary)

Poster Session 44: Urticaria

Poster Hall (Cancún Center)

4065

HLA and Chronic Urticaria with Positive Autologous Serum Skin Test Among Brazilians | Zamir Calamita (Brazil)

4066

CD63 Expression, IL3 Receptor, IgG Autoantibody and Autologous Serum Skin Test Accuracy In Patients with Chronic Urticaria In Brazil | Zamir Calamita (Brazil)

4067

Comparison of the Modified Autologous Serum Skin Test and the CD63 Basophil Activation Test in Chronic Urticaria B. Irinyi1, E. Gyimesi2, E. Garaczi3, Zs. Bata3, K. Hodosi2, M. Zeher2, É. Remenyik1, A. Szegedi1 Department of Dermatology1, 3rd Department o | Beatrix Irinyi (Hungary)

4068

The Frequency of Positivity in Autologous Serum Skin Test in Patients with Chronic Idiopatic Urticaria | Silvio Lima Filho (Brazil)

4069

Eleven Cases of Angioedema with Eosinophilia Treated In A Single Hospital In Japan | Shinichiro Nakachi (Japan)

4070

Chronic Urticaria and Infections | Dr. Nadia Aguilar (Mexico)

4071

Chronic Urticaria Associated with Thyroid Disease | Flor de Guadalupe Peñaloza-González (Mexico)

4072

EPIDEMIOLOGY of Urticaria Cases In A the Allergy SERVICE FROM A Third LEVEL MEDICAL CENTER. SIX YEAR EXPERIENCE Monica martin Del Campo perez (Mexico)

4073

Frequency Of Autoreactivity Demonstrated By Autologous Serum Skin Test in Patients with Chronic Urticaria in The Valley of Mexico During a Period of 8 Years | María Isabel Rojo Gutiérrez (Mexico)

4074

Chronic Idiopathic Urticaria and Neglected Toxocara Infection | Rosanna Qualizza (Italy)

Poster Session 45: Urticaria Treatment

Poster Hall (Cancún Center)

4075

Application of Intravenous Immunoglobulin for Treatment of Chronic Autoimmune Urticaria | Vladimir Alyoshkin (Russia)

Poster Session 46: Urticaria Case Reports

Poster Hall (Cancún Center)

4076

Mucocutaneous Disease As A Presentation of Hereditary Angioedema. Report of 2 Cases | Angelica Alaniz (Mexico)

4077

Plasmapheresis in a Patient with “Refractory” Urticarial Vasculitis Mustafa Gulec (Turkey)

4078

Delayed Diagnosis of Hereditary Angioedema. Case Report Karla Mejia (Mexico)

4079

Urticaria Pigmentosa. Cases Report Karla Mejia (Mexico)

4080

A Case of Chronic Urticaria Complicated by Raoultella Ornithinolytica Urinary Tract Infection, Bronchospasm and Angioedema | Rannakoe Lehloenya (South Africa)

4081

A Case of Idiopathic Recurrent Isolated Orbital Angioedema with Exophthalmos Susan Culverhouse (US)

4082

A Case of Multiple Simultaneous Urticarial Syndromes Refractory to Treatment | Jim Parkerson (US)

4083

Chronic Urticaria As First Sign of Sarcoidosis | María Socorro Pérez-Bustamante (Spain)

4084

Life-Threatening Angioedema without Urticaria (AE-U) | Jacquelynne Corey (US)

4085

URTICARIAL RASH ASSOCIATED WITH CHEST PAIN | Mouna Boulaich (Spain)

Poster Session 47: Autoimmunity Case Reports

Poster Hall (Cancún Center)

4086

Alopecia As a Symptom of Neonatal Lupus: A Report of Case Joselit Torres (Venezuela)

4087

Autoimmune Hepatitis Misdiagnosed As Hepatitis C Responding to Interferon/Ribavirine Therapy | Michal R. Pijak (Slovakia)

4088

Ocular Muscles Myopathy Associated with Autoimmune Thyroiditis. Cases Report | Eugenia Vargas-Camaño (Mexico)

4089

Pulmonary Arterial Hypertension Associated to Antiphospholipid Syndrome In An Infant | Raul Dorbeker (Mexico)

Poster Session 48: Autoimmunity

Poster Hall (Cancún Center)

4090

Autoimmune Diseases and Risk of Stroke | Anita Arsovska (Macedonia)

4091

Clinical Effects of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, on Patients with Autoimmune and Allergic Diseases | Toshio Tanaka (Japan)

4092

Association Between Autoimmune Reactions, Herpes Infection and Severity of Atopic Dermatitis in Children | Pavel Samoylikov (Russia)

4093

Immunomodulatory Effects of Extracorporeal Photochemotherapy in Systemic Sclerosis | Margit Zeher (Hungary)

4094

Comprehensive Analyses of Serum Peptides in Microscopic Polyangiitis | Yukiko Takakuwa (Japan)

4095

Detection of Anti-Nucclear Antibodies (ANA) Used for Diagnostic Approach of Systemic Autoimmune Diseases. Correlation with Double Stranded DNA (DSDNA) and Extractable Nuclear Antigen (ENA) Antibodies Asimoula Koteli (Greece)

4096

The Vasculitis Induced by the Cerebrovascular Coil | Seido Ooka (Japan)

4097

Prevalence of Thyroid Peroxidase Autoantibodies (anti-TPO) in Women with Autoimmune Connective Tissue Diseases (ACTD) Asimoula Koteli (Greece)

4098

Anticardiolipin Antibodies in Patients with Acute Myeloid Leukemia: Prevalence and Clinical Significance | Maryam Ayatollahi (Iran)

Poster Session 49: Allergies in Other Diseases

Poster Hall (Cancún Center)

4099

HLA-B58 Does Not Increase Allopurinol Hypersensitivity Among Patients with Hematologic Malignancy | Jae-Woo Jung (South Korea)

4100

Risk Factors Associated to Mortality In Pediatric Patients with Hemophagocytic Lymphohistiocytosis | Armando Partida-Gaytan (Mexico)

4101

The Clinical and Serological Findings in Patients with Toxocariasis in Korea | Sungjin Choi (South Korea)

4102

Interferon-Gamma Release Assay - Useful Tool for the Diagnosis of Pleural Tuberculosis | Andrea Ondrejkova (Czech Republic)

4103

The Parasite Echinococcus Granulosus Promotes Allergic Response In Human | Manel Amri (Algeria)

4104

Use of Transfer Factor in Patients with Persistent Genital Human Papillomavirus Infection | Blanca Maria Morfin-Maciel (Mexico)

4105

Experimantal Heterophyiasis: Histopathological & Immunological Study | Ahmed Daoud (Egypt)

4106

Chronic Obstructive Pulmonary Disease and Lung Cancer Share Inflammation Pathways | Kostas N. Syrigos (Greece)

4107

Risk Factors of Recurrent Upper Respiratory Infections In Children Under 5 Years. Habana Vieja | Xiomara Lopez Campos (Cuba)

4108

Long Term Asbestos Exposure As A Cause of Eozinophilic Pleural Effusions | Biserka Jovkovska Kaeva (Macedonia)

4109

A Novel Therapeutical Option in Resistant Ganglionar and Cutaneous Tuberculosis | Laura Vidal (Mexico)

Poster Session 50: Asthma Epidemiology

Poster Hall (Cancún Center)

4110

Epidemiology of Asthma Cases In the Allergy Service of A Third Level Medical Center. Six Year Expirience | Luis Rafael Sanchez-Gallardo (Mexico)

4111

Latin America Asthma Insight and Management (LA AIM): A Survey of Asthma Patients in 5 Latin American Locales | Sandra González-Díaz (Mexico)

4112

Understanding of Asthma Terminology by Patients Interviewed in the Latin America Asthma Insight and Management (LA AIM) Survey | Jose Jardim (Brazil)

4113

Asthma Management in Latin America: Learnings From the Latin America Asthma Insight and Management (LA AIM) Survey of Patients | Jorge Maspero (Argentina)

4114

Project for Prevention & Control of Asthma and Allergic Diseases in Korea | Eun Hee Chung (South Korea)

4115

Asthma In the CIS-Region: The Prevalence and Peculiarities of the Course | Tatiana Slavyanskaya (Russia)

4116

Asthma In the Elderly: A Mexican Point of View | Maria Rosario Perez-Chavira (Mexico)

4117

Control of Asthma and Its Relationship to Quality of Life in Adolescents Antônio Carlos Pastorino (Brazil)

4118

The Leukotriene C4 Synthase (A-444C) Promoter Polymorphism in Venezuelan Individuals with Asthma | Ingrid Quintana Quintero (Venezuela)

4119

Allergic Disorders Prevented by Helicobacter Pylori Colonization | Olf Herbarth (Germany)

Poster Session 51: Quality of Life Measures in Asthma and Allergic Diseases

Poster Hall (Cancún Center)

4120

Management of Twenty-Five Pediatric Patients with Hereditary Angioedema (HAE) Undergoing Home Treatment- A Clinical Surveillance Program | Inmaculada Martinez-Saguer (Germany)

4121

The Impact of Nasal Allergies: Results From the Allergies Surveys in America, Asia Pacific, Latin America, and Middle East | Michael S. Blaiss (US)

4122

The Impact of Nasal Polyposis on Quality of Life Using the EQ-5D Health Profile | Isam Alobid (Spain)

4123

Predictors Affecting the Quality of Life of Patients with Bronchial Asthma Andrzej Fal (Poland)

4124

Correlation Between Severity of Allergic Rhinitis and Impairment of Quality of Life in Allergic Adolescents | Eric Martinez Infante (Mexico)

4125

Chronic Urticaria Quality of Life Questionnaire (Cu-Q2 oL) and Urticaria Activity Score (UAS) | Dr. Nadia Aguilar (Mexico)

4126

The Relationship of Asthma Impairment Determined by Psychometric Tools to Subsequent Asthma Exacerbations Felicia Allen-Ramey (US)

Poster Session 52: Health Outcomes for Asthma

Poster Hall (Cancún Center)

4127

Developing An Adult Asthma Adherence Questionnaire (AAAQ) | Andrew Weinstein (US)

4128

Associations Between Self-Reported Adherence to Asthma Anti-Inflammatory Therapy and Risk Factors for Non-Adherence (NA) in Pediatric Patients | Andrew Weinstein (US)

4129

Inability of Medical Students to Use of Three Types of Inhaler | Jae-Won Jeong (South Korea)

4130

State of Asthma Education and Management in Urban Medical Residency Training Programs | John Kuryan (US)

4131

Impact of Providing Physical Education Teachers with Information about Asthma When Training Children and Adolescents WithThis Disorder | Dania Fabré (Cuba)

4132

Asthma Knowledge Among Parents and/or Caregivers of Asthmatic Children Attending A Practical Allergy Course | Eunice Sandoval-Ramírez (Mexico)

4133

4134

Usefulness of Asthma Control Test Questionnaire, FEV1 and Exhaled Nitric Oxide Level(FeNO) for the Clinical Assessment of Elderly Asthma | Yong Ho Roh (South Korea)

4135

Systematic Review of the Recommendations on the Prevention of Allergic Manifestations in Children Joerg Spieldenner (Switzerland)

4136

The Relationship Between Emotional Cognition and the Symptom Gap in Patients with Bronchial Asthma: The Effects of Alexithymia and Empathy | Sonomi Nakajima (Japan)

4137

Asthma control аnd quality of care of adult asthma patients in primary health care facilities in Saint- Petersburg, Russia | Alexander Emelyanov (Russia)

Poster Session 53: Severe and Fatal Asthma

Poster Hall (Cancún Center)

4138

Severe Asthma: Report of Five Clinical Cases At West National Medical Center, IMSS in Guadalajara City, Mexico | Carlos Torres-Lozano (Mexico)

4139

Factores De Riesgo De Muerte Por Asma Bronquial En Centro Habana En El Período Comprendido Entre 1995-2010 | Adelquis Guerrero (Cuba)

4140

Dolichyl Phosphate Dependent Mechanism of Exacerbations In Asthma: P-Glycoprotein Overexpression and E-Cadherin Loss | Galina Kuznecova (Latvia)

4141

Distribution of Asthma Mortality in Various Districts of Salvador, Brazil | Carolina Souza-Machado (Brazil)

4142

Geographical Distribution of Deaths From Asthma in Salvador, Brazil (2000-2009) | Carolina Souza-Machado (Brazil)

4143

Measurement of Long-Acting Natriuretic Peptide (LANP) in Exacerbation of Asthma | Michel Alkhalil (US)

4144

Is It Really Difficult-to-Treat Asthma? Don't Forget Other Causes of Wheeze A. Fusun Kalpaklioglu (Turkey)

4145

Sensitization profile in severe asthma Barbara Rogala (Poland)

Poster Symposium 4: Immunotherapy

Bacalar (Cancún Center)

Chairpersons: Harold Nelson (US) and Stephen Durham (United Kingdom)

12:45 - 13:30

Poster Viewing

13:30 - 00:00

4146: AAAAI Survey On Immunotherapy Practice Patterns Concerning Dosing, Dose-Adjustment After Missed Doses and Duration of Immunotherapy | Désirée Larenas Linnemann (Mexico)

13:30 - 00:00

4147: Development of A National Guideline On Skin Testing and Immunotherapy | Désirée Larenas Linnemann (Mexico)

13:30 - 00:00

4148: Efficacy of Mite Sublingual Immunotherapy In 130 Children with Atopic Dermatitis | Jianping Tang (China)

13:30 - 00:00

4149: Down Regulation of Allergic Inflammation with Allergy Vaccine Timpol In A Murine Model of Asthma | Igor Shilovskiy (Russia)

13:30 - 00:00

4150: Clinical Efficacy and Mucosal/Systemic Antibody Response Changes After Sublingual Immunotherapy in Mite-Allergic Children: A Randomized Double-Blind, Placebo-Controlled Study in Brazil Ernesto Taketomi (Brazil)

13:30 - 00:00

4151: Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting | Meike Hadler (Germany)

13:30 - 00:00

4152: Long Term Follow-up After Completion of Inhalant Allergen-Specific Subcutaneous Immunotherapy Jacquelynne Corey (US)

13:30 - 00:00

4153: Long-Term Clinical Efficacy of Immunotherapy in Rhino-Conjunctivitis with Pollen Extract | Carlos Nunes (Portugal)

13:30 - 00:00

4154: IgE/IgG4 Ratio As a Possible Surrogate Marker of Clinical Efficacy During Allergen-Specific Immunotherapy with House Dust Mite Vaccines | Alexis Labrada (Cuba)

13:30 - 00:00

4155: Allergy Training and Immunotherapy in Latin America: How Survey-results lead to a Regional Overview | R Maximiliano Gomez (Argentina)

13:30 - 00:00

4156: Clinical Effects of Immunotherapy in Patients with Allergic Disease in the National Institute of Respiratory Diseases | Ma del Rosario Gonzalez Galarza (Mexico)

13:30 - 00:00

4157: Approach of Paediatric Allergists to Allergen Immunotherapy in Severe Persistent Allergic Rhinitis | Alessandro Fiocchi (Italy)

13:30 - 00:00

4158: Compliance and Persistence to Grass Immunotherapy Treatment Is Comparable for Allergy Immunotherapy Tablets and Subcutaneous Immunotherapy: A Swedish Registry Study Simon Lawton (Denmark)

Oral Abstract Session 24: Atopic Dermatitis 2

Gran Cancún 1 (Cancún Center)

Chairpersons: Elizabeth Estrada Reyes (Mexico) and Mona Al-Ahmad (Kuwait)

12:45 - 13:00

4159: The Risk of Atopic Dermatitis in Children Exposed to Pets During Pregnancy | Neetu Vasu (US)

13:00 - 13:15

4160: Economic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis: Results From 5 European Countries Joerg Spieldenner (Switzerland)

13:15 - 13:30

4161: Prevalence and Associated Risk Factors for Atopic Dermatitis Symptoms in Mexican Children | Eunice Sandoval-Ramírez (Mexico)

13:30 - 13:45

4162: Involvement of Human Histamine N-Methyltransferase Gene Polymorphisms in Susceptibility to Atopic Dermatitis in Korean Children Yong Ju Lee (South Korea)

13:45 - 14:00

4163: Circadian Regulation of Scratching Behavior in NC/Tnd Mice, a Mouse Model for Human Atopic Dermatitis | Keitaro Ohmori (Japan)

14:00 - 14:15

4164: Metallic Soap Aggravates Skin Conditions in Patients with Atopic Dermatitis and a Mouse Model for Human Atopic Dermatitis, NC/Tnd Mice | Akane Tanaka (Japan)

Oral Abstract Session 25: Childhood Asthma and Allergies

Gran Cancún 2 (Cancún Center)

Chairpersons: S.G.O. Johansson and Mika Mäkelä

12:45 - 13:00

4165: The Allergic March Resolved At Allergen Component Level | Giovanni Melioli (Italy)

13:00 - 13:15

4166: Prevalence of Wheezing and Risk Factors Associated to Wheezing in Infants in the First Year of Life, Cuiabá, MT, Brazil | Lillian Sanchez Lacerda Moraes (Brazil)

13:15 - 13:30

4167: Specific IgE Sensitisation In A Six-Year Old Infant Cohort In New Zealand | Rob Siebers (New Zealand)

13:30 - 13:45

4168: Risk Factors Associated to Wheezing In Mexican Children. A Multicentric ISAAC-Based Survey Study | Armando Partida-Gaytan (Mexico)

13:45 - 14:00

4169: Association Between Eosinophil Apoptosis in Induced Sputum and Asthma Severity in Children | Alla Nakonechna (United Kingdom)

14:00 - 14:15

4170: Antibiotics but Not Paracetamol Reduce the Risk for Recurrent Wheezing in Infants | Herberto Jose Chong Neto (Brazil)

Oral Abstract Session 26: Cytokines and Chemokines

Gran Cancún 3 (Cancún Center)

Chairpersons: Francesca Levi-Schaffer (Israel) and Andrew Wardlaw (United Kingdom)

12:45 - 13:00

4171: Hypoxia-Inducible Factor 1 (HIF-1) Transcription Is a “Signalling Driver” for Allergic Inflammation, Host Innate Immune Defence and Leukaemia Progression | Vadim Sumbayev (United Kingdom)

13:00 - 13:15

4172: Keratinocytic Thymic Stromal Lymphopoietin Plays An Important Role in Epicutaneous Sensitization and the Atopic March | Juan Manuel Leyva Castillo (France)

13:15 - 13:30

4173: Pivotal Role of Intestinal Interleukin-17-Producing Gammadeltat Cells In the Food Allergy | Ryusuke Nakagawa (Japan)

13:30 - 13:45

4174: Effect of Formoterol on Eosinophil Trans-Basement Migration Induced by Interleukin-8-Stimulated Neutrophils | Akiko Kawashima (Japan)

Oral Abstract Session 27: Drug Allergy

Gran Cancún 4 (Cancún Center)

Chairpersons: David Khan (US) and Luis Felipe Chiaverini Ensina (Brazil)

12:45 - 13:00

4175: Characteristics of Liver Injury in Drug-Induced Systemic Hypersensitivity Reactions | Chan Sun Park (South Korea)

13:00 - 13:15

4176: Outcomes of Reintroducing Antituberculous Drugs Following Cutaneous Adverse Drug Reactions | Rannakoe Lehloenya (South Africa)

13:15 - 13:30

4177: Penicillin - Diagnosis of Allergy | Janni Hjortlund (Denmark)

13:30 - 13:45

4178: Clinical Features and Risk Factors of Oxaliplatin Hypersensitivity in Koreans Yoon-Seok Chang (South Korea)

13:45 - 14:00

4179: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): What We Still Have to Learn? | Luciana Kase Tanno (Brazil)

Oral Abstract Session 28: Food Allergy

Gran Cancún 5 (Cancún Center)

Chairpersons: Kyu-Earn Kim (South Korea) and Sami Bahna (US)

12:45 - 13:00

4180: Glutathione Exposed Sequential Epitopes of Ovomucoid Are Relevant for Persistent Egg-Allergic Patients Tamar Kinaciyan (Austria)

13:00 - 13:15

4181: The Choice of Hypoallergens for Fish and Peach to Develop Food Allergy Specific Immunotherapy (The FAST Project) | Laurian Zuidmeer-Jongejan (Netherlands)

13:15 - 13:30

4182: IFN-ã Induces Milk Allergen-Specific IL-10-Producing Regulatory B Cells in Non -IgE Mediated Milk Allergy | Jae Ho Lee Sr. (South Korea)

13:30 - 13:45

4183: Analysis of IgE, IgE RAST Value and Prick Test in Wheat or Hen's Egg-Allergy Infants Treated with Slow Specific Oral Tolerance Induction Therapy | Takeshi Noma (Japan)

13:45 - 14:00

4184: Efficacy of Slow Oral Immunotherapy for Cow's Milk Allergy | Kiyotake Ogura (Japan)

14:00 - 14:15

4185: Factors Associated with Development of Food Allergy in Liver-Transplanted Children | Tetsuo Shoda (Japan)

Oral Abstract Session 29: Hymenoptera Allergy

Cozumel 2 (Cancún Center)

Chairpersons: James Tracy (US) and Mubeccel Akdis (Switzerland)

12:45 - 13:00

4186: Clinical Features and Diagnostic Value of Specific IgE to Component Allergen in Bee Venom Allergy in Korea | Yoo Seob Shin (South Korea)

13:00 - 13:15

4187: Is Basophil Specific Response to Hymenoptera Venom Related to T Regulatory Cells? | Petr Kucera (Czech Republic)

13:15 - 13:30

4188: Improving the Diagnosis of Hymenoptera Venom Allergy: Component Resolved Diagnosis | Liliana Cifuentes (Germany)

13:30 - 13:45

4189: Efficacy of Venom Immunotherapy Given Every 3 or 4 MONTHS. A DIRECT Prospective COMPARISON with the Conventional REGIMEN | Livio Simioni (Italy)

13:45 - 14:00

4190: SERUM CTLA-4 and IL-10 In Hymenoptera Venom Immunotherapy: Equivalence of DIFFERENT INDUCTION Regimens | Anna Maria Riccio (Italy)

14:00 - 14:15

4191: Purification of the Allergenic Protein Hyaluronidase From the Venom of Social Wasp Polybia Paulista (Hymenoptera: Vespidae) | Débora Laís Justo Jacomini (Brazil)

Oral Abstract Session 30: Immunobiology of Allergens

Isla Mujeres (Cancún Center)

Chairpersons: Barbara Gepp (Austria) and Christian Radauer (Austria)

12:45 - 13:00

4192: High Immunogenicity of the Allergen Phl p 5 Expressed in Transgenic Mice As a Membrane-Anchored Protein | Andreas Farkas (Austria)

13:00 - 13:15

4193: Specific Recognition of the Major Birch Pollen Allergen Bet v 1 Programs Dendritic Cells to Induce Either Th2 or Tolerogenic Responses | Ursula Smole (Austria)

13:15 - 13:30

4194: Recombinant Scfv Antibodies for IgE Epitope Mapping and Detection of Parvalbumins | Merima Bublin (Austria)

13:30 - 13:45

4195: Bet v 1-Specific T-Cell Receptor/Forkhead Box Protein 3 Transgenic T-Cells Suppress Bet v 1-Specific T-Cell Effector Function in An Activation-Dependent Manner | Klaus Schmetterer (Austria)

13:45 - 14:00

4196: Grass Pollen Allergen-Induced Surface Expression of CD203c, CD63 and CD107a on CRTH2+ Basophils: Novel Biomarkers for Monitoring Efficacy of Allergen-Specific Immunotherapy | Mohamed Shamji (United Kingdom)

14:00 - 14:15

4197: Specific IgE and IgG Binding to Allergoids of Phleum Pratense | Barbara Cases (Spain)

Oral Abstract Session 31: Mechanisms of Asthma and Allergic Inflammation

Tulum (Cancún Center)

Chairpersons: Homer Boushey (US) and Elliot Israel (US)

12:45 - 13:00

4198: Heterogeneity of Allergen Epitope-Specific CD4+ T Cells Responses: Steps Toward Optimal Composition for Peptide-Based Immunotherapy | Erik Wambre (US)

13:00 - 13:15

4199: The Association Between Mast Cells and Remodelling of the Small Airways in Chronic Asthma | Kenneth Snibson (Australia)

13:15 - 13:30

4200: Creation of a Humanized Model for Respiratory Allergy Using a Human Mugwort-Specific T-Cell Receptor and HLA-DR1 | Alina Neunkirchner (Austria)

13:30 - 13:45

4201: Eosinophils Enhance Airway Smooth Muscle Cell Proliferation Via the Release of Cysteinyl Leukotrines | Rabih Halwani (Saudi Arabia)

13:45 - 14:00

4202: Colour Change In the Human Histamine Wheal; A Sign of Desensitized Histamine Vasoconstrictory Receptors | Lars Malm (Sweden)

14:00 - 14:15

4203: Involvement of the Hypoxia-Inducible Factor-1 Transcription Complex in the Inflammatory Responses of Human Mast Cells and Basophils Vadim Sumbayev (United Kingdom)

Oral Abstract Session 32: Primary Immunodeficiency

Xcaret (Cancún Center)

Chairpersons: Hani Ababneh (Jordan) and Charlotte Cunningham-Rundles (US)

12:45 - 13:00

4204: Mycobacterial Infections In Children with Chronic Granulomatous Disease | Saul Lugo-Reyes (Mexico)

13:00 - 13:15

4205: Increased Pro-Inflammatory Cytokine Production After Lipopolysaccharide Stimulation in Patients with X-Linked Agammaglobulinemia | Maria Edith Gonzalez Serrano (Mexico)

13:15 - 13:30

4206: Hypogammaglobulinemia in a Boy: Consider Also X- Linked Lymphoproliferative Disease | Luisa Gamez (Mexico)

13:30 - 13:45

4207: Transmission Pattern and Carriers Identification in Male Patients with Chronic Granulomatous Disease | Blancas-Galicia Lizbeth (Mexico)

13:45 - 14:00

4207A: Genetic Association Study of the IgE Immunodeficiency in Mexican Population | Jose Augusto Malpica Cruz (Mexico)

14:00 - 14:15

4208: CD21-/Low B Cells Are Increased in Both Common Variable Immune Deficiency (CVID) and Specific Antibody Deficiency (SAD) | Araceli Elizalde (US)

Oral Abstract Session 33: Rhinitis Treatment 2

Costa Maya 1 (Cancún Center)

Chairpersons: Joaquim Mullol (Spain) and James Baraniuk (US)

12:45 - 13:00

4209: Patterns of Initiation and Adherence to De Novo Allergen-Specific Immunotherapy Among Adults and Children with Newly-Diagnosed Allergic Rhinitis: Findings From Research Jointly Funded by the AAAAI and ACAAI | Cheryl Hankin (US)

13:00 - 13:15

4210: Effect of Simvastatin on Transforming Growth Factor Beta-1-Induced Myofibroblast Differentiation and Collagen Production in Nasal Polyp-Derived Fibroblasts | Il-Ho Park (South Korea)

13:15 - 13:30

4211: Onset of Action of MP29-02 in the Treatment of Seasonal Allergic Rhinitis | Jonathan Bernstein (US)

13:30 - 13:45

4212: MP29-02 in the Treatment of Nasal Symptoms of Seasonal Allergic Rhinitis | William Wheeler (US)

13:45 - 14:00

4213: A 26-Week Study Evaluating the Safety and Efficacy of Ciclesonide Hydrofluoralkane Nasal Aerosol in Subjects with Perennial Allergic Rhinitis John Karafilidis (US)

14:00 - 14:15

4214: Omalizumab Improves Asthma but Not Nasal Symptoms in Japanese Patients with Severe Allergic Asthma and Rhinitis | Fuyumi Nishihara (Japan)

Oral Abstract Session 34: Allergen Immunotherapy 2

Costa Maya 2 (Cancún Center)

Chairpersons: Lars Jacobsen (Denmark) and Guillermo Salamanca (Spain)

12:45 - 13:00

4215: Efficacy and Safety of Ragweed Allergy Immunotherapy Tablet in Multisensitized North American Adults: Preliminary Findings | Peter Creticos (US)

13:00 - 13:15

4216: Comparison of Efficacy and Safety of A Depigmented Polymerized Allergen Extract of Grass and Birch with Placebo In Patients with Type-I Allergic Rhinoconjunctivitis | Angelika Sager (Germany)

13:15 - 13:30

4217: Allergenic Composition of Polymerized Allergen Extracts of Betula Verrucosa, Dermatophagoides Pteronyssinus and Phleum Pratense | Enrique Fernandez-Caldas (Spain)

13:30 - 13:45

4218: A Proteomic Style Approach to Characterise a Grass Mix Product Reveals Potential Immunotherapeutic Benefit Alan Bullimore (United Kingdom)

13:45 - 14:00

4219: Seasonal Vs. Symptom-Based Evaluation of A Depigmented Grass-Birch Allergoid | Oliver Pfaar (Germany)

14:00 - 14:15

4220: Efficacy and Tolerability of HDM Injective Immunotherapy with Monomeric Allergoid | Enrico Compalati (Italy)

University Training Programs 3: Henry Ford Hospital, Georgia Health Sciences University, the University of California San Francisco and The University of Michigan: Allergy Prevention: Do Cats and Dogs Feed Infants Microbes?

Gran Cancún 1 (Cancún Center)

Chairpersons: Christine Cole Johnson (US) and Edward Zoratti (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

3-1UTP: The Link Between Pets and Reduced Risk of Allergic Disease | Dennis Ownby (US)

15:25 - 15:45

3-2UTP: Molecular Analysis of the Link Between Pets and an Infant's Microbiome | Homer Boushey (US)

15:45 - 16:05

3-3UTP: The Microbiome-Allergy Hypothesis | Nicholas Lukacs

16:05 - 16:30

Panel Discussion

Year in Review 4: COPD

Costa Maya 1 (Cancún Center)

15:00 - 15:35

4-1YiR: Pathophysiology | Qutayba Hamid (Canada)

15:35 - 16:10

4-2YiR: Treatment | Klaus Rabe (Germany)

16:10 - 16:30

Discussion

Sister Society Symposium 14: Mexican College of Clinical Immunology and Allergy: Genetics and Immune Responses

Gran Cancún 3 (Cancún Center)

Chairpersons: Maria Antonia Rivera Gomez MD (Mexico) and Jaime Mellado Abrego (Mexico)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

14-1SSS: Genetic Risk Factor for Asthma in Latin America | Nora Martínez Aguilar (Mexico)

15:25 - 15:45

14-2SSS: Gene Environment Interactions with Air Pollution | Maria Eugenia Vargas (Mexico)

15:45 - 16:05

14-3SSS: Immunogenetics and Pharmacogenomics of Allergic Diseases | Clara Gorodezky,Prof. PhD. (Mexico)

16:05 - 16:30

Panel Discussion

Sister Society Symposium 15: The International Primary Care Respiratory Group: Rhinitis and Asthma in Primary Care

Xcaret (Cancún Center)

Chairpersons: Roy Gerth van Wijk (Netherlands) and Jan Lötvall (Sweden)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

15-1SSS: Adaption of Asthma Guidelines to Primary Care | Miguel Roman Rodriguez (Spain)

15:25 - 15:45

15-2SSS: Sublingual Immunotherapy (SLIT) in Primary Care | Dermot Ryan (United Kingdom)

15:45 - 16:05

15-3SSS: Management of Rhinitis or Sinusitis in Primary Care Patients with Asthma | Michael Schatz (US)

16:05 - 16:30

Panel Discussion

Sister Society Symposium 16: Argentine Association of Allergy and Clinical Immunology: Eosinophilic Related Conditions

Costa Maya 2 (Cancún Center)

Chairpersons: Jorge Maspero (Argentina) and Jorge Alvarez (Argentina)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

16-1SSS: Evaluation of Patients with Eosinophilia | Martin Bozzola (Argentina)

15:25 - 15:45

16-2SSS: Hypereosinophilic Syndromes | Mónica S. De Gennaro (Argentina)

15:45 - 16:05

16-3SSS: Novel Therapies for Eosinophilic Disorders | Bruce Bochner (US)

16:05 - 16:30

Panel Discussion

Workshop 22: Immunotherapy for the Polysensitized Patient: Balancing the Evidence with Experience

Coral Gallery 1 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

22-1WS: Monotherapy for the Polysensitized Patient | Noel Rodriguez-Perez (Mexico)

15:20 - 15:35

22-2WS: Multiallergen Immunotherapy: The Evidence | Harold Nelson (US)

15:35 - 15:50

22-3WS: Multiallergen Immunotherapy: The Experience | Linda Cox (US)

15:50 - 16:30

Discussion

Workshop 23: Austrian Society of Allergology and Immunology Sister Society Session: Novel Laboratory Tests for Allergic Diseases

Coral Gallery 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

23-1WS: Recombinant Allergens for Diagnosis | Susanne Vrtala (Austria)

15:20 - 15:35

23-2WS: Improving Diagnosis of Venom Allergy with Recombinant Allergens | Irene Mittermann

15:35 - 15:50

23-3WS: Allergen Chips for Predicting, Diagnosing and Monitoring Allergy | Rudolf Valenta (Austria)

15:50 - 16:30

Discussion

Workshop 24: University Training Program - Cleveland Clinic: An Evidence Based Approach to Diagnosis and Management of Urticaria and Angioedema

Coral Gallery 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

24-1WS: Evaluation | Jonathan Bernstein (US)

15:20 - 15:35

24-2WS: Management | David Lang (US)

15:35 - 15:50

24-3WS: C1 Inhibitor Deficiency Syndromes | Bruce Zuraw (US)

15:50 - 16:30

Discussion

Workshop 25: Drug Allergy Testing and Desensitization

Coral Sea (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

25-1WS: Beta-lactams | Louis Mendelson (US)

15:20 - 15:35

25-2WS: Non Betalactic Antibiotics | David Khan (US)

15:35 - 15:50

25-3WS: Biologics | Miguel Blanca (Spain)

15:50 - 16:30

Discussion

Workshop 26: Obesity and Asthma: Implications for Asthma Control and Treatment

Coral Kingdom 1 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

26-1WS: Observational Studies | Fernando Holguin (US)

15:20 - 15:35

26-2WS: Interventional Studies | Carlos Camargo (US)

15:35 - 15:50

26-3WS: Genetics of Obesity and Asthma | Juan Carlos Celedon (US)

15:50 - 16:30

Discussion

Workshop 27: Update on Smoking Cessation

Coral Kingdom 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

27-1WS: Natural History of Tobacco Dependence | R Maximiliano Gomez (Argentina)

15:20 - 15:35

27-2WS: New Pharmaceutical Options and Electronic Cigarette | Riccardo Polosa (Italy)

15:35 - 15:50

27-3WS: Clinical Trials and Patient Education for Smoking Cessation | Maureen George (US)

15:50 - 16:30

Discussion

Workshop 28: Allergic Rhinitis and Its Impact on Asthma (ARIA)

Coral Kingdom 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

28-1WS: How Can the GRADE System Improve Guideline Driven Care? | Holger Schünemann (Canada)

15:20 - 15:35

28-2WS: Are Rhinitis and Asthma Two Manifestations of One Disease? | Stephen Durham (United Kingdom)

15:35 - 15:50

28-3WS: Rhinitis: A Risk Factor for Asthma? | Ronald Dahl (Denmark)

15:50 - 16:30

Discussion

Workshop 29: Adherence to Treatment: How Can It Be Improved?

Coral Garden 1 (Fiesta Americana)

15:00 - 15:05

Introductory Remarks

15:05 - 15:20

29-1WS: Non-Adherent Patient | Fulvio Braido (Italy)

15:20 - 15:35

29-2WS: Socio-economic Status and Adherence | Alvaro Cruz (Brazil)

15:35 - 15:50

29-3WS: Improving Adherence | Fernan Caballero-Fonseca

15:50 - 16:30

Discussion

Symposium 29: Primary Immune Deficiencies: Rapid Diagnosis and Referral

Gran Cancún 4 (Cancún Center)

Chairpersons: Thomas Fleisher (US) and John Sleasman (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

29-1SY: Clinical Presentation | James Oleske (US)

15:25 - 15:45

29-2SY: Screening | Charlotte Cunningham-Rundles (US)

15:45 - 16:05

29-3SY: Treatment Options | Elena Perez (US)

16:05 - 16:30

Panel Discussion

Symposium 30: Allergy, Asthma and the Athlete

Gran Cancún 5 (Cancún Center)

Chairpersons: Estrella Asayag (Argentina) and Zineb Sayah (Morocco)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

30-1SY: Mechanisms of Exercise-Induced Asthma | Timothy J. Craig (US)

15:25 - 15:45

30-2SY: Exercise-Induced Allergic Diseases | Sergio Bonini (Italy)

15:45 - 16:05

30-3SY: Asthma and Elite Athletes | Marcin Kurowski (Poland)

16:05 - 16:30

Panel Discussion

Workshop 30: Hands-On Demonstration: Bronchial Provocation Challenges

Coral Garden 2 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

30-1WS: Methacholine | Paul O'Byrne (Canada)

15:20 - 15:35

30-2WS: Mannitol | Charles Irvin (US)

15:35 - 15:50

30-3WS: Exercise | Matteo Bonini (Italy)

15:50 - 16:30

Hands-On Demonstration

Symposium 31: Hymenoptera Allergy: Ants and Flying Insects

Cozumel 1 (Cancún Center)

Chairpersons: John Kelso (US) and Ioana Agache (Romania)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:25

31-1SY: Overview | Jeffrey Demain (US)

15:25 - 15:45

31-2SY: Immunotherapy | James Tracy (US)

15:45 - 16:05

31-3SY: Immunologic Response with Venom Immunotherapy | Mubeccel Akdis (Switzerland)

16:05 - 16:30

Panel Discussion

Workshop 31: Non-Allergic Rhinitis

Coral Garden 3 (Fiesta Americana)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

31-1WS: Classification | Glenis Scadding (United Kingdom)

15:20 - 15:35

31-2WS: Mechanisms | Ruby Pawankar (Japan)

15:35 - 15:50

31-3WS: Treatment | Alkis Togias (US)

15:50 - 16:30

Discussion

Debates 10: Are Basophils Important in Allergy?

Gran Cancún 2 (Cancún Center)

Chairpersons: Francesca Levi-Schaffer (Israel) and Joshua Boyce (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

10-1DB: Pro | Hirohisa Saito (Japan)

15:20 - 15:35

10-2DB: Con | Massimo Triggiani (Italy)

15:35 - 15:40

Pro Rebuttal

15:40 - 15:45

Con Rebuttal

15:45 - 16:00

Discussion

Debates 11: Are We Ready for Oral Immunotherapy for Food Allergy?

Cozumel 2 (Cancún Center)

Chairpersons: Sami Bahna (US) and Hugh Sampson (US)

15:00 - 15:05

Welcoming Remarks

15:05 - 15:20

11-1DB: Pro | Lyndon Mansfield (US)

15:20 - 15:35

11-2DB: Con | A. Wesley Burks (US)

15:35 - 15:40

Pro Rebuttal

15:40 - 15:45

Con Rebuttal

15:45 - 16:00

Discussion

New Horizons Session 6: Advances in Food Allergy: Session 1

Gran Cancún (Cancún Center)

Chairpersons: Alessandro Fiocchi (Italy) and Ichiro Nomura (Japan)

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

6-1NH: Allergen Component and Cross Reactivity | Motohiro Ebisawa (Japan)

08:30 - 08:55

6-2NH: Advances in Diagnosis | Hugh Sampson (US)

08:55 - 09:20

6-3NH: Oral Immunotherapy | A. Wesley Burks (US)

09:20 - 09:30

Discussion

New Horizons Session 6: Advances in Food Allergy: Session 2

Gran Cancún (Cancún Center)

Chairpersons: Alessandro Fiocchi (Italy) and Miguel Vinuesa (Argentina)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

6-4NH: Hidden Food Allergens | Thomas Holzhauser (Germany)

10:30 - 10:55

6-5NH: Food Allergy and Eosinophilic Esophagitis | Jonathan Spergel (US)

10:55 - 11:20

6-6NH: Non-IgE-Mediated Gastrointestinal Food Reactions | Ichiro Nomura (Japan)

11:20 - 11:30

Discussion

New Horizons Session 7: Asthma in Children: Risk Factors

Cozumel (Cancún Center)

Chairpersons: Kazuo Akiyama (Japan) and Cissy Rachiana Sudjana Prawira

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

7-1NH: Genetics | Fernando D. Martinez (US)

08:30 - 08:55

7-2NH: Environmental | Dennis Ownby (US)

08:55 - 09:20

7-3NH: Viral | Robert Lemanske, MD (US)

09:20 - 09:30

Discussion

New Horizons Session 7: Asthma in Children: Treatment

Cozumel (Cancún Center)

Chairpersons: José Antonio Ortega Martell (Mexico) and Alvaro Teijeiro (Argentina)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

7-4NH: Prevention | Ulrich Wahn (Germany)

10:30 - 10:55

7-5NH: Step Care | Stanley Szefler (US)

10:55 - 11:20

7-6NH: Management of Asthma Exacerbations | Jose A. Castro-Rodriguez (Chile)

11:20 - 11:30

Discussion

New Horizons Session 8: Is Your Patient Immunodeficient (ID)?: Session 1

Costa Maya (Cancún Center)

Chairpersons: Elena Perez (US) and Steven Holland

08:00 - 08:05

Welcoming Remarks

08:05 - 08:30

8-1NH: Primary IDs | Charlotte Cunningham-Rundles (US)

08:30 - 08:55

8-2NH: Common Variable | Mark Ballow (US)

08:55 - 09:20

8-3NH: Approach to the Patient with Recurrent Infections | Zuhair Ballas (US)

09:20 - 09:30

Discussion

New Horizons Session 8: Is Your Patient Immunodeficient (ID)?: Session 2

Costa Maya (Cancún Center)

Chairpersons: Elopy Sibanda (Zimbabwe) and Charlotte Cunningham-Rundles (US)

10:00 - 10:05

Welcoming Remarks

10:05 - 10:30

8-4NH: Immunodeficiency Secondary to Anticytokine Autoantibodies | Steven Holland

10:30 - 10:55

8-5NH: HIV | John Sleasman (US)

10:55 - 11:20

8-6NH: Susceptibility to Infections | Elena Perez (US)

11:20 - 11:30

Discussion

Browse by Day

Sunday, 4 December 2011

08:00 - 16:30

08:00 - 16:00

08:00 - 11:30

12:30 - 14:00

13:00 - 16:30

Monday, 5 December 2011

07:00 - 08:15

08:30 - 10:00

10:45 - 12:15

10:45 - 11:45

12:15 - 14:15

12:45 - 14:15

15:00 - 16:30

15:00 - 16:00

16:30 - 17:30

Tuesday, 6 December 2011

07:00 - 08:15

08:30 - 10:00

10:45 - 12:15

10:45 - 11:45

12:15 - 14:15

12:45 - 14:15

15:00 - 16:30

15:00 - 16:00

Wednesday, 7 December 2011

07:00 - 08:15

08:30 - 10:00

10:45 - 12:15

10:45 - 11:45

12:15 - 14:15

12:45 - 14:15

15:00 - 16:30

15:00 - 16:00

Thursday, 8 December 2011

08:00 - 11:30